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This thesis explores factors that affect successful primary total hip replacement (THR) 
surgery. Future success in THR will likely occur through reducing the incidence of 
adverse events and need for revision surgery. Such improvements rely on precision 
in addressing patient, implant and surgical factors and are essential as the demands 
on THR are ever higher. The key topics of contention in contemporary THR concern 
stem fixation, bearing surfaces and infection. 
 
Stem fixation 
Patient age and activity influence the longevity of THR. This thesis will examine the 
evidence for femoral stem fixation, i.e. cemented or uncemented, according to patient 
age group and the influence of femoral stem offset on the survivorship of cemented 
stems. Furthermore, the reliability of short cemented stems will be examined. Patients 
requiring THR often have bilateral disease and the surgeon may offer single-
anaesthetic bilateral total hip replacements. This thesis investigates if this is safe when 
using cemented stems.    
 
Bearing surface factors 
This thesis will examine the New Zealand Joint Registry to determine the best 
performing bearing surface couple in THR. In addition, the evidence for the latest 
polyethylenes will be investigated. 
 
Preventing and diagnosing infection 
Prosthetic joint infection is a devastating complication of THR, its incidence is 
increasing and the success of diagnosis and treatment is time-critical. Prevention and 
early diagnosis are of paramount importance in improving THR outcomes. This thesis 
examines the evidence for the surgeon’ decisions regarding operating theatre 
environment factors such as the use of laminar flow and modern spacesuits. The 
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Total Hip Replacement and Pathology Indicating Its Use 
Total joint replacement is a surgical procedure whereby once nonoperative measures 
have failed a symptomatic, damaged joint is removed and replaced with prosthetic 
implants. The resulting prosthetic joint is designed to replicate the pain-free movement 
and function of a normal, healthy joint. Whilst Total Hip Replacement (THR) and Total 
Knee Replacement (TKR) are the most commonly performed joint replacements such 
surgery can also be performed on shoulder, elbow, ankle and wrist joints.  
 
Several pathological conditions can cause not only joint pain but also functional 
disability and impediments to the patient’s quality of life. In the majority of cases the 
pathology affects articular (hyaline) cartilage with other indications being less common 
(Dreinhöfer et al, 2006). Osteoarthritis (OA) is the commonest joint disease worldwide 
and affects 10% of males and 18% of females over the age of 60 (Woolf and Pflege 
2003). The socioeconomic burden of OA in developed countries costs between 1 and 
2.5% of the gross domestic product (Hiligsmann et al., 2013). Primary OA is the 
commonest indication for THR across all ages and the proportion of patients requiring 
THR for OA increases with age (New Zealand Joint Register 2018).  
 
Articular cartilage itself is a matrix consisting of collagen bundles intertwined with non-
collagenous proteins and negatively charged hydrophilic molecules. Collagen 
provides the tensile property of articular cartilage. Gel-like proteoglycan lies between 
the collagen fibrils thereby reinforcing the three-dimensional structure and protecting 
chondrocytes. The role of chondrocytes is to regulate the consistency of the extra-
cellular matrix consisting of 65-80% water, 10-20% type 2 collagen and complex 
proteoglycan molecules known as aggregan. Aggregan contributes to the swelling 
pressure necessary to resist compressive forces imposed on articular cartilage 





Figure Intro 1. Micrographic view of normal joint and articular cartilage (LEFT) and OA 
(RIGHT) with loss of articular cartilage, fibrosis and lymphocytic infiltrate (purchased 
stock image from shutterstock.com) 
 
OA is a process that alters and culminates in damage and subsequent loss of articular 
cartilage (Hammerman, 1989) (Figure Intro 1). This is demonstrable on radiographs 
as loss of joint space signifying the loss of articular cartilage with other features being 
bone remodelling, formation of osteophytes, formation of subchondral bone cysts and 
the production of secondary deformity (Watt and Dieppe, 1990) (Figure Intro 2). A 
diarthroidal joint requires an even distribution of load across it to maintain integrity for 
the resilience of subchondral bone which, in turn, supports articular cartilage. The 
proper bone alignment, stability, biomechanics and biology for the hip joint are 
therefore essential (Felson, 2004). Abnormalities of bone alignment occur for example 
from previous trauma; abnormalities of biomechanics are encountered with hip 
dysplasia (Hasegawa et al., 1992) and femoroacetabular impingement (Ganz et al., 
2003); pathological problems associated with subchondral bone (Shimizu et al., 1993) 
occur for example in disorders of bone turnover such as Paget’s disease, and 
abnormalities of associated soft tissues occur, for example, in ochronosis and crystal 
deposition diseases. Such processes may all predispose to secondary OA (Apley and 
Solomon’s System of Orthopaedics and Trauma 2017). Other pathology in order of 
frequency that indicates the need for THR comprises fractured neck of femur in high 
functioning patients (Figure Intro 3), inflammatory arthritis, avascular necrosis (AVN), 
the sequelae of paediatric hip conditions leading to secondary arthritis, tumour 
(primary or metastatic) and miscellaneous conditions such as pigmented villonodular 
synovitis (Vigorita, 2008).  
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Figure Intro 2. AP pelvic radiograph showing OA of LEFT hip with loss of joint space, 
osteophytes and a large supra-acetabular cyst (purchased stock image from 
shutterstock.com) 
 
The History and Evolution of the Modern THR 
THR involves the replacement of both the acetabulum and the femoral head. A metal 
stem is inserted into the femoral canal with a modular head and this then articulates 
with a prosthetic cup. THR has been described as “the operation of the 20th century” 
given its excellent clinical results, the predictably-high patient satisfaction and the 
improvement in the quality of life (Learmonth, Young and Rorabeck, 2007). THR today 
is not only clinically effective but it is also highly cost-effective (Garellick et al., 1998) . 
More than one million THRs are performed worldwide per year and according to 
National Joint Registry 796,636 THRs were performed between 2003 and 2015 
(National Joint Registry for England. Wales, Northern Ireland and the Isle of Man, 13th 
Annual Report, 2016) and in the United States of America more than 2 million people 
live with an implanted THR (Maradit Kremers et al, 2015). Demand for THR is growing 




Figure Intro 3. AP Pelvic radiograph showing a displaced intracapsular fracture of the 
RIGHT hip (purchased stock image from shutterstock.com) 
 
Origins of THR 
The earliest recorded attempts at THR occurred in Germany in 1891 with the use of 
ivory to replace femoral heads destroyed by tuberculosis presented by Professor 
Themistocles Gluck (Eynon-Lewis, Ferry and Pearse, 1992). Subsequently surgeons 
experimented with interpositional arthroplasty in the 19th and 20th Centuries using a 
range of tissues including fascia lata (Lexer, 1908) and pig’s bladder (Baer, 1909). 
Marius Smith-Petersen created a glass “mould arthroplasty” consisting of a hollow 
hemisphere that fitted over the femoral head and provided a new, smooth surface for 
articulation (Smith-Petersen, 1948). Whilst biocompatible and strong the brittle nature 
of this material lead to catastrophic failure from shattering. Wiles subsequently in 1938 
introduced a stainless steel THR fitted to bone with bolts and screws (Wiles, 1957). In 
1938 Judet developed his short-stemmed acrylic prosthesis (Judet and Judet, 1950) 
and then in 1939 Thompson (Thompson, 1952) and Moore introduced their monobloc 
femoral stems (Moore and Bohlman, 1983).  
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Other design evolutions emerged including the first metal-on-metal hip resurfacing by 
Haboush (1953). Mckee and Farrar (McKee and Watson, 1966) then introduced their 
cemented metal-on-metal THR but by the mid 1970s these and similar metal-on-metal 
designs such as the Ring prosthesis (Ring, 1971) were associated with high revision 
rates from aseptic loosening and osteolysis. Ceramic on ceramic articulations were 
first introduced in 1970 by Boutin (Boutin, et al., 1988) and this bearing surface 
combination is still favoured today by many Orthopaedic surgeons. Hip resurfacings 
continued to be developed with metal on polyethylene articulations such as by 
Freeman (Freeman and Bradley, 1983), Furuya (Furuya, Tsuchiya and Kawachi, 
1978), Wagner (Wagner and Wagner, 1996). and Amstutz implants (Amstutz et al., 
1981). Ultimately these designs displayed high rates of mechanical failure, fracture, 
wear, osteolysis and loosening.  
 
Introduction of the Modern THR 
In 1962, Sir John Charley pioneered and implanted the first “modern” cemented THR. 
Charnley’s “low friction arthroplasty” consisted of three parts: a metal femoral stem 
with a 22mm femoral head, an ultra-high molecular weight polyethylene (UHMWPE) 
acetabular component and acrylic bone cement (Charnley, 1979). The key advances 
with Charnley’s THR were firstly the concept of low frictional torque which was based 
on the finding that low friction depends mostly on the friction coefficient of the bearing 
surface materials rather than the hydrodynamic lubrication of intervening fluid.  
Secondly, Charnley adopted a new high molecular-weight polyethylene polymer which 
had long chains between 2 and 6 million atomic mass units. Thirdly, Charnley’s use of 
cement was revolutionary as he employed it as a grout rather than an adhesive 
between the components and bone.  
 
Charnley not only worked with the local engineering department at the University of 
Manchester Institute of Science and Technology and dental school regarding his 
materials and acrylic cement but also developed a clean, enclosed operating theatre 
environment to diminish the risk of prosthetic infection with Howarth Air Conditioning, 
another local resource experienced in building air filtration systems. Charnley 
appreciated that another source of contamination was through the surgeon’s gown 
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and therefore he also developed a full-body gown with a negative-pressure exhaust 
system.  
 
At the Annual Meeting of the British Orthopaedic Association, London 1964 GK McKee 
(Norwich) presented his initial work with the McKee-Farrar metal-on-metal prosthesis 
(McKee and Watson-Farrar, 1965). At the same meeting Sir John Charnley 
(Wrightington) showed one of his patients walking normally across the stage having 
undergone a metal-on-polyethylene Low Friction Arthroplasty under his care 
(Charnley, 1972). 
 
The results of THR displayed at this meeting were revolutionary compared to the 
experience of most surgeons with surgery for OA of the hip at the time namely upper 
femoral osteotomy, cup arthroplasty, Girdlestone’s pseudoarthrosis and arthrodesis. 
The THR operation could apparently offer pain relief, restore mobility and function and 
be coupled with a short hospital stay and benign convalescence. Interest in THR 
escalated and spread globally and also led to the introduction of similar procedures in 
other joints. Multidisciplinary collaboration of surgeons, engineers, tribologists, 
pathologists and chemists accelerated. The long-term survival of these implants was 
encouraging with <81% of Charnley THR not requiring revision THR at 25 years 
(Learmonth ID et al., 2007.) 
  
The evolution of THR occurred differently in different centres. In Exeter for example 
the McKee-Farrar prosthesis was introduced in 1969 and over 300 were implanted. 
Aseptic loosening and severe osteolysis were encountered which tempered 
enthusiasm for cemented THR. Many surgeons attributed this to the use of cement 
despite the excellent ongoing results from Wrightington. This suggested that it was the 
method of cementation rather than an inherent problem with the cement itself. 
Cementing technique evolved from “first generation” which did not involve washing or 
drying of the bone before unpressurised antegrade finger packing of cement with 
neither cement restrictor nor pressurisation. This technique was associated with 
cement lamination, the inclusion of blood clots and voids within the cement mantle and 
poor cancellous bone penetration of cement (Berry and Harmsen, 2002).  
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“Second generation” cementing technique with thorough cleaning and drying of 
cancellous bone, use of a cement gun and distal occlusion of the femoral canal 
increased the cement penetration of cancellous bone and thereby increased the 
mechanical interlock that provides shear strength at the cement-bone interface 
(Askew et al., 1984). Second generation cementing techniques reduced the incidence 
of femoral loosening (Barrack, Mulroy and Harris, 1992).  
 
“Third generation” or contemporary cementing techniques focus on improved 
pressurisation of cement at all times to improve cement-bone microinterlock. Such 
techniques include the use of a rubber seal around the cement gun nozzle. Pulsed 
lavage is used to clean endosteal bone. In addition, vacuum mixing of cement in a 
centrifugal manner reduces porosity (Wixson, 1992). Using centralisers improves the 
likelihood of obtaining a uniform cement mantle. (Breusch et al., 2001). 
 
The femoral stem component of THR should transmit torsional and axial load to the 
cement and bone without excessive stress or micromovement thereby allowing the 
stem to remain stable despite repetitive loading (Scheerlinck and Casetleyn, 2006). 
Two modes of achieving these goals were adopted: (i) the “force-closed” or “loaded-
taper” and (ii) the “shaped-closed” or “composite beam”. The loaded-taper model 
epitomised by the Exeter stem subsides and wedges into the cement during axial 
loading reducing peak stresses within the cement mantle (Stefansdottir et al., 2004). 
In the composite-beam model the stem is bound rigidly to the cement itself and the 
stems in this concept are not meant to subside (Alfaro-Adrian, Gill and Murray, 2001).  
The original loaded-taper design of the Exeter polished cemented stem was 
introduced in collaboration with the University of Exeter Department of Engineering in 
1960. Whilst the original Exeter cemented stem has evolved, the loaded-taper and 
polished stainless-steel stem concept has endured. This is the commonest femoral 
component implanted in New Zealand today (New Zealand Joint Registry 2018).  
 
During the 1970s and 1980s concerns over what was considered “cement disease” 
i.e. implant loosening occurring in association with cement fixation (Jones and 
Hungerford 1987) drove the parallel development of uncemented THR components 
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such the Engh (Engh, et al., 2001) and Zweymueller uncemented stems (Garcia-
Cimbrelo et al., 2003). Uncemented stems rely on bony in-growth or on-growth which 
is permitted by the creation of micro-fractures during femoral canal reaming. Such 
early designs were associated with mismatch of the elastic modulus of implant versus 
bone which affected the stress distribution under applied loads (Engh, Bobyn and 
Glassman, 1987). The greater the mismatch then the greater the propensity for 
proximal bone stress shielding as biomechanically the stems transferred load directly 
to the femoral diaphysis. Cementless cup fixation evolved from smooth surfaces which 
had high rates of loosening to various methods including coatings, screw-in designs 
and press-fit. The press-fit concept involves implanting a slightly oversized component 
into the prepared acetabulum with or without the addition of accessory screw fixation 
(Yamada et al., 2009). The evolution of manufacturing of polyethylenes and the 
introduction of highly crosslinked polyethylenes have subsequently reduced wear-
induced osteolysis and associated prosthetic loosening (Devane et al., 2017). The 
introduction of modular implants afforded greater surgical options and versatility. 
Current THR implants can use various femoral head sizes and have four main groups 
of bearing surface combination: metal-on-polyethylene, ceramic-on-polyethylene, 
ceramic-on-ceramic and metal-on-metal. Fixation techniques comprise fully 
cemented, fully uncemented, hybrid (when the femoral stem has been cemented and 
the cup uncemented) and reverse hybrid (cup cemented and stem uncemented). 
Whilst the concept “cement disease” has fallen from favour there is still little evidence 
that uncemented fixation is superior to cemented (Abdulkarim et al., 2013). 
 
Outcomes of Interest After THR 
It is imperative to use outcome measures to ascertain temporal changes and the 
results of THR not only to compare the patient value of the intervention but also to 
determine whether the incremental health benefits are worth the associated financial 
investment. Patient outcomes should be monitored closely and regularly to optimise 
surgical results. A plethora of outcome measures exist which can therefore make it 
difficult to not only apply evidence into clinical practise but also to compare the results 
from different studies (Clarke, 2007).  
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Outcome measures are artificial and an individual’s health and well-being not only 
fluctuates but is influenced by many factors other than their diagnosis or treatment 
(Paterson et al., 2009). The “outcome” of a THR can be assessed by the patient, 
surgeon, relative or spouse and therefore can vary depending on perspective. Adverse 
events such as mortality and prosthesis failure (Wylde and Blom, 2011), whilst very 
important, have been accompanied by clinician-administered tools such as Harris Hip 
Score (Harris, 1969) and patient-completed outcome scores (PROMs) such as the 
Oxford Hip Score (Dawson et al., 1996), Hip disability and osteoarthritis outcome 
score (HOOS) (Nilsdotter et al., 2003) and the Western Ontario and McMaster 
Universities osteoarthritis index score (WOMAC) (Bellamy et al., 1988).  Both clinician 
and patient reported scores are important given the dissonance between clinician and 
patient perspectives (Hewlett, 2003). PROMs allow patients to report their pain, 
function, health-related quality of life, mental health, satisfaction and social 
participation. Outcome measures may be generic or “joint-specific”. Routine collection 
of PROMs occurs before elective THR surgery in the UK (Department of Health, 2009) 
since the Darzi report (Darzi, 2008). There are many different outcome measures and 
such tools must be validated, appropriate, responsive to change and have high 
validity. 
 
Pain and Loss of Function 
The predominant symptoms experienced by patients prior to a THR are pain and loss 
of function. The characterization and context of the pain and the types of functional 
loss may vary. (Blom et al., 2016); Lenguerrand et al., 2016). Whilst pain is subjective, 
function can be assessed in a number of ways including PROMs, performance testing 
(Senden et al., 2009) and gait analysis (Ornetti et al., 2010). In the ADAPT study HHS 
correlated well with PROMs such as the WOMAC and walk time in patients with hip 
pathology (Lenguerrand et al., 2016). In this study pain levels were closely associated 
with patient function. Age was associated strongly with performance tests, most likely 
related to sarcopenia, but not PROMs. Patient gender was associated strongly with 
disability in patients undergoing THR. Patient anxiety and depression was associated 
strongly with PROMs and clinician-administered scores but not performance-based 
assessments. Therefore, when comparing functional assessments pain, age and 
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psychological status must be accounted for. This important study also suggested that 
patient function should be assessed with both PROM and performance tests.  
 
Societal Participation and Quality of Life 
Outcome measures can also reflect patient well-being, their ability to function in 
society and their quality of life (QoL). QoL can be regarded as a “utility” and patients’ 
QoL level can be assessed using generic patient-completed Health Related QoL 
questionnaires such as the EQ-5D, SF-12, SF-36 scores which can then be used to 
calculate Quality-Adjusted Life Years, a preferred outcome measure for cost-
effectiveness analysis (Williams and Kind, 1992).  1 QALY is a year in perfect health 
whilst 0 is deceased. In a recent study of 5,463 THRs performed for OA the mean 
QALY at baseline was 0.6 QALY and the mean increase two years following THR was 
0.25 QALY (SD 0.2) from baseline (Konopka et al., 2018). 
 
Longevity of Implant 
The risk of first revision surgery after THR for any reason, so-called “all-cause revision 
rate”, is highly relevant as this is what is experienced by the individual patient and any 
patient who has a THR is at risk of revision surgery. In an immortal cohort all THR 
would ultimately fail. In a recent study of 13,212 THRs the 25-year pooled survival for 
THR from National joint registries was 57.9% (95%CI 57.1 to 58.7) and from case 
series this was 77.6% (95%CI 76 to 79.2) (Evans et al., 2019). Further analysis of 
revision rates can be indication-specific e.g. aseptic loosening/wear or periprosthetic 
fracture. Revision rates may then be further quantified by relevant patient, implant or 
surgical factors to create hazards ratios comparing outcomes between groups. The 
increased risk of complications after THR is 40% for every decade above the age of 
65 (Bayliss et al., 2017). In this study the lifetime risk of revision surgery was 5% in 
patients over the age of 70 with no difference between sexes. Conversely if THR was 
performed under 70 years of age the lifetime risk of revision increased and was 35% 
(95%CI 30.9 to 39.1) in men in their early 50s and the risk was 15% less for women 
of the same age.   
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Excess Mortality After THR 
THR is associated with a short-term increase in mortality rate. Quantification of this 
risk and identification of modifiable factors allows risk-management strategies to 
reduce mortality. Quantification of mortality risk facilitates informed consent and aids 
shared decision making with patients making prior to surgery. The 90-day mortality 
after THR for OA has been reported at <1% (Hunt et al., 2013). This study also 
performed cumulative hazard estimates that showed that the mortality risk after THR 
plateaus at approximately 90 days following surgery which indicates that the mortality 
rate has likely returned to baseline risk at this stage. In modern series cardiovascular 
disease is the leading cause of death rather than pulmonary embolism (Berstock et 
al., 2014). In this systematic review of 32 studies comprising 1,139,330 patients the 
pooled incidence of mortality within 30-days was 0.3% (95%CI 0.22 to 0.38) and 90-
days was 0.65% (95% CI 0.5 to 0.81). This study provided a benchmark to identify 
excess mortality rates. There was a strong trend for diminishing mortality rates despite 
increasingly comorbid patients. Early mortality was associated with the non-modifiable 
factors of increasing age and male gender. Modifiable risk factors for mortality after 
THR were patient comorbidity indices including ASA grade >3, Charlson comorbidity 
index >3 and prior cardiovascular disease. Cardiovascular disease has been shown 
to increase the risk of mortality after THR by an Odds Ratio 8.8 (95%CI 1.78 to 43.6) 
(Comba et al., 2012).  
 
Current Modes of Failure in THR 
Substantial demands are placed on modern THR implants as patients expect to 
remain active for longer. Furthermore, the global population is ageing, and patients 
have associated increased numbers of comorbidities and associated treatments which 
adds complexity to the overall operative situation. In New Zealand, as in many other 
countries, the ageing population and projected incidence of debilitating OA has seen 
the rate of THR increase to 363/100,000 in 2014, with projections of increasing to 
around 600/100,000 by 2026 (Hooper, 2016).   
 
Current modes of failure of primary THR are multifactorial. Understanding why THRs 
fail is of great importance to surgeons given the high and increasing demand for this 
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procedure, the healthcare funding costs and the potential to reduce the risk of revision 
rates (Liu et al., 2016).  Improved insight into why a primary THR fails, when it fails, 
and what the relevant risk factors are, advantageous. This allows an Orthopaedic 
surgeon to address modifiable risk factors or mitigate against the risk of a certain 
complication or mode of failure. The overall rate of revision THR, both early and late, 
is increasing and the common modes of failure are wear, loosening, dislocation, 
instability and infection.  All of these may cause the patient severe pain and disability 
(Kurtz et al., 2007). In 2017 of 8,589 revision THR procedures reported in the National 
Joint Registry of England, Wales and Northern Ireland and the Isle of Man 44% were 
for aseptic loosening, 16% for instability, 15% for periprosthetic fracture, 16% for 
infection. (National Joint Registry for England, Wales, Northern Ireland and the Isle of 
Man, 15th Annual Report 2018). 
 
Patient factors that affect the risk of revision THR include age at surgery, underlying 
diagnosis, Body Mass Index (BMI) and comorbidities. Implant factors include design, 
modularity, bearing surfaces and fixation; surgical factors include the choice of 
surgical approach, number of operations performed i.e. surgical experience and 
theatre environmental factors that mitigate against the risk of the infection. The 
common current modes of failure are outlined briefly below.  
 
(i) Wear, aseptic loosening and problems associated with bearing surface 
articulations 
Particulate debris formation from various types of wear has been the principle 
underlying cause of osteolysis around THR. Wear debris from adhesive wear of THR 
bearing surfaces is the principal factor limiting long-term THR survival. Other types of 
wear include abrasive wear (i.e. the prosthesis scraping off wear particles), third body 
wear (i.e. particles within the articulation cause abrasion), linear wear (i.e. the femoral 
head penetrates into the liner of the articulating surface) and volumetric wear (which 
is affected by femoral head size and is the main determinant of the number of wear 
particles) (Bennett et al., 2002). Increasing the femoral head size increases volumetric 
wear.  A metal or ceramic femoral head combined with a UHMWPE cup have been 
used in the majority of recorded THR. Wear leads to particulate debris formation which 
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then triggers a cellular response. These particles are taken up by macrophages which 
then release osteolytic factors including TNF-alpha, osteoclast activating factor, 
hydrogen peroxide, acid phosphatase, interleukin 1 and 6 and prostaglandins. Further 
macrophages are recruited. Osteolytic factors activate osteoclasts which then 
differentiate. Osteoclasts increase RANK and RANKL gene transcripts and cause 
osteolysis and aseptic implant loosening (Jacobs et al., 2001; Harris, 1995; Broomfield 
et al., 2017).  
 
UHMWPE is associated with osteolysis and implant loosening (Dumbleton, Manley 
and Edidin, 2002). To reduce wear-related failures PE was modified to Highly 
Crosslinked PE (HXLPE).  Cross-linking increases the mechanical wear-resistance of 
the UHMWPE (Muratoglu et al., 1999; Muratoglu et al., 2001) yet the process of 
achieving this such as with gamma-irradiation produces free-radicals. The free-
radicals potentiate oxidation and make PE more brittle and more likely to undergo 
wear. Annealing, remelting and the addition of antioxidants have been used to diminish 
the amount of residual free radicals in HXLPE (Zagra and Gallazzi, 2018). Prospective 
randomised controlled trials have shown that HXLPE use reduced both wear (Devane 
et al., 2017; Digas et al., 2004) and revision rates (Devane et al., 2017) compared to 
UHMWPE.  The study by Devane et al. showed that HXLPE had higher rates of initial 
creep than UHMWPE. Patient-related risk factors for aseptic loosening in THR are 
young age at index surgery and male gender (Bayliss, 2017; Cherian et al., 2015; 
Munger, 2006) and BMI (Munger et al., 2006). 
 
Hard-on-hard bearing surfaces were introduced to improve biomechanics and reduce 
wear rates. Ceramic-on-ceramic (CoC) articulations, at the expense of squeaking and 
requiring precise positioning to avoid edge-loading and breakage have achieved 
excellent long-term survivorship (Varnum, 2017). In a recent study of the National Joint 
Registry using multivariable flexible parametric survival models CoC articulations with 
larger femoral heads were associated with improved survival and a 5-year revision 
rate of 3.3% (95%CI 2.6 to 4.1) with 28mm and 2.0% (95% CI 1.5 to 2.7) with 40mm 
diameter heads for men aged 60 (Smith et al., 2012).  
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Metal-on-metal (MoM) articulations were reintroduced given optimism in advances in 
both metallurgy and tribology in the early 2000s (Zywiel et al., 2011). MoM have been 
used in firstly, hip resurfacings in which the acetabulum is replaced by a metal cup 
and the femoral head is rounded and a metal cap placed upon it, and secondly, in 
combination with a stemmed THR. The popularity of metal-on-metal resurfacings has 
diminished tenfold in a decade and was <1% in England and Wales in 2015 given the 
significant problems of early failures and metal ion release specifically Cobalt and 
Chromium. Metal ions can cause not only systemic toxicity but also affect local soft-
tissue (Davies et al., 2005) and cause pseudotumours (Mahendra et al., 2009; Pandit 
et al., 2008) with bone loss, osteolysis and implant failure (Langton et al., 2011; 
Henegan, Langton and Thompson, 2012). The Depuy ASR metal-on-metal hip 
resurfacing and THR were recalled in 2010 (Cohen, 2011) by the Medicines and 
Healthcare products Regulatory Agency (MHRA) in the UK and all metal-on-metal 
implants are recommended to be monitored closely along with screening of blood ion 
level (Medicines and Healthcare products regulatory agency, 2017; Gunther et al., 
2013). When MoM was used in combination with conventional THR stems these 
issues were particularly problematic (Reito et al., 2017). In a study of the National Joint 
Registry of England and Wales, Smith et al. (2012) showed high failure rates for MoM 
THR and larger heads failed earlier: 6.1% (95%CI 5.2 to 7.2) for 46mm heads 
compared with 1.6% (95%CI 1.3 to 2.1) for 28mm MoP (Smith et al., 2012).   
 
For MoM resurfacings the revision rate is >8 additional revisions in 100 cases by 10 
years compared to contemporary THR alternatives (Hunt et al., 2018). In the study by 
Smith et al., 2012 multivariable flexible parametric survival models were used to 
estimate covariate-adjusted cumulative incidences of revision adjusting for the 
competing risk of mortality. In women, resurfacings had worse survivorship than 
conventional THR irrespective of femoral head size:  in 55-year old women the 
predicted 5-year revision rate was 8.3% (95%CI 7.2 to 9.7) with a 42mm head 
resurfacing, 6.1% (95%CI 5.3 to 7.0) with a 46mm head and 1.5% (95%CI 0.8 to 2.6) 
for a 28mm metal-on-polyethylene cemented stemmed THR. In 55-year old men a 
46mm resurfacing head had a 5-year survival rate of 4.1% (3.3 to 4.9), 2.6% (95%CI 
2.2 to 3.1) with a 54mm resurfacing head and 1.9% (95%Ci 1.5 to 2.4) with a 28mm 
cemented metal-on-polyethylene stemmed THR (Smith et al., 2012). The risk of MoM 
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failure is significantly higher than a conventional THR with no apparent benefit in terms 
of early revision rates, function, activity or pain relief (Costa et al., 2012) and purported 
benefits in lower mortality rates has been shown to be purely a function of healthy 
patient selection (Hunt et al., 2018). This thesis will examine the New Zealand Joint 
Registry to determine the most reliable bearing surface for a particular patient in terms 
of all-cause revision rate and aseptic loosening. 
 
(ii) Instability 
The incidence of postoperative dislocation in the USA after primary THR has been 
reported at 3.2% after a posterior approach, 2.2% after anterolateral approach and 
1.27% after a transtrochanteric approach (Masonis and Bourne, 2002). In the UK there 
are similar results at 4.1% for the posterior approach and 3.4% for the anterolateral 
approach (Blom et al., 2008). In this study, with follow up for 8 to 11 years after surgery, 
58.5% of dislocations were recurrent and the mean number of dislocations per patient 
was 2.81.  Most dislocations occur within 2 months of surgery (Blom et al., 2008, 
Ullmark, 2017; Kunutsor et al., 2019). Dislocation following THR may be under-
reported in National joint registries as the majority of dislocation events are managed 
with closed reduction and do not require revision THR (Devane, et al., 2012). In a 
recent systematic review and meta-analysis Kunutsor et al. synthesised data on 
4,633,935 primary THR and 35,264 dislocations from 149 articles. The overall pooled 
incidence of instability was 2.1% (95%CI 1.83 to 2.38%) with a mean follow-up of 6 
years. Dislocation rates have decreased between 1971 and 2015 (Kunutsor et al., 
2019). The cost of dislocation is significant as the problem is often recurrent resulting 
in multiple hospital admissions. In the study by Sanchez-Sotelo, Haidukewych and 
Boberg, 2006, the hospital cost of each closed reduction was 19% of an uncomplicated 
THR. When a revision was performed for recurrent instability the cost was 148% of an 
uncomplicated THR (Sanchez-Sotelo, Haidukewych and Boberg, 2006).  
  
The true incidence of postoperative instability varies depending on patient, implant 
and surgical factors (Bozic et al., 2009). Patient risk factors for instability are age >70 
(RR 1.27; 95%CI 1.02 to 1.57) compared to patient age <70 but not female gender 
(RR 0.97; 95%CI 1.02 to 1.57), drug use disorder, social deprivation, BMI >30 kg/m2 
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(RR 1.38; 95%CI 1.03 to 1.85) compared to patients with BMI<30 kg/m2, neurological 
disorders, psychiatric disease, comorbidity indices, previous surgery including spinal 
fusion (Wyatt et al., 2020), underlying diagnoses of AVN, rheumatoid and other 
inflammatory arthritis (Kunutsor et al., 2019). Implant-related factors that decrease the 
ratio between the femoral head relative to the femoral neck increase the risk of 
instability. A larger femoral head increases the head-to-neck ratio, jump distance and 
functional range of motion without impingement and thereby increases construct 
stability (Girard, 2015).  The use of lipped liners, dual-mobility implants and standard 
femoral neck lengths also reduce the incidence of instability (Kunutsor et al., 2019, 
Wyatt et al., 2020). Using a femoral head ³36mm in diameter though, significantly 
increases the risk of corrosion at the head-neck junction - a process known as 
“trunnionosis” (Berstock et al., 2018). Surgical factors affecting instability include 
implant malpositioning, failure to recreate the requisite hip biomechanics such as 
femoral offset, leg-length or the use of a particular surgical approach (Ullmark, 2016). 
Surgical approaches that reduce the risk of dislocation are the direct anterior, lateral 
and the posterior approach if the capsule is repaired (Karachalios et al., 2018; 
Kunutsor et al., 2019). Surgeon experience and volume also significantly reduce the 
risk of dislocation (Kunutsor et al., 2019). Late instability is a function of not only the 
causes of early instability but also include polyethylene wear and subsequent trauma, 
neuromuscular dysfunction and subsequent spinal fusion procedures (Pulido et al., 
2007; Stefl et al., 2017).  
 
In recent years there has been research interest in examining the relationship of the 
pelvic tilt and resultant acetabular anteversion and its relationship to spinopelvic 
dynamics (Phan, Bederman and Schwarzkopf, 2015). Some surgeons advocate the 
use of preoperative sitting and standing radiographs to assess the functional 
acetabular anteversion as a means of planning precise implant positioning thereby 
reducing the risk of instability and wear (DiGioia, Hafez and Jaramaz, 2006; 
Pierrepont, et al., 2017). However, this practice has not yet been demonstrated to 
improve patient function, prevent instability or reduce wear rates in prospective clinical 
studies. This thesis will examine which bearing surface combination is most reliable at 
minimising all-cause revision rates for a patient, and specifically revision for instability.  
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(iii) Periprosthetic fractures 
The incidence of periprosthetic fractures in THR in a recent systematic review and 
meta-analysis was 0.1% for men and 0.2% for women, odds ratio 0.82 (95%CI 0.52 
to 1.27) (Deng, et al., 2019). Periprosthetic fractures may occur either intraoperatively 
(incidence 0.1 to 27.8%) or following trauma at some duration after THR (incidence 
0.07 to 18%) (Sidler-Maier and Waddell, 2015). Such fractures are associated with 
disappointing clinical outcomes including high associated mortality rates (Miettinen et 
al., 2016; Sidler-Maier and Waddell, 2015). Risk factors for intraoperative fractures 
include osteoporosis, rheumatoid arthritis, surgical technique and the use of press-fit 
cementless implants (Sidler-Maier and Waddell, 2015). Postoperative fractures are 
more common in elderly females, patients with rheumatoid arthritis, osteoporosis, 
aseptic loosening, osteolysis and prior hip surgery (Karachalios et al., 2018). This 
thesis will examine the New Zealand Joint Registry comparing patient, implant and 
surgical factors in both cemented and uncemented stems. 
 
(iv) Infection 
In the 1970s there was a high rate of potentially lethal septic complications (Fitzgerald, 
1992). Advances in surgical technique, the use of antibiotic prophylaxis and modern 
operating theatre environments mean that infection is <1% following primary THR 
(Blom et al., 2003; Lindgren et al., 2014; Springer et al., 2017). The annual volume of 
revision THR performed for Periprosthetic Joint Infection (PJI) however increased 2.6-
fold between 2005 and 2013 and although the overall risk is low this increase coupled 
with the predicted increase in demand for THR represents a growing healthcare 
burden (Lenguerrand et al., 2017; Bozic et al., 2009). PJI has a profoundly negative 
impact on patients physically, emotionally, socially and economically (Kunutsor et al., 
2017). PJI also has profoundly negative effects on the surgeon themselves (Mallon et 
al., 2018). PJI causes a significant increase in not only the hospital length of stay and 
cost, estimated to amount to up to 8 million dollars in New Zealand per year, (Gow et 
al., 2016).  
 
The evolution of antibiotic-resistant biofilms forming on the implant surface, more 
complex patient comorbidities, increased BMI, diabetes or indeed the 
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immunosuppressive effect of drugs used to treat chronic conditions contribute to the 
concerning trend of increasing PJI (Kurtz et al., 2008). In a systematic review Kunutsor 
et al., 2016 showed that increased BMI, diabetes, rheumatoid arthritis, depression, 
steroid use and previous surgery were all associated with an increased risk of PJI 
(Kunutsor et al., 2016). To compliment this study factors shown to be associated with 
PJI from a recent study of the National Joint Registry for England and Wales included 
younger age, male gender, elevated BMI, diabetes, previous infection, fractured neck 
of femur, not using antibiotics in the cement of cemented THR and use of the lateral 
surgical approach (Lenguerrand et al., 2018).  This thesis will examine the impact of 
modern theatre environments on revision THR for deep infection and examine modern 
methods for early diagnosis and future prevention of this devastating complication. 
 
Major Current Issues in Primary THR 
Despite good results, many variations have been introduced during in THR with the 
stated aims of further improving patient outcomes. Firstly, the indications for THR have 
become broader and with this the optimal method of stem fixation remains disputed. 
Secondly, the techniques and devices have evolved as have the approaches, tissue 
preservation philosophy and tribological advances to diminish wear, osteolysis and 
subsequent loosening and need for revision surgery. Thirdly, the processes 
surrounding the patient journey have improved with renewed focus on perioperative 
management of patient expectations and goals, scaled digital templating, minimising 
blood loss, improved analgesia with minimal opiate use and postoperative protocols 
permitting Enhanced Recovery After Surgery (ERAS). Some variations are market 
driven and it is crucial to differentiate between “innovations that will improve patient 
outcomes” and “innovations that will improve market share and commercial profit”. 
Lastly, as the burden of periprosthetic joint infection increases, strategies to prevent 
and detect this terrible complication attract renewed attention. 
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Avoiding Complications and Poor Outcomes 
Strict indications must be followed as younger age is associated with a higher risk of 
revision during the patient’s lifetime (Bayliss et al., 2017). Patients after THR have 
diminished long-term PROMs, perform less well than the general population, but are 
much improved compared to those with untreated OA (Nilsdotter et al., 2003). The 
level of surgical satisfaction is high with 7% overall dissatisfaction reported after THR 
(Bourne et al., 2010). Adequate informed consent and managing patient expectation 
are important (Palazzo et al., 2014). Postoperative functional scores, pain relief, and 
restoration of function are factors associated with a good outcome whilst a major 
complication is not a predictor of dissatisfaction. The proportion of patients with long-
term pain according to a systematic review of prospective studies was 7-23% following 
a THR (Beswick et al., 2012). 
 
Choice of Surgical Approach to the Hip 
The aim of any surgical approach to the hip is to provide safe, minimally traumatic and 
blood conserving access. An excellent, direct surgical view of the anatomical 
landmarks for implant positioning allow accurate referral to the preoperative template. 
The approach should be suitable for different types of implants whatever the fixation 
type. The approach should be extensile to address a complex situation or 
complication. The surgeon must avoid excessive force in retraction to protect 
surrounding soft tissues and also prevent intraoperative tilting of the pelvis which might 
compromise implant positioning. The rate of complications must be acceptable in 
association with the supposed advantages.  
 
The posterior or “Southern” approach was popularised by Moore (Moore, 1957).  The 
posterior approach divides the fibres of gluteus maximus to expose the short external 
rotators. The sciatic nerve is identified and protected, and the short external rotators 
and capsule are released from the posterior part of the proximal femur (Figure Intro 




Figure Intro 4. Anatomical representation of the LEFT hip showing the gluteus medius 
and short external rotators inserting onto the proximal femur (purchased stock image 
from shutterstock.com) 
 
The anterolateral approach exploits the internervous plane between tensor fascia lata 
and gluteus medius and this was first described by Watson-Jones (1936). It was 
subsequently modified by Charnley (1979), Harris (1967) and then Muller (1974) and 
involves at least partial detachment of the abductor mechanism.  
 
Lateral approaches are subdivided into direct lateral and transtrochanteric techniques 
and both detach the entire abductor mechanism during the approach (Onyemaechi et 
al., 2014). The rationale for this approach is that the gluteus medius and vastus 
lateralis are in functional continuity through the periosteum covering the greater 
trochanter (McFarland and Osborne, 1954). Hardinge modified this approach 
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subsequently to the transgluteal approach by incising the tendon of gluteus medius 
obliquely across the greater trochanter and leaving the posterior portion attached 
(Hardinge, 1982). 
 
Berstock et al. compared the posterior approach with the lateral approach in a 
systematic review and meta-analysis. Compared to the lateral approach the posterior 
approach was less likely to have femoral stem malposition (Odds Ratio 0.24; p=0.02) 
and was less likely to have a Trendelenburg gait (Odds Ratio 0.31; p=0.0002) 
(Berstock et al., 2015). In another systematic review and meta-analysis a mini-
posterior approach was superior to a standard posterior approach with less blood loss, 
shorter in-patient stay and better functional scores without compromising implant 
positioning, stability or thromboembolic risk (Berstock et al., 2014).  
 
“New” surgical approaches such as the Direct Anterior Approach (DAA), have been 
promoted on the basis of a claimed reduction in THR instability and faster 
rehabilitation. Spaans et al. analysed their first 46 consecutive minimally invasive 
(MIS) anterior approaches matched versus 46 posterolateral approach THR. They 
reported: longer duration of surgery, greater blood loss, four intraoperative 
conversions to the posterior approach, more complications and the same length of 
stay in hospital with no functional difference (Spaans, van den Hout and Bolder, 2012). 
Higgins et al., in a systematic review and meta-analysis concluded that “current 
evidence comparing outcomes following anterior versus posterior THA does not 
demonstrate clear superiority of either approach. Until more rigorous, randomised 
evidence is available, it is recommended to choose a surgical approach based on 
patient characteristics, surgeon experience and surgeon and patient preference” 
(Higgins et al., 2015). Another systematic review and meta-analysis compared DAA 
with posterior approach showed early postoperative functional scores favoured DAA 
yet there was no difference at 1 year after surgery (Wang et al., 2018). Recently, 
Aggarwal et al. reported increased infection rates with the DAA compared to other 
surgical approaches in THR (Aggarwal et al., 2019). Less invasive posterior 
approaches such as the Spare Piriformis And Internus, Repair Externus (SPAIRE) 
approach may offer advanatges (Hanly, Sokolowski and Timperley, 2017). 
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 New Technologies 
Computer navigation and robotic surgery are currently expensive. There is some 
evidence that demonstrates greater precision of the acetabular cup placement (Domb 
et al., 2014) and improved functional outcomes compared to traditional methods 
(Bukowski et al., 2016).  THR navigation does not improve mid-term functional 
outcome (Banchetti et al., 2018), bony ingrowth nor polyethylene wear. Randomised 
controlled studies with long-term follow-up are needed to ascertain whether navigation 
is cost-effective and of long-term clinical benefit to patients.  
 
Methods Used in This Thesis and context 
This thesis has made use of my particular access to data from the New Zealand Joint 
Registry (NZJR) for a number of studies as well as the Exeter Hip team database 
whilst a Ling Fellow in 2015. My affiliation with University of Bristol permitted excellent 
tuition and mentorship in formal systematic review and meta-analysis of high-quality 
studies. The use of a variety of sources and research methods permits triangulation 
of and substantiates research findings. This permits the broad application and 
generalisability of evidence to guide the delivery of healthcare. A brief discussion of 
the research methods and evidence follows.  
 
Consent 
The NZJR was established in 1998 and has a >96% data capture rate of all joint 
replacement surgeries. Prospective entry of data into the NZJR is a mandatory 
requirement of all members of the New Zealand Orthopaedic Association with all data 
secured in Christchurch, New Zealand. Patients consent to information concerning 
their joint replacements being recorded in the NZJR prospectively. Similarly, the 
Exeter Hip database records information concerning their joint replacements after 
prospectively obtained informed consent. The systematic reviews and meta-analyses 
performed in this thesis were done so with prospective registration with PROSPERO 




Systematic Review  
This is a review conducted by a systematically applied process performed to minimise 
the risk of bias and random errors. The review has clear, explicit objectives and aims. 
A systematic review is carried out with the same scientific rigour as the RCT. Biases 
are considered and the quality of the evidence assessed objectively to understand 
their effect, magnitude and direction. The steps involved in a systematic review are (i) 
formulation of the question using the Patients, Intervention, Comparator and 
Outcomes (PICO) method (Chalmers and Altman, 1995), (ii) development of a 
protocol that defines both inclusion and exclusion criteria, outcomes of interest and 
publication of this protocol before the review commences for example with 
PROSPERO, (iii) perform the literature search (iv) application of  the eligibility criteria 
(v) extraction of the data using standardised proforma (vi) assessment of the risk of 
bias (vii) synthesis. A systematic review may permit a meta-analysis to provide a single 
estimate of the treatment effect. Statistically meta-analysis can be performed using 
either a fixed-effects or random-effects model. A fixed-effects model assumes that all 
of the studies included are measuring the same treatment effect and this approach is 
advantageous when there is low heterogeneity between studies. A random-effects 
model assumes that the treatment effect varies between studies and is in fact normally 
distributed. The random-effects method accounts better for heterogeneity (Berstock 
and Whitehouse, 2019).  
 
Registry Cohort Study 
National joint registry data improve awareness and allow surgeons to make more 
informed choices and improve outcomes. The purported advantage of introducing a 
new prosthesis must be carefully scrutinised. A systematic review of Randomised 
Controlled Trial’s (RCT’s), comparative observational studies and registry data on new 
orthopaedic devices stated that “new technologies are being introduced to the 
commercial market without sufficiently high-quality evidence for improved benefit over 
existing, well proven, and safe alternatives. Moreover, the existing devices may be 
safer to use in total hip and knee replacement” (Nieuwenhuijse et al., 2014).  
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National joint registries provide simultaneous comparison of multiple treatments and 
include the effects of multiple factors that affect THR outcomes. Registry data however 
cannot infer causality but rather the strength of associations. The hierarchy of levels 
of clinical evidence is based on the ability of a study design to determine causality 
from data with respect to outcome and support a hypothesis. Registry studies in this 
hierarchy are therefore classified as observational studies and as such are considered 
to be less valuable that RCTs or systematic reviews. Unlike National Joint Registries 
however RCTs require adequate statistical power and they also have a defined 
endpoint. The focus of a registry is ongoing quality assurance and not determining 
causality. They have a different purpose than RCTs and therefore data collection and 
analysis are different from RCTs. When registry data analysis shows a difference, 
factors associated with that difference are identified. This information can guide 
surgeons in their choice of treatment options, and this can improve outcomes.  This is 
without determining the specific question of causality which can subsequently be 
examined by other scientific means such as an RCT. RCTs require high internal 
validity yet this limits the wider applicability. In contrast a study of Registry data is likely 
to have high external validity (Graves, 2010). Registries can also, given the large 
number of patient data recorded within, determine rates of clinically rare events such 
as early mortality and revision following primary THR, both relatively rare but important 
events. When studying single-anaesthetic bilateral THR (SABTHR) in a RCT for 
example, if we assumed a 90-day mortality of 0.7% one would need 1,346 patients 
with SABTHR along with 13,460 controls to detect an increase in 90-day mortality by 
a factor of 2 (alpha=0.05; power=80%) (Wyatt et al., 2018). From a purely scientific 
perspective therefore prospective randomised controlled trials (RCTs) are the best 
way to investigate causation of revision rates and patient-reported outcome measures 
in performing THR. However, this is often not feasible from a logistical or financial 
standpoint (Sayers et al., 2017). Therefore, RCTs and registries provide different 
information and as such are complimentary.  
 
A number of registry studies in this thesis use survival analysis using not only Kaplan-
Meier but also Cox regression (Cox proportional hazards regression). This permits the 
investigation of multiple covariates upon the time a specific event such as revision 
THR takes to occur. This type of survival analysis assumes that the effects of predictor 
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variables upon survival remain constant over time which is reasonable for say gender, 
ASA grade at surgery, BMI and diagnosis/indication for THR. Some covariates are 
time-dependent and can be considered in Cox proportional regression hazards 








Rationale for this thesis 
 
The introduction therefore highlights three key areas of research focus regarding 
decision making in primary THR namely (i) the optimum femoral stem fixation, (ii) the 
optimal bearing surface combination and (iii) strategies for reducing the risk of 
periprosthetic joint infection. At the synthesis level this thesis aims to provide an 
evidence base and synthesis for the author’s clinical practice in hip replacement 
surgery. In the following rationale I will describe why and how I embarked on this 
research and how the research story unfolded. 
 
Section 1 Stem fixation 
 
Background to Chapter 1 
Firstly, it was apparent during my Higher Orthopaedic training that Consultant 
Orthopaedic Surgeons made choices of THR fixation based on their personal 
preference, i.e. a function of their experience, training, familiarity and local tradition. I 
do not believe that these factors, though relevant, were sufficient to justify fixation 
choices in THR. I wished therefore to determine the evidence-based optimal type of 
fixation for femoral stems in primary THR for a particular patient. At this stage of 
my career I had the opportunity to learn both uncemented and cemented techniques 
in centres of excellence and therefore wished to elucidate for my own practice an 
evidence-based approach for a particular individual patient.  
 
In the wider context uncemented fixation has historically been preferred in North 
America and cemented stem fixation in Europe especially in the UK (Dunbar 2009, 
Murray 2011). Centres of excellence in the USA have published 98% 20-year Kaplan-
Meier femoral stem survivorship with extensively porous-coated cylindrical stems for 
example (Belmont et al., 2008). In addition, metaphyseal porous uncemented or 
hydroxyapatite-coated uncemented stem series have been reported with 
approximately 99% survivorship at 20 years (Lombardi et al., 2009; McLaughlin and 
Lee 2010; Vidalain 2011). The use of uncemented stem fixation globally is also 
 54 
increasing despite national registries reporting superior survivorship with cemented 
stems especially in older patients (Troelsen et al., 2013). Excellent results with 
cemented stems such as the Exeter have also been reported in young patients by 
specialist centres (Lewthwaite et al., 2008).  
 
Potentially there is therefore a danger that fashion and market forces would mean that 
cemented techniques would be forgotten at the detriment of patient care. I wished to 
determine an evidence-based decision-making reationale for stem-fixation. 
Furthermore, the question of which stem fixation type is optimum for the New Zealand 
patient population remains unanswered. To address these important questions it is 
logical to examine the large-volume datasets of the National Joint Registries. 
Therefore I addressed these issues in chapter one. 
 
Chapter 1 research question: Which type of femoral stem fixation should be adopted 
and is one type of stem more appropriate in a particular age of patient?  
 
The first chapter of this thesis examines the issue of THR failure related to the type of 
femoral stem fixation in the New Zealand Joint Registry. The primary question is which 
type of femoral stem fixation should be adopted and is there a pattern for example is 
one type of stem more appropriate in a particular age of patient. The findings will be 
interpreted in the context of other National Joint Registry findings. 
 
Background to Chapter 2 
Establishing the correct biomechanics for a THR is recognised as crucial to not only 
obtain a stable construct but also to promote its longevity and minimise the risk of 
failure from aseptic loosening secondary to wear (Charnley 1979). Femoral offset is 
defined as the distance between the centre of the femoral head and the central femoral 




Offset affects clinical outcomes of THR and affects wear; an increased femoral offset 
may potentiate the function of the abductor muscles and in theory this is associated 
with reducing wear (McGory BJ et al., 1995; Sakalkale DP et al., 2001). However the 
effect of femoral offset on THR survivorshipor reasons for revision has not been 
examined at a national registry level. Moreover the effect of femoral component offset 
on these outcomes of interest have not been examined with regards to different types 
of fixation. Therefore I addressed these questions in chapter two: 
 
Chapter 2 research question: In patients undergoing primary THR does femoral 
offset affect the revision rates of cemented compared to uncemented stem 
prostheses? 
The second chapter explores the biomechanical concept of femoral offset and whether 
this factor affects the all-cause and cause-specific revision rates of primary cemented 
compared to uncemented stems. The NZJR is examined to compare diminished, 
normal and increased offset groups in both cemented and uncemented stems.  
 
Background to Chapter 3 
Short stems in THR have gained recent popularity and potentially permit less-invasive 
surgical exposures yet there are no long-term results published. In theory such stems 
potentiate bone-stock for the future revision scenario and minimise proximal stress-
shielding and therefore are potentially “bone-preserving” compared to standard length 
femoral stems. In addition, short stems may promote more physiological loading of 
femoral bone and reduce the incidence of thigh pain. This rationale makes the use of 
these stems in the younger patient attractive. Short stems vary in their design and how 
they transfer load to the proximal femur and have been classified (Falez, Casella and 
Papaliaet, 2015). The majority of short stems are uncemented designs and in a recent 
systematic review short uncemented stems showed similar clinical and radiological 
outcomes compared with conventional length implants at the mid-term (Lidder, 
Epstein and Scott, 2019). In a recent registry study both short and conventional length 
uncemented stems had >90% survival at 15 years which is an excellent result 
compared to standard length stems (Giardina et al., 2018).   
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There is a relative paucity of published results regarding cemented short stems 
however. This is of great relevance as short cemented stems should in theory convey 
the same advantages as short uncemented stems in terms of bone preservation. Choy 
et al. 2013 reported on the medium-term results of the Exeter short stems in the 
Australian Joint Registry. Since then the Exeter cemented stem, which was identified 
in previous chapters to have excellent clinical outcomes, was modified in 2011 to 
include short stems with more available offsets,  The outcomes of such Exeter short 
stems are unreported in the NZJR. The purpose of the next chapter was to examine 
the NZJR outcomes of short Exeter cemented stems: 
 
Chapter 3 research question: In patients undergoing primary THR does a shorter 
length of cemented stem affect outcomes compared to standard length stems? 
The third chapter touches on the topical issue of shorter femoral stems which have 
been purported to be “bone conserving”. The NZJR is used to compare the all-cause 
and cause-specific revision rates of standard cemented stems, short cemented stems 
with the normal offsets and short cemented stems with smaller offsets. 
 
Background to Chapter 4 
Symptomatic bilateral hip OA is not infrequently encountered and may be addressed 
by single-anaesthetic bilateral THR (SABTHR). Given the global trend for more 
uncemented fixation especially in younger patients it follows therefore that SABTHR 
is performed more commonly using cementless THR. Several series with uncemented 
stems have reported excellent results with SABTHR (Berend et al., 2005; Aghayev et 
al., 2010; Gondusky et al., 2015). 
 
In Exeter, however, cemented stems have been used in SABTHR for mover 40 years 
yet concerns about embolic-associated complications remain (Christie  et al., 1994; 
Pitto et al., 2002; Donaldson et al., 2009). The key questions to be addressed in the 
next chapter are whether SABTHR can be done safely using cemented Exeter stems. 
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Chapter 4 research question: In patients requiring single-anaesthetic bilateral THR 
is it safe to use cemented stems?  
The fourth chapter examines the issue of bilateral THR which is most commonly 
performed in younger, higher demand patients compared to unilateral THR. The safety 
of this practice using cemented stems is examined. 
 
Section 2 Bearing surfaces 
 
(ii) Secondly this thesis will focus on the optimal bearing surface combination to be 
used in primary THR. Bearing surface combinations can be considered in two broad 
groups: “hard-on-soft” such as metal or ceramic femoral heads on polyeyhtlene or 
“hard-on-hard” such as metal-on-metal or ceramic-on-ceramic. Furthermore, the size 
of the femoral head in hard-on-soft combinations is highly relevant given its influence 
on polyethylene wear rates and THR stability. 
 
Background to Chapter 5 
Lopez-Lopez et al., 2017 showed in a systematic review of randomised controlled trials 
that there was little evidence that any bearing surface combination was superior to 
metal-on-polyethylene.  However ceramic femoral heads have been shown to have 
improved wear rates compared to metal heads (Dahl et al., 2013). The evolution of 
polyethylene to highly-crosslinked has also been shown to improve survival rates 
(Devane et al., 2017). 
 
Whilst metal-on-metal has fallen from favour in the UK (Smith et al., 2012) its 
performance in New Zealand remains unknown. Ceramic-on-ceramic has very low 
wear rates and excellent long-term survivorship (Petsatodis et al., 2010) yet 
comparative studies to other bearing surfaces in New Zealand are lacking. The next 
chapter therefore focused on the NZJR to identify which bearing surface combination 
has the best survival rates: 
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Chapter 5 research question: In patients undergoing THR which bearing surface 
combination has the lowest rate of revision? The fifth chapter focuses on the NZJR 
evidence for the bearing surface combination with the lowest all-cause revision rate. 
 
Background to Chapter 6 
A recent prospective randomised controlled trial with 10 years of follow up compared 
UHMWPE to HXLPE in primary THR. The HXLPE group had significantly reduced 
wear and lower revision rates compared to the UKMWPE group (Devane et al., 2017).  
 
The latest generation of HXLPE includes Vitamin E. The antioxidant effects of Vitamin 
E are purported to reduce wear rates compared to previous generations of HXLPE. A 
recently published study has reported linear wear rates of 0.02mm/year compared to 
UHMWPE at 0.058mm/year on RSA studies (Rochcongar et al., 2018).  Whether 
Vitamin E HXLPE is superior in vivo compared to HXLPE is unknown. In this Chapter 
this assertion is examined through a formal systematic review and meta-analysis. 
 
Chapter 6 research question: In patients undergoing primary THR for osteoarthritis 
does the recently introduced Vitamin E highly crosslinked polyethylene convey 
advantage over more established highly crosslinked polyethylene?  
HXLPE has been advocated as a major advance in THR tribology. The latest evolution 
of HXLPE incorporates vitamin E. A systematic review and meta-analysis is performed 
to examine the evidence for this latest bearing surface. 
 
Section 3 Periprosthetic infection 
 
(iii) Thirdly this thesis will examine issues related to preventing and diagnosing 




Background to Chapter 7 
Prosethtic joint infection (PJI) is a serious and devastating complication of THR. The 
Lidwell prospective multicenter randomised controlled trial found that the incidence of 
infection in laminar flow theatres was reduced when compared to the control group 
(Lidwell et al., 1987). This study foud that infection rates were reduced further when 
the ultraclean environment was combined with the practice of wearing body exhaust 
suits. However, there was no accounting for the use of antibiotic prophylaxis. 
Subsequent randomised controlled trials have not shown that laminar flow theatres 
offer greater protection from infection compared to non-laminar flow theatres (Marotte 
et al., 1987; Brandt et al., 2008). The NZJR is the only National Joint Registry that 
records surgeon use of laminar flow theatres and body exhaust suits. As the burden 
of PJI is increasing with considerable associated costs this Chapter will address 
whether using laminar flow and space suits is associated with lower deep infection 
rates. 
 
Chapter 7 research question: In patients undergoing primary hip and knee 
replacement does the use of laminar flow and modern space suits reduce the rate of 
periprosthetic infection?  
The seventh chapter examines the NZJR and the use of commonly adopted 
preventative theatre environmental measures against PJI.  
 
Background to Chapter 8 
The burdern of PJI is increasing (Padegimas et al., 2015) and from a patient’s 
perspective the impact and experience of PJI should not be underestimated (Moore 
AJ et al., 2015). The surgical treatment for PJI can be, in ascending order of 
magnitude, Debridement, Antibiotics and Implant Retention (DAIR), a one-stage 
revision or lastly a two-stage revision. An early diagnosis of PJI may mean less 
invasive surgery can successfully address the PJI (Kunutsor et al., 2015).  
 
Establishing the diagnosis of PJI swifltly therefore affects the patient outcome (Moojen 
et al., 2014).  However, the classic clinical features may be absent and acquiring the 
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diagnosis may be challenging. The Musculoskeletal Infection Society (MSIS) 
developed diagnostic criteria to standardise and facilitate this diagnostic process 
(Parvizi et al., 2011). The search for a single diagnostic test on synovial fluid with the 
requisite accuracy, sensitivity and specificity has yielded numerous biomarkers as 
potential candidates – the term biomarker meaning a biologically pertinent molecule 
that can be evaluated objectively to indicate the presence of a disease or biological 
state. The most promising biomarkers are alpha-defensin and leucocyte esterase. The 
next chapter will examine the efficacy of these tests for the diagnosis of PJI. 
 
Chapter 8 research question: In patients with a possible periprosthetic infection what 
is the optimal biomarker as a diagnostic tool: alpha-defensin or leucocyte esterase?  
The eighth chapter is a formal systematic review and meta-analysis that examines the 
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Total hip replacement (THR) is a successful and reliable operation for both relieving 
pain and improving function in patients who are disabled with end stage arthritis. The 
ageing population is predicted to significantly increase the requirement for THR in 
patients who have a higher functional demand than those of the past. Uncemented 
THR was introduced to improve the long-term results and in particular the results in 
younger, higher functioning patients. There has been controversy about the value of 
uncemented compared to cemented THR although there has been a world-wide trend 
towards uncemented fixation. Uncemented acetabular fixation has gained wide 
acceptance, as seen in the increasing number of hybrid THR in joint registries, but 
there remains debate about the best mode of femoral fixation.  In this article we review 
the history and current world-wide registry data, with an in-depth analysis of the New 
Zealand Joint Registry, to determine the results of uncemented femoral fixation in an 




The best mode of implant fixation in primary total hip replacement (THR) has long 
been a source of debate. Cemented implants achieve stability from cement-bone 
mechanical interlock once the polymethylmethacrylate has cured, whereas 
cementless fixation relies on primary press fit stability with long term stability occurring 
secondary to endosteal microfractures at the time of preparation and subsequent bone 
ongrowth or ingrowth. The optimum fixation choice should be guided by patient-based 
outcomes, in particular the implant survivorship as measured by revision for aseptic 
loosening, as this was a major reason for the introduction of uncemented implants. 
 
Advocates of cemented implants cite the excellent and reliable long-term reported 
survivorship  (Wroblewski, Siney and Fleming, 2007; Ling et al., 2010; Burston et al., 
2012) whereas proponents of cementless fixation contend that this method is equally 
reliable (Gwynne-Jones et al., 2009; Engh and Massin, 1989; Ihle et al., 2008; 
McAuley et al., 1998) and in fact superior in younger, high-demand patients (Hooper 
et al., 2009; Kim et al., 2011).  Furthermore, cementless implants provide a broader 
range of options especially for the acetabulum where liner exchange may be required 
for postoperative instability; the commonest cause for early re-operation in all primary 
THR (Ulrich et al., 2008). Modular cups offer the option for changing the femoral head 
diameter which may improve the functional outcome especially in the younger or more 
active patient, yet cemented cups also offer various internal diameters. A hybrid THR, 
where the stem is cemented and the cup uncemented, has been suggested to provide 
the benefits of both fixation methods (Clohisy and Harris, 1999; Pennington et al., 
2013) although the reported results have been mixed (Horne et al., 2007; Swedish Hip 
Registry, 2011; Norwegian Joint Registry, 2011). Worldwide there has been an 
observed trend towards uncemented fixation with confirmatory joint registry results in 
Australia, New Zealand, England, Wales and Sweden. Both Canada and the USA 
have continued to have a predominant use of uncemented THR (Swedish Hip 
Registry, 2011; Norwegian Joint Registry, 2010; New Zealand Joint Registry, 2011; 
Australian Joint Registry, 2012; NJR Steering Committee report, 2013). 
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One of the traditional arguments against uncemented THR has been the increased 
cost with implants often being three to four times more expensive than the cemented 
variety. In the immediate future, the burden of an ageing population with the projected 
increase in demand for THR will put considerable strain on health funding agencies 
requiring balanced economic arguments for the use of THR implants. There is also 
likely to be an increase in the absolute number of revision procedures which are 
approximately four times more expensive than primary procedures, especially when 
both the femoral and acetabular components are revised. This has implications if one 
form of fixation is inferior to the other. Those that advocate uncemented implants 
suggest that following successful bonding of both the femoral and acetabular 
components to bone then future revision procedures may only involve exchange of 
articulating surfaces, which is likely to be a procedure whereby patients recover rapidly 
with a lower overall health cost (Briggs, 2012).  
 
Uncemented acetabular implants are widely used in all age groups with registry results 
showing satisfactory early and mid-term results (Gwynne-Jones et al., 2009; Swedish 
Hip Registry, 2011; Norwegian Joint Registry, 2010; New Zealand Joint Registry, 
2011; Australian Joint Registry, 2012; NJR Steering Committee report, 2013). 
However, uncemented femoral implants have been less widely accepted with several 
countries continuing to favour the cemented option as seen in the increasing number 
of hybrid THR performed in registries across the world (Norwegian Joint Registry, 
2010; NJR Steering Committee report, 2013). We have reviewed the recent evidence 
supporting femoral implant fixation, in particular joint registry outcomes, in an attempt 
to provide sound recommendations for future practise. 
 
History of fixation in primary total hip replacement 
The British Orthopaedic Association meeting in London, September 1964 was a 
turning point for the treatment of patients with crippling osteoarthritis of the hip. McKee 
(Norwich) presented the results of the cemented metal-on-metal McKee-Farrar 
arthroplasty and Charnley (Wrightington) demonstrated the results of his cemented 
metal-on-polyethylene THR by having one of his patients walk normally across the 
stage. Widespread high rates of aseptic loosening of cemented THR during the 1960s 
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and 1970s tempered enthusiasm and “cement disease” was widely held as the cause 
of this loosening. Many surgeons began to favour the use of cementless fixation as 
recommended by Ring with his metal-on-metal replacement (Ling, 2010). However 
excellent results with cemented fixation were maintained with the Charnley prosthesis.  
The Exeter group, who believed that poor cementing technique and not cement per 
se was the issue, developed their collarless, taper-slip cemented prosthesis 
specifically designed to subside into the cement mantle while providing even load. The 
early metal-on-metal design soon fell from favour with high failure rates, possibly 
related to poor manufacturing tolerances of the implant, and the improving results of 
cemented metal-on-polyethylene replacements. 
 
The high rates of early loosening and failures observed in younger, active patients 
coupled with concerns regarding “cement disease” continued to drive a renewed 
interest in uncemented fixation (Dorr, Kane and Conaty, 1994; Joshi et al., 1993; 
Mulroy and Harris, 1997). Early failures of cemented implants in these younger 
patients were often associated with a varus positioning of the femoral stem whereas 
the acetabular component often failed after 12 years with polyethylene wear and 
loosening.  The use of cementless components in this patient cohort initially 
established the wider use of these implants throughout the world in the hope that they 
would improve survivorship. Once it had been established that aseptic loosening was 
in fact due to the polyethylene debris and not ‘cement disease’ uncemented THR had 
become firmly established as a recognised and viable option for surgeons. 
 
The modern primary femoral stem 
Over the last 20 years significant attention has been paid to improving the cementing 
technique which has emphasised both the preparation of the femoral canal and the 
pressurisation of the cement on insertion. These changes have improved the cement-
bone interface with more stable interlocking and as a result the intermediate survival 
rates of cemented stems have improved. Current joint registries record between 92% 
at 11 years and 86% at 22 years survival for these implants (Swedish Hip Registry, 
2011; Norwegian Joint Registry, 2010; NJR Steering Committee report, 2013). These 
improved survival statistics have been interpreted as a cemented THR is likely to be 
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a ‘life-long’ implant for patients aged 62 or older, whereas for a 58-year-old patient 
there is a 50:50 chance of undergoing a revision within their life time (Wainwright et 
al., 2011). 
 
There are currently two philosophies of cemented femoral fixation: composite beam 
and polished, tapered wedge. The former is predominant in North America whereas 
the latter is more widely used in Europe.  A composite beam relies on rigid bonding to 
the cement and is not intended to subside. This is in contrast to the loaded taper wedge 
which converts radial compression into hoop stresses within the cement mantle, and 
is expected to subside. The addition of cement around an implant provides an 
additional buffer that the surgeon can manipulate to control correcting leg length and 
version during insertion. Cement use has sporadically been reported as producing 
potentially fatal associated cardiovascular and embolic phenomena at implantation, 
especially in the elderly compromised patient (Parvizi et al., 1999). 
 
Cementless stems rely on bone on-growth or ingrowth to provide stability. A 
roughened titanium stem has been shown to attract bone and provide early stability 
(Wieland et al., 2000) and most uncemented stems today have this type of surface. 
The addition of hydroxyapatite to this surface has been shown to also stimulate bony 
fixation (Vidalain, 2011) without the initial early concern of producing ceramic particles 
in the joint that could cause third body wear.   
 
There are two major uncemented stem designs: proximal (metaphyseal) loading or 
fully coated. Proximal loading has been advocated to avoid the stress shielding that 
was observed with early ‘distal fitting’ implants (Chambers, St Clair and Froimson, 
2007). Often these implants are bulky in the proximal metaphyseal region, which is 
responsible for the early resistance to subsidence and rotation, and smooth distally to 
prevent bone apposition. They are inserted following minimal reaming and are rarely 
associated with femoral fracture. On the other hand, fully coated stems rely on a 
graduated loading of the proximal femur, allow bone apposition throughout their length 
and provide stability by their wide, flat nature. Initial stability is achieved by either 
reaming the femur to accept a maximally sized implant which undergoes three-point 
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fixation in the proximal femur or by compaction of cancellous bone. The former type 
of implants requires exact sizing and significant reaming and are associated with a 
higher incidence of femoral fracture (Yoshihara et al., 2006). The latter type, such as 
the Corail does not have the cancellous bone removed with broaching. 
 
European Joint Registry outcomes and trends in femoral fixation 
The Swedish Hip Registry reports a gradual trend for the increased use of uncemented 
fixation although cemented THRs were used in 64% of all patients in 2011 regardless 
of age (Swedish Hip Registry, 2011). Overall cementless stem fixation was more 
common in the younger, active patient whereas cemented fixation was favoured for 
patients over 70 years of age. Cemented THR had a 90% 16-year survivorship and 
was 30-80% less likely to be revised compared to uncemented and hybrid THRs 
during the first eight years, suggesting that early revision was more likely to be related 
to acetabular problems. After eight years the survivorship of the uncemented group 
tended towards that of the cemented group. Up to age 70 years the uncemented hips 
had fewer revisions attributed to loosening.  The hybrid combinations did not convey 
a clear advantage over either group. 
 
The Norwegian Hip Registry also reported an overall trend towards less cemented 
fixation but in Norway this was largely due to an increase in hybrid THR (Norwegian 
Joint Registry, 2010). Overall cemented THRs had a 20 year survival rate of 85% 
compared to 50% for uncemented total hips. Hybrids had no clear advantage over 
either cemented or uncemented THRs in terms of implant survival during the same 
time period. Uncemented or hybrid fixation were preferred in patients under the age of 
60 years whilst cemented fixation was used in the great majority > 60 years old. 
 
In the National Joint Registry of England and Wales cemented THRs represented only 
33% of all primary THRs yet were used the majority of times for patients over 80 years 
of age (Briggs, 2012). Total cementless fixation was used in 43% of patients and was 
the major type of fixation for patients less than 70 years old. Hybrid THRs accounted 
for 20% of primary THRs. The cumulative percentage of revision (with 95% confidence 
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intervals) at 9 years was 2.71% (2.57-2.87) for cemented, 6.71% (6.40-7.05) for 
uncemented and 3.42% (3.10-3.76) for hybrid THR. 
 
Results from the New Zealand Joint Registry 
The data from the world-wide joint registries portray a similar pattern for the survival 
of cemented THR compared to uncemented THR, and these results are supported by 
those of the New Zealand Joint Registry (Table 1 and Figure 1). On this basis it would 
be easy to dismiss the uncemented variety as inferior, but revision as an end point is 
a ‘blunt tool’ and needs to be interpreted in conjunction with several other factors. We 
have reviewed the results of the New Zealand joint Registry in detail to elucidate this 
and to look at cofounding variables which may contribute to these revision rates. 
 









Events Rate/100 cy 95% CI 
Cemented 14,9098 870 0.58 0.55 to 0.62 
 
Hybrid 16,8604 117 0.66 0.62 to 0.70 
 
Reverse hybrid 3124 19 0.61 0.37 to 0.95 




Figure 1. Thirteen NZJR Kaplan-Meier survival curve of THR by fixation type 
 
One of the primary reasons for the introduction of the uncemented stem was to 
improve the outcome in younger, more active patients, particularly males.  The New 
Zealand Joint Registry has shown a revision rate of 0.89/100 component years (cy) 
for uncemented THRs in patients under 55 years compared to 1.73/100cy for 
cemented THRs and 0.90/100cy compared to 0.98/100cy for those between 55 and 
65 years (p < 0.001) (New Zealand Joint Registry 2013). Over 65 years this was 
reversed with the cemented THR surviving longer than the uncemented variety (p < 
0.001).  The overall revision rate was significantly higher (p < 0.001) in patients under 
65 years (1.00-0.83/100cy) compared to those over 65 years (0.65-0.45/100cy) and 
an argument could be made that because of this the uncemented stem was more 
robust in a high demand patient. Hybrid fixation also showed poorer survival in the 
under 55 year age group compared to uncemented THR (1.03/100cy compared to 
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0.93/100cy, p < 0.002) suggesting that it may be the uncemented stem in this age 
group which has helped improve the survival statistics. 
 
Early revision (within 90 days) was far more common (p < 0.001) in the uncemented 
THR (0.899%) compared to cemented THR (0.353%) which continued across all age 
groups but only reached significance in those over 65 years (p < 0.001) (See Table 
2). When the reason for revision was analysed, the major cause for early revision in 
uncemented implants was either due to femoral fracture (30%) or dislocation (40%) 
whereas 75% of early revisions in the cemented group were secondary to dislocation. 
Femoral fracture with uncemented stems has been identified as an early cause for 
failure by others (Swedish Hip Registry, 2011). Femoral fracture was shown to be age 
dependent, with older patients and presumably those with poorer bone density having 
a much higher incidence of this complication (Figure 2). This complication may be due 
to surgical inexperience and/or attempting to ‘over ream’ the femur to insert the largest 
implant to avoid early subsidence or failure of bonding to the prosthesis. The early rate 
of femoral fracture did not continue beyond 90 days as the overall 13 year results 
showed, using Kaplan-Meier analysis and log rank testing, that there was no 
significant difference in revision for femoral fracture between the fixation methods (p 
= 0.208) (Table 3).  This contradicts the Swedish registry results which show that 
uncemented stems are revised twice as frequently as cemented stems during the first 
5 years and that cemented stems were ten times less likely to require revision for 
periprosthetic fracture.   
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Figure 2. The NZJR results showing the comparison of the incidence of femoral 
fracture and age with cemented and uncemented stems (65-75 years p = 0.008, > 75 
years p = 0.001) 
 








































































p-values  < 0.001 < 0.001 < 0.001 0.003 < 0.001 0.208 
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The rate of femoral loosening within 90 days was significantly higher in uncemented 
stems (p < 0.009) but decreased over the 13-year period to become essentially the 
same as cemented stems (0.62% compared to 0.66%). This early ‘loosening’ of 
uncemented stems is likely to be associated with surgical technique and under sizing 
of the component, whereas the longer results are more likely to reflect the true aseptic 
loosening rate. Figure 3 shows the increasing failure rate of cemented stems due to 
aseptic loosening compared to uncemented stems. The fact that failure of hybrid 
fixation secondary to femoral loosening was 0.77% (p < 0.001) adds evidence to the 
suggestion that the cemented femoral stem may be more likely to fail by this 
mechanism. These results are supported by the Swedish registry which showed that 
from 8 to 16 years cemented stems had a higher rate of revision over cementless 
stems and 80% of these were for loosening.   
 
Figure 3. The NZJR results showing the comparison between cemented and 
uncemented stems and the incidence of revision for aseptic loosening 
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In the past there has been controversy over the use of antibiotic loaded cement and 
whether this would decrease revision for prosthetic infection. Most have accepted that 
it was unlikely to do any harm, however the results from the NZJR are interesting when 
you consider that the great majority (> 90%) of cemented implants are performed with 
antibiotic cement. The combined revision rate for infection for both cemented and 
hybrid THR was 0.50% compared to 0.40% for uncemented THR which suggests that 
antibiotic cement may not have the protective effect against infection that has been 
assumed. This result is similar to the Swedish registry which demonstrated that 
cemented stems were 1.4 times more likely to be revised for infection. 
 
In the past, unexplained pain has been a feature of the uncemented femoral stem, but 
with a move away from distal fixation, the incidence of revision for this complication 
was low at 90 days, however by 13 years pain became the second commonest cause 
for revision surgery behind dislocation in this group of implants. Pain as a cause for 
revision was not specified and so may not have been due to femoral pain. Regardless, 
it is encouraging to find that pain was now a low cause for early revision of uncemented 
stems. 
 
Another complicating variable which is unique to uncemented THR has been the ability 
to use different bearing surfaces in an attempt to improve the wear associated with a 
polyethylene articulation. Both metal-on-metal and ceramic-on ceramic surfaces 
however have been associated with early failures due to reasons not associated with 
cemented THR. However, most of these complications have arisen from the 
articulating surface itself, with ceramic fracture and excessive metal ion debris two of 
the primary reasons for early failure. These problems have not necessarily resulted in 
failure of the uncemented stem secondary to loosening and as a result have almost 
certainly skewed the overall revision rates in favour of cemented THR. The problem 
can be illustrated in the 14 year NZJR report where the revision rate for metal-on-
metal articulations with femoral head size > 36mm was 3.08/100cy. The use of larger 
femoral head sizes is almost solely used in uncemented implants and those with a 
head size > 36mm had a combined revision rate of 2.75/100cy, irrespective of the 
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articulating surface. This offers a potential explanation for the different revision rates 
between the two forms of femoral fixation. 
 
Implant Cost 
Although uncemented implants are more costly than cemented there have been 
studies suggesting that the overall cost differential between the two types of fixation is 
not dramatically different (Kallala et al., 2013; Yates et al., 2006). With the increasing 
use of hybrid fixation, the overall cost difference between a cemented and uncemented 
THR is even smaller and likely to be less relevant in the overall economic assessment. 
Determining the exact cost of a femoral stem can be difficult as the list price may be 
significantly different from the purchase price after discounting for bulk purchases and 
other company driven incentives. We cannot make a comment about pricing in other 
countries but are aware that companies in our country are required to price their 





Controversy continues to exist regarding the best form of fixation to use in THR. Often 
opinions are polarised by such factors as training, tradition, and personal preference 
with proponents of cemented fixation often citing the overall poorer revision rates for 
uncemented THR reported in the various national joint registries. This review has 
attempted to clarify the differences between cemented and uncemented THR, with the 
emphasis on femoral fixation, by analysing the reported joint registry data. There has 
been a world-wide trend towards uncemented THR over the last 10 years, and even 
countries who in the past have been the major proponents of cemented fixation have 
not been excluded from this trend.  
 
Uncemented THR was introduced to address the poorer results observed with 
cemented THR in younger patients with higher functional requirements and to this end 
the registry results would confirm that inpatients < 65 years have a lower revision rate 
with uncemented fixation. In particular the uncemented stem has performed better in 
this age group with a lower rate of aseptic loosening compared to the cemented 
variety. Femoral fracture remains a significant reason for early revision with 
uncemented stems which is more likely to be related to surgical technique and 
potentially could be improved by increased exposure to this technique in surgical 





The optimum mode of implant fixation has long been debated.  The previous chapter, 
essentially an editorial published in 2014, examined the NZJR 13-year report 
comparing patients undergoing cemented, hybrid, reverse hybrid and uncemented 
THR. The decision of which stem fixation to use is important however as this decision 
carries with it a prognosis of survival for that patient’s THR. The choice of stem fixation 
should be based in principle on which type of fixation has the best chance of delivering 
to the patient a long-lasting, well-functioning hip, avoiding complications and 
minimising the risk of revision surgery. The methodology used in the previous chapter 
warrants further explanation and clarification. An update from the more recent 
literature and national joint registry findings is also warranted as more recent literature 
may have permitted new insights. 
 
Methodology in previous chapter 
When searching the literature to compose the previous chapter Web of Science, 
Pubmed and Google Scholar were searched using the following MESH terms: 
cemented, uncemented, total hip replacement. Examining the NZJR, all-cause 
revision rates were compared between fixation types with the lowest rate observed in 
cemented THR constructs. The reasons for revision for each fixation option were then 
compared and cemented cups were significantly more likely to require revision for 
aseptic loosening compared to uncemented constructs. Periprosthetic femoral 
fractures required revisions more commonly with uncemented rather than cemented 
stems. When patient ages were examined this difference was more pronounced with 
increasing patient age. Kaplan-Meier survival analysis was performed will all-cause 
revisions as the endpoint. Cemented THR had the lowest rate of all-cause revision at 
all time points following surgery. When revisions for aseptic loosening of the femoral 
stem were compared between cemented and uncemented stems there were 
significantly fewer revisions than cemented stems until 10 years following surgery. The 
other national joint registry reports were then examined to provide comparison. The 
key pertinent outcomes regarding stem fixation were therefore all-cause revision rates 
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and the influence of patient age, rate of revision for periprosthetic femoral fracture, 
rate of revision for periprosthetic joint infection and relative cost-effectiveness.  In 
terms of the statistical analysis used in Chapter 1, the lack of regression modelling is 
a potential limitation. 
 
Up-to-date literature search 
The following databases were searched from 2014 to 27.3.2020 using the programme 
Papers: ACM, ADS, arXiv, CERN DS, CrossRef DOI, DBLP, Espacenet, Google 
Scholar, Gutenberg, Highwire, IEEExplore, Inspire, JSTOR, OAIster, Pubget, 
PubMed, ScienceDirect, Scopus and Web of Science. Search terms related to: 
Cemented stem, Uncemented stem, Total hip. 
 
299 references were identified of which 21 were collected as potentially relevant. The 
article described in this chapter was cited in 7 published articles, and these were 
examined. Journals with impact factors <2 were excluded. Any correspondence 
relating to the article described in this chapter was reviewed. In addition, the national 
joint registry reports of (i) Norway, (ii) Sweden, (iii) England, Wales, Northern Ireland 
and the Isle of Man, (iv) Australia and (v) New Zealand were revisited. 
 
All-cause revision rates of stem fixation methods and patient age 
The use of uncemented acetabular implants has remained popular in many countries 
with reliable survivorship data (Swedish Hip Arthroplasty Register, 2017; Norwegian 
Arthroplasty Register, 2018; National Joint Registry for England, Wales, Northern 
Ireland and Isle of Man 2018, New Zealand Joint Registry 2018). The trends for THR 
fixation however have changed in recent years, with cemented stem fixation the overall 
most preferred option in both Norway and Sweden, and uncemented stems more often 
inserted in New Zealand and the UK. 
 
According to the Norwegian Arthroplasty Register, in patients under the age of 65 
there has been an increase in the use of reverse hybrid THR, i.e. an uncemented stem 
with a cemented cup, with this becoming the preferred choice in Norway (Norwegian 
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Arthroplasty Register, 2018). Those patients aged 65 to 75 years of age have good 
all-cause survivorship with all types of fixation methods whilst those > 75 years of age 
should receive cemented THR. In particular female patients > 75 years of age have a 
54-60% increased risk of revision THR if uncemented fixation is used. Overall 
cemented THR, from 1987 to 2017, has the lowest rate of revision and uncemented 
fixation has a 1.29 relative risk of revision compared to cemented (p < 0.001). In the 
Swedish Hip Arthroplasty register 2017 report, cemented fixation is still the most 
commonly preferred fixation although in 2017 the proportion of cemented THR had 
fallen from 93% in 2000 to 60% (Swedish Hip Arthroplasty Register, 2017). Completely 
uncemented fixation in 2017 was 24% overall and this increase occurred 
predominantly in patients under 60 years of age.  Hybrid THR has increased steadily 
and in 2017 was 1.5% of THR. 
 
Conversely the National Joint Register of England, Wales, Northern Ireland and the 
Isle of Man, 2018 report showed that overall uncemented THR is the most often 
performed (38.9%) followed by all cemented (34.2%), and uncemented THR has been 
the preferred method of fixation since 2008 followed by hybrid THR. When the registry 
is examined for survivorship stratified by age group and gender the survivorship in 
cemented THR is equitable to uncemented stems in patients under 65 years of age. 
In the NZJR there has been a steady decline in the past 19 years in cemented THR 
with the uncemented fixation preferred closely followed by hybrid THR (NJR England, 
Wales, Northern Ireland and Isle of Man 2018, NZJR 2018).  
 
Moskal et al., commented that cemented THR was more commonly performed in 
Europe whilst uncemented fixation was widely adopted in the USA although there is a 
worldwide trend for performing more uncemented THR. Uncemented fixation using 
anatomic medullary locking extensively porous coated cylindrical stems and some 
hydroxyapatite coated stems metaphysial porous fixation stems have reported <98% 
20-year survivorship in series from the USA (Moskal et a;., 2016). These results may 
be prone to both publication and performance bias. At a society and economic level 
however, there is a strong incentive to use cemented stems over uncemented stems 
yet paradoxically there remains a lack of training and experience in using cemented 
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stems especially in Northern America (Moskal et a;., 2016). Orthopaedic surgeons 
often make implant choices based on personal preference and familiarity, yet these 
healthcare decisions should be made based on scientific evidence. The authors of this 
article commented that a reasonable evidence-based approach including the use of 
registry data would be to adopt cemented fixation in patients >70 years of age and 
uncemented in younger patients given the all-cause revision rates and the high rate of 
periprosthetic femoral fractures in patients >70 years of age. Moreover, it is imperative 
that the excellent results of cemented fixation do not deteriorate due to a lack of 
technical skill in cementing.  
 
Pursuing the same theme Liu et al., 2019 performed a retrospective review with a 
minimum 5 year follow-up of the South China Hip Arthroplasty database comparing 
cemented and uncemented THR in patients who had sustained a neck of femur 
fracture. The mean age was 68.7 years in each group and the cemented THR had 
better Harris Hip Scores and significantly fewer complications (revision surgery, 
loosening and periprosthetic fracture) compared to the uncemented THR group. 
 
Dale et al., 2020 recently examined 66,995 primary THR in the Norwegian Arthroplasty 
Register and showed that uncemented stems, both in all uncemented and reverse 
hybrid THR constructs, had an increased all-cause risk of revision compared to 
cemented THR (RR 1.4; 95%CI 1.2 to 1.6) mainly due to the increased risk of 
periprosthetic fractures. Women had a much higher risk of revision for periprosthetic 
fracture after all uncemented THR (RR 12; 95CI 6 to 24). The increased risk of revision 
with uncemented fixation in women >55 years of age was mainly because of 
periprosthetic fractures and recurrent instability. Similar to the NZJR findings in this 
chapter the different risk of periprosthetic fracture observed between cemented and 
uncemented stems increased with patient age. The authors recommended therefore 
using cemented stems in females >55 years of age. 
 
Tyrpenou et al., 2020 reported a 15 year minimum follow-up study of a metaphyseal 
fit-and-fill uncemented femoral stem inserted in patients mean age 49.6 (19 to 71 
years). This single centre series from Toronto reported 97.7% all-cause survivorship 
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with those cases that failed being revised for periprosthetic fractures and 
periprosthetic joint infection.  
 
Keeling et al., 2020 reported on the use of cemented Exeter stems from Exeter in 
patients with mean age of 41.8 (17 to 50 years of age). Of 130 THR the 22 years all-
cause revision rate was 25% and the survivorship for stem revision for aseptic 
loosening 96.3%.  This series of THR were all performed by surgeons highly trained 
and experienced in cementing stems yet shows that with technical competence in 
cementing cemented stems can be performed reliably and successfully in patients <50 
years of age.  
 
Bunyoz et al., 2020 also reviewed the annual reports from the arthroplasty and hip 
registries comprised Australia, Denmark, England and Wales, Finland, the 
Netherlands, New Zealand, Romania, Norway, Sweden and Switzerland. All-cause 
revision rates were compared between cemented and uncemented fixation and in the 
various age groups (Dennmark <50, 50 to 59, 60 to 69, 70 to 79, >80 years of age 
whilst for Australia, New Zealand, England/Wales and Finnland <55, 55 to 64, 65 to 
74 and >75 years of age). Risk estimates were presented as either hazard ratios, rate 
per 100 component years or as Kaplan-Meier estimates of revision.  
 
This study showed that uncemented component use has increased in Australia, 
Norway, Denmark and Sweden whilst it has decreased in England/Wales, New 
Zealand and Finland. In patients >75 years of age the proportion of patients having 
uncemented fixation has remained stable in the Netherlands, Sweden, New Zealand 
and England/Wales. When compared with uncemented fixation, the all-cause revision 
risk for THR using cemented components was lower in patients >75 years of age in 
all registries except for the oldest males in the Finnish Arthroplasty register in which 
there was no difference between cemented and uncemented fixation. 
 
Younger patient age is associated with a lower mortality yet better functional outcomes 
after THR but with a greater risk of revision during the patient’s lifetime (Bayliss et al., 
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2017). In this important study of 63,158 patients who had undergone THR between 
1991 and 2011 the 10-year survival rate was 96.1% and 20-year implant survival rate 
was 89.7%. The lifetime risk of requiring revision surgery for those over the age of 70 
was 5% with no difference between genders. The lifetime risk for a patient in their 50s 
however was 35% (95%CI 30.9 to 39.1) and was 15% less if female. If the patient was 
younger than 60 the median time to revision was 4.4 years. This does not necessarily 
mean that a young patient should be denied THR but does mean that both surgeons 
and patients should be aware of these facts in order to facilitate appropriate shared 
decision making.  
 
Periprosthetic joint infection and stem fixation 
The issue of fixation in conjuction with the risk of periprosthetic infection has been 
addressed in more recently published research in the study by Lenguerrand et al., 
2018.  This study was a prospective observational study linking the NJR with Hospital 
Epsidoe Statistics data on 623,253 primary THR between 2003 and 2013. The study 
examined the association of risk factors for periprosthetic joint infection across the 
follow-up period using Poisson multilevel models. The incidence of infection per 1000 
person-years was 0.85 (95% CI 0.8 to 0.9) for cemented THR and 0.97 (0.92 to 1.03) 
for uncemented THR. Moreover Trela-Larsen et al., 2018 using the same data source 
showed that there was no significant difference in observed revision rates between 
plain and antibiotic-loaded cement fixation in cemented THR. Kunutsor et al., 2019 in 
a systematic review and meta-analysis examined the evidence for risk of 
periprosthetic joint infection and implant fixation method. In pooled analyses 
uncemented THR was associated with decreased risks yet only after 6 months 
following surgery. Plain cement was associated with an increased risk of periprosthetic 
joint infection compared to antibiotic-loaded cement (RR 1.52 95%CI 1.36 to 1.70). 
The authors concluded that uncemented and antibiotic-loaded cemented fixations 
reduce the risk of periprosethetic joint infection in THR. 
 
Cost-effectiveness  
A recent study examining the NJR and Swedish Hip Arthroplasty Register showed that 
the greater the patient age the more likely that the cheapest implants, smaller headed 
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metal-on-polyethylene implants were cost-effective. There was no evidence that 
uncemented, hybrid or reverse hybrid THRs were more cost-effective for any patient 
group. This important study is highly pertinent for both patients, surgeons and 
healthcare providers alike (Fawsitt et al., 2019). 
 
To reflect therefore on the conclusions made in Chapter 1 the validity of preferred 
uncemented stem fixation in the younger patient, despite its increasing popularity, has 
been subsequently challenged in favour of cemented stem fixation both in terms of 
survivorship and cost-effectiveness by the findings of the UK Joint Registry NJR for 
England, Wales, Northern Ireland and the Isle of Man and the study by Keeling et al., 
2020. Having established therefore that correctly implanted cemented stems are of 
great value in all ages and that uncemented stems are reliable in younger patients, 
what are the important biomechanical features that we must consider during the 
preoperative planning process? 
 
Preoperative planning and templating may decrease iatrogenic complications such as 
leg length inequality, instability, incorrect implant sizing, pain and potentially therefore 
periprosthetic fractures (Alnahhal, Aslam-Pervez and Sheikh, 2019). Firstly, the 
detailed clinical assessment recorded in the out-patient clinic letter is scrutinised. The 
diagnosis, history of previous trauma or paediatric hip conditions, functional 
limitations, treatment to date and patient expectations should have been recorded. 
Risk factors for postoperative delirium, bleeding, thrombotic events and instability are 
noted. The current medical problems and treatments are recorded. The physical 
examination should commence with a general appreciation of the patient’s fitness to 
rehabilitate. The examination should exclude signs of infection, note previous scars 
and contractures, identify sources of leg length discrepancy and record neurovascular 
status. This permits consideration of soft-tissue releases, accommodation of previous 
incisions and metalware (possibly with the need to acquire prior operation notes and 
registry data) and anticipation of additional procedures. Both digital and acetate 
templating can be used. Using acetates applied to the viewing screen of a digital 
templating radiograph is also highly accurate and a viable alternative (Brew et al., 
2012). Alternatiively digital templating with a templating marker allows for accurate 
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scaling (Wimsey et al., 2006; Zhang et al., 2019). Using a systematic approach 
identifies the underlying condition (OA DDH, Perthes, Trauma, normal variants), the 
offset required, what change in leg-length is required and where the centre of rotation 
of both the femoral head and the acetabulum are situated and planned for. The 
position of intraoperatively identifiable anatomical structures are checked. The correct 
size and orientation of the implants is planned. The femoral canal geometry is noted.  
 
This templating and planning process should be done well ahead of the day of surgery 
and once completed allows clear communication with the theatre team, implant 
company representatives and checking of implant inventories. Alternative operative 
reconstructive strategies are contemplated and mentally rehearsed well ahead of time 
and this permits a more fluid and less stressful operative workflow. This process is an 
excellent training discipline for junior surgeons. Furthermore, the preoperative 
template can then be used to compare the postoperative radiographs as a tool for 
audit and reflective practice. 
 
In stance phase the centre of gravity is anterior to the S2 vertebra and posterior to the 
axis of the hip joints.  The centre of gravity deviates as the torso moves with respect 
to the pelvis. The hip can be considered as a “first order lever” where the body weight 
moment is countered by the tension in abductor muscles. The joint reactive force (JRF) 
is the result of these two forces acting on the hip joint. The JRF varies depending on 
the patients’ activity. For example, the JRF is twice the patient’s body weight when 
they perform a straight leg raise and this in fact is a useful provocative diagnostic 
examination test in the out-patient clinic known as the Ling Test. The JRF varies during 
the gait cycle: at heel strike the JRF is 94% of total body weight, at mid-stance it is 
345% of total body weight, at terminal stance phase it is 223% of total body weight 
and at toe off it is 80%. Thus there is considerable force acting on the hip joint during 
even simple activities of daily living and the correct restoration of hip biomechanics is 
crucial to minimise JRF and therefore wear (Terrier, Florencio and Rüdiger, 2014; 
Bonnin et al., 2011).  
 
 86 
When considering common anatomical variants in bony hip morphology in coxa valga 
there is an increased neck/shaft angle, the tip of the greater trochanter lies lower than 
the centre of the femoral head and in a more medial position which thereby results in 
a shorter offset and abductor lever arm. The body weight lever arm remains 
unchanged but overall there is an increased JRF and more abductor force is required 
during swing phase. In coxa vara there is a decrease neck/shaft angle and the tip of 
the greater trochanter lies not only more lateral but also more distal than the centre of 
the femoral head. The abductor lever arm is increased but the abductor muscle length 
is less and therefore disadvantaged. There is a comparatively reduced JRF. In 
dysplastic hips, there may be a more proximal centre of hip rotation, a reduced 
abductor moment and a shortened abductor lever arm. The centre of rotation of the 
hip joint is more lateral and the body weight lever arm is increased. Global offset is the 
sum of femoral offset (centre of the femoral head to the midmedullary axis of the 
femur) and the acetabular offset (centre of the femoral head to the base of the 
acetabulum). Furthermore, increased femoral neck anteversion will reduce femoral 
offset. 
 
The offset of the hip is therefore of great importance yet femoral offset can vary up to 
4cm in individuals (Terrier, Florencio & Rüdiger, 2014). The centre of rotation of the 
acetabulum achieved during reaming and implantation of the acetabular component 
must be carefully considered along with femoral offset to achieve both the correct hip 
centre and global hip offset. When considering a femoral component, the resulting 
offset is a function of the offset of the stem component itself and that coming from the 
femoral head length. The next chapter of this thesis will examine the influence of 
femoral component offset on survivorship of THR with both cemented and 
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Femoral component offset influences the torque forces exerted on a femoral stem and 
may therefore adversely affect femoral component survival. This study investigated 
the influence of femoral component offset on revision rates for primary total hip 
replacements (THR) registered on the New Zealand Joint Registry (NZJR). 
 
Methods 
There were 106,139 primary THRs registered, resulting in 4,960 revisions for any 
cause. There were 46,242 THRs performed using the five commonest femoral 
components listed on the NZJR. A total of 41,100 were done for primary osteoarthritis 
of which 40,548 had all the offset information available for analysis. We defined low 
offset as <42mm, standard as 42-48mm and high offset as >48mm offset and 
examined revision rates according to the reasons for revision. We performed survival 




The all-cause revision rate was 0.54/100cys. Stems with <42mm offset had a revision 
rate of 0.58/100cys (mean 0.58; 95%CI 0.53 to 0.63), 42-48mm offset 0.47 (95%CI 
0.43 to 0.52) and >48mm offset 0.67 (95%CI 0.57 to 0.79). 
 
There was no significant difference in all-cause revision rates between varying stem 
offsets in uncemented stems adjusting for age and gender. In cemented stems both 
high and low offset stems were more likely to be revised. Uncemented stems of all 






Femoral component offset affects the overall all-cause revision rate of the most 
commonly used cemented stem, but not uncemented stem designs. In cemented 




Total hip replacement (THR) for hip osteoarthritis is one of the most successful and 
cost-effective operations in modern medicine (Garellick et al., 1998). THR is now 
performed in increasingly younger patients but this trend places growing demands on 
implant longevity. The most common mode of implant failure is aseptic loosening 
(Herberts and Malchau, 2000) primarily from osteolysis secondary to wear debris 
(Beksaç et al., 2009; Johanson et al., 2012; Kuzyk et al., 2011). 
 
The femoral offset is defined as the horizontal distance between the neutral axis of the 
femur and the centre of the femoral head (Ling et al., 2010; Lecerf et al., 2009). It is 
an indicator of the abductor lever arm length, which, in principle, should be restored 
correctly in THR surgery to recreate normal anatomy and biomechanics. Restoration 
of the correct offset will, in theory, improve implant joint stability by optimising soft 
tissue tension and reducing the risk of impingement (Weber et al., 2014; Malik, 2007). 
Furthermore, the correct femoral offset should maximise the range of motion, abductor 
muscle strength (Tezuka et al., 2015) and decrease wear (Ling et al., 2010; Sakalkale 
et al., 2001). 
 
Increasing the offset will increase the moment arm of the abductors which, in turn, 
reduces the abductor muscle force required during normal gait (Sariali et al., 2014). 
Secondarily, this reduces the transarticular hip forces (Davey et al., 1993) which 
should reduce articular surface wear. An association with trochanteric pain syndrome 
has also been described, however this is controversial (Ries, 2003; Sayed-Noor and 
Sjoden, 2006). An increased offset femoral component may also lead to increased 
bending moments and torsional forces in the proximal femur and potentially lead to 
premature failure of the femoral component by aseptic loosening (Thien and Kärrholm, 
2010). However, it remains unknown how increased offset stems affect cemented or 
uncemented fixation in THR in the long-term. An increased femoral stem offset may 
potentiate earlier failure in cemented stems due to increased strain into varus and 
retroversion (Kleeman et al., 2003), but this is controversial (Davey et al., 1993). 
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A decreased offset of the reconstructed hip compared to the preoperative state can 
result from using a femoral component that has less offset than the anatomy of the 
patient, from using a more valgus femoral stem or from using a short-necked femoral 
component. In addition, acetabular malposition and excessive deepening and 
resultant medialisation can similarly reduce functional hip offset. Either way, a reduced 
functional hip offset decreases the abductor lever arm, increases joint reaction forces 
and increases the energy requirement for normal gait. This may manifest itself as an 
abductor lurch, limited range of motion and decreased stability. 
 
The primary aim of this study was to examine the New Zealand Joint Registry (NZJR) 
to determine whether the offset of the femoral component affected the revision rates 
of primary THR and to compare the reasons for revision. The secondary aim was to 
determine whether this primary result was affected by the femoral component being 




Materials and methods 
We performed a retrospective cohort analysis of the 16 year results of the NZJR 
identifying primary THRs performed between 1 January 1999 and 31 December 2015 
for osteoarthritis, ensuring a minimum 2 year follow-up. Our primary outcome measure 
was the all-cause revision rate for each of the stem types. The revision rates for the 
five most commonly implanted femoral stems which had both standard and high offset 
(CLS, Corail, Exeter V40, twinSys Cemented and twinSys Uncemented) registered on 
the NZJR, were compared. The addition of a collar to the Corail prosthesis to resist 
motion is unproven in finite element analysis (Al-Dirini et al., 2017) and we therefore 
did not examine the presence of a collar or skirted head as covariates. Using femoral 
component and head product codes, the true offset was measured explicity for each 
prosthesis, and revision rates were once again compared for low (< 42mm), standard 
(42 - 48mm) and high (> 48mm) offset groups. 
 
Large metal-on-metal heads were excluded. A revision was defined as a new 
operation in a previous THR during which one of the components was exchanged, 
removed, manipulated or added. It included excision arthroplasty and amputation, but 
not soft tissue procedures. Bilateral THRs were considered independently for the 
purposes of this study. 
 
The all-cause revision rate was chosen to provide the most conservative estimate of 
survivorship. The revision rate was expressed as the rate per 100-component-years 
(100cys) to give an average estimate of survival for each coupling, allowing for the 
variable number of years that each had been implanted. This estimate allows 
comparison of revision rates when analysing data with varying follow up times but 
does assume consistent revision rates over time. Kaplan-Meier survival curves and 
Cox-proportional hazards regression were therefore also performed to summarise the 
proportion of revision-free and to allow for confounders such as age at surgery, 




The reason for revision as listed on the NZJR was compared between the couplings 
used and femoral offsets attained. Demographic data including age and gender as 
well as procedure specific data such as head size, fixation technique, surgical 
approach and surgeon volume were all compared between couplings using ANOVA 
and Chi-square tests as appropriate. All-cause revision rates were calculated with 
95% confidence levels using a Poisson approximation. A p-value of less than 0.05 was 





There were 106,139 primary THRs registered on the NZJR during the study period 
with 4,960 (4.7%) revision procedures performed on these implants, giving an overall 
revision rate of 0.74/100cys (0.72 to 0.76, 95% CI). 46,242 THRs were performed 
using the femoral components in question of which 41,100 were inserted for primary 
osteoarthritis and a study group of 40,548 of these had the offset information available 




There were no significant differences in gender distribution between implants used 
with 51.5% female and 48.5% male (Table 4). The mean age for patients in this study 
was 66.8 years (SD 10.6 years). 
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Type of femoral stem Sex  
 
Total F M 
 CLS Count 
% 
2767 4220 6987 
39.6% 60.4% 100.0% 
Corail Count 
% 
2489 2963 5452 
45.7% 54.3% 100.0% 
Exeter V40 Count 
% 
12254 9492 21746 
56.4% 43.6% 100.0% 
TwinSys cemented Count 
% 
823 441 1264 
65.1% 34.9% 100.0% 
TwinSys uncemented Count 
% 
2570 2565 5135 
50.0% 50.0% 100.0% 
Total  Count 20903 19681 40584 




The all-cause revision rate was 0.54/100cys. Stems with < 42mm offset had a revision 
rate of 0.58/100cys (mean 0.58; 95%CI 0.53 to 0.63), 42-48mm offset 0.47/100cys 
(95%CI 0.43 to 0.52) and > 48mm offset 0.67/100cys (95%CI 0.57 to 0.79) (Figure 4). 
Standard offset femoral components were significantly less likely to undergo revision 
than both small (p = 0.002) and higher offset stems (p < 0.001). 




Std. Deviation Minimum Maximum 
CLS 6987 59.16 9.141 18 92 
Corail 5452 61.90 9.636 20 91 
Exeter V40 21746 70.14 9.451 17 96 
TwinSys cemented 1264 74.32 7.178 43 96 
TwinSys 
uncemented 5135 66.38 10.859 19 94 




Figure 4. K-M curves for each offset overall 
 
When examining uncemented and cemented stems there was no significant difference 
in all-cause revision rates between offsets in either groups in unadjusted analyses 
(Tables 5 and 6). However, when adjusting for gender and age while the uncemented 
group continued to show no difference across the various offsets, the cemented group 
had significantly higher rates of revision in low and high offset stems in contrast to 
standard offset stems (Tables 5 and 6). The all-cause survival for each stem type is 







Table 5. Influence of offset (mm) on revision rates in uncemented THR 
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Table 6. Influence of offset on revision rates in cemented THR. 
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Figure 9. K-M curves for each offset in Twinsys uncemented stem. 
 
 
Reason for revision 
The most common revision performed was acetabular component revision. In the 
cemented stem group, cup revision was significantly less in those components with 
standard versus low offsets (Hazards ratio 0.551; 95%CI 0.366 to 0.829; p = 0.004). 
These differences were true in both unadjusted and analyses adjusted for age and 
gender alike. In the uncemented group there was no difference in the risk of acetabular 
component revision based on femoral component offset. 
 
There was no significant difference in revision rates by offset for pain overall, or when 
sub-analysing cemented versus uncemented femoral components (Tables 7 and 8). 
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Table 8. Influence of offset on revision rates for pain loosening in cemented THR 
 
 
Revision for femoral periprosthetic fracture was higher in the uncemented group than 
the cemented group for all offset groups (Tables 9 and 10). The risk of revision for 
periprosthetic femoral fracture was 0.07/100cys (95%CI 0.06 to 0.08). However, when 
we examined the risk of revision for femoral fracture in cemented components high 
offset components (Hazards ratio 0.486; 95%CI 0.267 to 0.886, p = 0.019)) showed 
an increased risk of femoral fracture compared to standard components (Table 10). 
This was not observed in the uncemented group, where no significant differences in 
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Revision rates for aseptic femoral component loosening were higher in uncemented 
femoral components than cemented components across all offset groups (Tables 11 
and 12). Furthermore, offset did not influence aseptic femoral loosening revision rates 
in uncemented stems (Table 11). In the cemented group lower offset stems were 
revised more often compared to standard offset stems (Hazards ratio 0.321; 95%CI 
0.15 to 0.736, p = 0.007) (Table 12). 
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Revision for dislocation overall was 0.19/100cys (95%CI 0.17 to 0.21). Standard offset 
cemented femoral stems were significantly less likely to undergo revision for instability 
than high offset stems (Hazards ratio 0.59; 95%CI 0.399 to 0.872, p = 0.008). This is 
shown graphically in Figure 10. 
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Our study showed that in uncemented stems there was no significant difference in all-
cause revision rates between varying stem offsets. However, in cemented stems both 
higher and lower offset stems were more likely to be revised than standard offset 
stems. This suggests that femoral component offset is potentially less critical in 
uncemented fixation. 
 
When examining the causes of revision, lower offset cemented components had 
greater risk of revision for acetabular loosening than other offset classes. This may 
reflect the higher transarticular hip forces with a decreased offset with both higher 
torque forces applied to the acetabulum and increased wear. All uncemented stems 
were more likely to undergo revision for femoral fracture. We have previously reported 
on the revision for femoral fracture comparing cemented and uncemented stems 
where femoral fracture was much more likely to occur within the first year for the 
uncemented stem (Wyatt et al., 2014). This difference was not apparent after 1 year, 
with almost equal rates, suggesting that the early fracture rate was probably due to 
either perioperative fracture on stem insertion or subsidence secondary to stem 
undersizing. The difference in rates of periprosthetic fracture is unlikely to be due to 
the offset of the stem alone. 
 
In our study both high and low offset cemented stems were at higher risk of revision 
than standard offset cemented stems, consistent with the results observed in the 
Swedish Hip Register (Thien and Kärrholm, 2010). For the higher offset stems the 
increased lever arm may potentiate abrasive wear between the stem and the cement 
mantle (Thien and Kärrholm, 2010; Harman et al., 2016). In a Norwegian Registry 
study, high offset cemented stems had a significantly greater risk of revision (relative 
risk 3.3; 95%CI 2.3 to 4.8) compared to standard offset stems (p < 0001) (Hallan et 
al., 2012). 
 
The offset in uncemented stems did not show a correlation with risk of revision for 
aseptic femoral loosening in our study. This indicates that recreating the precise offset 
in uncemented THR may be less critical for the longer-term survival of the femoral 
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component. This might be explained by higher offset cemented stems being more 
likely to be smaller sized stems than the uncemented equivalent (i.e. accommodated 
with the cement mantel), whereas in the uncemented component the femoral size is 
almost always reamed to accept the biggest stem size. In a study of the CLS, the 
uncemented stem 3-dimensional measurement of micromotions showed no difference 
between offsets which is in accordance with our findings (Fottner et al., 2011). 
Therefore, the concept that higher offsets, in uncemented components, cause 
excessive interface stresses could not be substantiated. Our findings also corroborate 
with those of Krushell and colleagues (Krushell, Fingeroth and Lehman, 2012), who 
examined a high offset hydroxyapatite-coated femoral implant in the revision scenario 
and found no evidence of aseptic loosening with this component. In the National Joint 
Registry study of England and Wales, Jameson and colleagues examined the Corail 
uncemented stem at 7.5 years follow-up (Jameson et al., 2013). They found no 
association with a higher revision rate and femoral offset. 
 
The findings of our study did not show an increased rate of revision for pain in relation 
to femoral offset. This did not therefore extrapolate the functional results of Liebs and 
colleagues (Liebs et al., 2014) who showed a correlation between offset and pain after 
uncemented THR. However, our study only assessed revision for pain and therefore 
failed to identify pain scores in those not requiring revision. While it seems counter-
intuitive that higher offset stems dislocated more than standard in cemented stems, 
the authors feel this reflects the common practice of increasing offset to achieve 
stability in those patients who are intraoperatively unstable and therefore there is a 
selection bias towards these patients. Furthermore, patients with a higher BMI may 
have larger offset stems as a strategy to reduced extra-articular soft-tissue 
impingement. Unfortunately, this registry study cannot determine implant alignment, 
leg length and soft tissue laxity to understand the cause of instability in these cases. 
 
The strengths of this study relate to the quality data provided by the NZJR with a high 
capture rate of 98% across the whole country, and large data sets pertaining to THRs 
for the various femoral component offsets. This study is representative of a wide 
spectrum of Orthopaedic surgeons with varied clinical experience covering an entire 
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nation. A potential weakness is that we have used all-cause revision as a surrogate 
marker for failure. This has the potential to not identify patients who are living with a 
painful hip, awaiting revision, or are too unwell for revision surgery. Furthermore, the 
NZJR does not include revisions for soft tissue procedures such as soft tissue 
tensioning and addressing trochanteric bursitis which are highly relevant to offset. 
 
Whilst it has been suggested that restoring the correct offset and centre of hip rotation 
is advantageous, we have no information on whether this was achieved in our 
analysis. In our study the reason for offset chosen was not declared and the decision 
may have been done intraoperatively. One of the other differences between cemented 
and uncemented is stem positioning, and it may be easier to put a cemented stem in 
varus and thus increase offset than in an uncemented stem. Furthermore, the 
anteversion of the femoral component is not accounted for in our study. In cemented 
stems excessive cement stresses occur with highly anteverted stem positions as well 
as high offsets in finite element models (Harman et al., 2016). Some implant-related 
factors may be biased by other unknown influences. In uncemented stems the level of 
neck resection, for example, is much more critical than in cemented fixation. The level 
of neck resection can profoundly influence the flexibility to change the patient’s offset 
intraoperatively without dramatic changes in leg length, anteversion and stability. One 
potential example may be that a THR operated on with a maximum femoral head 
length may represent a technically difficult case or one in which there was suboptimal 
preoperative templating. 
 
Generally, surgeons select the offset based upon preoperative templating and 
intraoperative findings to reproduce leg length and offset. A large offset stem is often 
used if the hip was potentially unstable with the standard offset prosthesis. The 
limitations of a registry study preclude analysis of selecting standard offset stems in 
these patients, however surgeons should recognise a potentially higher revision rate, 
particularly in cemented higher offset components, and incorporate this knowledge 





This retrospective study of the New Zealand Joint Registry has identified that femoral 
component offset has an association with the overall all-cause revision rate of the most 
commonly used cemented stem, but not uncemented stem designs. This may be 
because the biomechanics become more critical with the additional interface of 
cement. In addition, this may be confounded for example by surgeon preference for a 
particular implant fixation. Furthermore, despite the risk of loosening and femoral 
fracture being higher in uncemented stems, only in cemented stems was offset 






In this chapter the influence of the femoral component offset and how this affects the 
overall THR survivorship especially with cemented fixation was examined. This study 
suggests that accurate restoration of the correct femoral offset becomes of great 
importance when using cemented stems. In the previous chapter however, we 
acknowledge that the methodology of analysing a large observational data set 
precluded insight into whether templating occurred or not and there is potentially 
confounding in comparing cemented and uncemented stems using a proportional 
hazards model. We also did not have precise information on what the patients’ true 
offsets were preoperatively. In addition, the data did not include soft tissue procedures 
such as fascia lata release which may have been performed to address trochanteric 
pain associated with increased femoral offset after THR. Finally, the anteversion of 
the stems inserted was not ascertained and this affects the functional offset. However, 
such imprecisions may have reasonably been countered by the large number of THR 
in the analysis and the nationwide capture of the dataset. In addition, regression 
modelling may have improved the strength of the results and conclusions drawn. 
 
Up-to-date literature search 
The following databases were searched from 2018 to 27.3.2020 using the programme 
Papers: ACM, ADS, arXiv, CERN DS, CrossRef DOI, DBLP, Espacenet, Google 
Scholar, Gutenberg, Highwire, IEEExplore, Inspire, JSTOR, OAIster, Pubget, 
PubMed, ScienceDirect, Scopus and Web of Science. Search terms related to: Offset, 
Total hip. 
 
51 references were identified of which 2 were collected as potentially relevant. Articles 
that cited the study described in this chapter were examined. Journals with impact 
factors <2 were excluded. Any correspondence relating to the article described in this 
chapter was reviewed.  
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There were no other publications that examined the effect of femoral component offset 
on THR outcomes. One study compared short uncemented stems and standard length 
stems and suggested that whilst femoral offset was increased postoperatively in both 
groups there was less of an increase with the short stem group (Erivan et al., 2020). 
 
Chapter 2 identified that both the Exeter V40 and the Twinsys cemented stems had 
lower revision rates for periprosthetic femoral fractures compared to uncemented 
stems. Palan et al., 2016 examined the National Joint Register for England, Wales 
and Northern Ireland and discerned that the type of cemented stem also influenced 
the rate of revision for periprosthetic fracture. In adjusted analyses controlling for age, 
gender and ASA grade, the CPT cemented stem had a hazards ratio of 3.89 (95% CI 
3.07 to 4.93) compared to the Exeter V40 cemented stem. There was no significant 
difference between the Exeter V40 and the C-stem whilst the Charnley had a hazards 
ratio of 0.41 (95%CI 0.24 to 0.7) compared to the Exeter. Chatziagorou, Lindahl and 
Kärrholm (2019), examined the Norwegian Joint Arthroplasty Register and showed 
that the Exeter stem had a higher risk of Vancouver B (i.e.periprosethtic femoral 
fractures within the bed of the stem) fractures compared to the Lubinus cemented 
stem but not other fracture types.  
 
Overall from Chapter 2 it is apparent that the offset of cemented stems is important for 
THR survivorship yet how important is cemented stem length? The increased 
indications for THR in younger patients and the higher risk of revision in this population 
provided the rationale for considering bone-preserving stems, able to transmit the load 
to the proximal femur, to avoid stress-shielding and thigh pain. Bone loss in revision 
THR is challenging and therefore strategies to preserve bone stock and/or facilitate 
femoral stem revisions such as using cement-in-cement revision or femoral impaction 
grafting are worthy of consideration.  
 
Interestingly the cemented Exeter short stem, which is an identical design to the 
conventional Exeter stem except being 125mm rather than 150mm in length has 
shown promising results in the Austrarian National Joint Replacement Registry. This 
stem applies the same Exeter polished taper-slip philosophy and provides proximal 
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femoral loading given the transferred hoop stresses through the low modulus cement 
mantle which may preserve not only proximal bone but also the femoral isthmus 
potentially providing options for revision in the longer term (Choy et al., 2013). Connor 
et al., 2016 reviewed a database of CT images of femora to evaluate the risk of the 
distal tip of the femoral rasp contacting the endosteal cortical surface. Standard rasps 
were significantly more likely to have the rasp in contact with the endosteal surface of 
the cortex and in theory such broach contact may compromise the cement mantle 
thickness. Short stems therefore may be suitable for a greater range of femoral 
anatomy, preserve bone and reduce proximal stress-shielding. In the next Chapter we 
will examine the NZJR experience of the Exeter short cemented stems compared to 
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The standard Exeter cemented stem is 150mm long with standard offsets ranging from 
37.5mm to 56mm. Exeter short stems of 125mm are also available in the offsets of 
37.5mm, 44mm and 50mm. In addition smaller (125mm and shorter) Exeter cemented 
stems with offsets of 35.5mm or less are available. The aim of this study was to 
examine the New Zealand Joint Registry (NZJR) comparing survival rates and 
functional outcomes of standard-length stems with short Exeter stems of various 
offsets in patients undergoing primary total hip replacement (THR).  
 
Methods 
Using the New Zealand Joint Registry we reviewed the results of three separate 
groups of patients with Exeter stems. Patients with standard 150mm length Exeter 
stems (Standard), were compared with those with short 125mm stems with regular 
37.5mm, 44mm, 50mm offsets (Short 37+) and short £ 125mm stems with offsets 
35.5mm and below (Short 37-).  The demographic data, preoperative diagnosis, 
patient reported outcome measures and reasons for revision were compared between 
groups. Kaplan-Meier survival analysis, Cox multi-variate regression analysis and 
proportional hazards ratios were used to examine implant survival and the influence 
of stem group on revision rates adjusting for gender, age and surgical approach. 
 
Results 
There were 43,427 Exeter cemented stems registered in the NZJR between 1st 
January 1999 and 31st May 2018: 1,501 were Short 37-, 657 Short 37+ and 41,269 
Standard stems. In all three groups the posterior surgical approach was preferred 
(Short 37- 76.6%; Short 37+ 94.7%; Standard 76.1%; p < 0.001). In the Short 37- 
group, 94.1% were female whilst in the other two groups there was an equal gender 
ratio (p < 0.001). The Short 37- group was also significantly younger than the other 
two groups with 41.6% under 65 years of age compared to Short 37+ (37.2%) and 
Standard groups (36.9%) (p < 0.01). There was no difference in ASA grade between 
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groups. Body Mass Index (BMI) was significantly higher in the both the Short 37- and 
Short 37+ groups compared to Standard group (Short 37- 29.09, SD 7.07; Short 37+ 
29.69, SD 6.67; Standard 28.71, SD 5.72; p < 0.001). The all-cause revision rate for 
standard stems was 0.55/100cy (95% CI 0.52 to 0.58). The Short 37- group had a 
higher rate of revision compared to the Standard group (Hazard Ratio 1.60 (95% CI 
1.30 to 1.98; p < 0.001) whilst the Short 37+ group had a hazard ratio of 0.84 (95%CI 
0.38 to 1.88; p = 0.674) compared to the Standard group.  
 
The differences in Oxford Hip Scores between groups at 6 months were statistically 
significant (Standard 40.29, SD 7.61; Short 37+ 39.11, SD 7.83; Short 37- 39.28, SD 
8.14; p = 0.018) and maintained at 5 years for Standard versus Short 37- stems 
(Standard 42.21, SD 7.06; Short 37- 40.2, SD 8.39; p = 0.003). However, these 




At 20 years there was a significant difference in all-cause revision rates with standard 
length Exeter stems out-performing short stems with offsets 35.5mm or less. Short 
stems with offsets of 37.5mm or greater performed similarly to standard length stems. 
 




Total hip replacement (THR) for hip osteoarthritis is one of the most successful and 
cost-effective operations in modern medicine (Garellick et al., 1998). THR is now 
performed in increasingly younger patients but this trend places growing demands on 
implant longevity. In New Zealand the Exeter stem is the most commonly used 
cemented femoral component and has been for the last 20 years. 
 
The Exeter stem was first introduced in 1970 and despite small modifications the 
essential collarless, polished, dual tapered design has endured. This design transmits 
compressive load into circular hoop stresses which are then transmitted into the 
surrounding low modulus cement mantle and subsequently the surrounding bone 
(Ling et al., 2010). The standard Exeter stem is 150mm in length and is available in 
37.5mm, 44mm, 50mm and 56mm offsets. To address smaller femoral canals such 
as those of the Asian population, patients with juvenile arthritis or hip dysplasia the 
35.5mm offset 125mm long “CDH stem” was introduced in 2001. In addition, stems 
with smaller offsets of 33mm (115mm long) and 30mm offset (95mm long) were 
produced (Figure 11). Despite concerns about insufficient mechanical strength and 
premature stem breakage in short stems (Thien and Kärrholm, 2010) a recent study 
from the Australasian Orthopaedic Association National Joint Registry showed that at 
7 years there was no significant difference in survival rates between standard length 
Exeter stems and short stems of offsets of 35.5mm or less (Choy et al., 2012). 
However, this study did not address how Exeter 125mm short stems of offsets 
37.5mm, 44mm and 50mm, introduced in 2011, compared in terms of function or 
survivorship. Small changes in implant designs can lead to dramatic clinical failures 
(Thien and Kärrholm, 2010), (Rockborn and Olsson, 1993) therefore the performance 
of smaller Exeter stems of various offsets must be proven to at least be the equivalent 
of the established standard length stem.
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Figure 11. Short and standard length Exeter cemented stems. Left to right: 95mm length with 30mm offset, 115mm length with 33mm 
offset, 125mm length with 35.5mm offset, 150mm length with 37.5mm offset 
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The purpose of our study was to examine the New Zealand Joint Registry (NZJR) to 
investigate the long-term survivorship of Exeter short stems (£ 125mm) of offsets 
37.5mm, 44mm and 50mm (Short 37+ group) with Exeter short stems (£ 125mm) of 








The NZJR was established in 1998 and has a > 96% data capture rate of all joint 
replacement surgeries. Prospective entry of data into the NZJR is a mandatory 
requirement of all members of the New Zealand Orthopaedic Association with all data 
secured in Christchurch, New Zealand. One of the authors (CF) accessed the 
database to acquire data specifically for this study. Deidentified data of all patients 
undergoing primary THR from the NZJR inception to 31st May 2018 was available for 
analysis. We performed and reported this study in accordance with STROBE and 
RECORD guidelines (Benchimol et al., 2015). 
 
Ethical approval 
No formal Institutional Review Board (IRB) approval was required as this was a review 
of the NZJR which already has IRB approval for publication of results stored in its 
registry.  
 
Patient demographics and diagnosis 
We collected the following patient demographics: age, gender, Body Mass Index 
(BMI), American Society of Anesthesiologists class (ASA) and preoperative diagnosis. 
These factors were then compared between the three groups. 
 
Operative cohort 
We identified all Exeter stems used and divided these into three groups: Standard 
150mm length Exeter stems (Standard), Short 125mm stems with offsets 37.5mm or 
greater (Short 37+) and Short £ 125mm stems with offsets 35.5mm and below (Short 
37-). The surgical approach used in each of the three groups to access the hip was 






(i) Revision rates 
We examined the all-cause rates of revision between study groups with revision 
recorded as the rate/100 component years (cy) with 95% confidence intervals. We 
define observed component years as the number of registered primary procedures 
multiplied by the number of years each component has been in place. The revision 
rate/100cy is equivalent to the yearly revision rate expressed as a percentage and is 
derived by dividing the number of prostheses revised by the total observed component 
years multiplied by 100. This estimate allows the comparison of revision rates when 
examining implant data with varying follow-up times but does assume consistent 
revision rates over time. 
 
A revision was defined as a new operation in a previous THR during which one or 
more of the components was exchanged, removed, manipulated or added. It included 
excision arthroplasty and amputation, but not soft tissue procedures. The all-cause 
revision rate provides the most conservative estimate of prosthesis survivorship. In 
addition, we examined the reasons for revision and compared them within each group, 
in particular we examined revisions for stem-related reasons such as fracture and 
aseptic loosening. 
 
(ii) Functional outcome scores 
We examined the Patient Reported Outcome Measures (PROMs) collected from 
patients at 6 months and at 5 years post arthroplasty (Oxford 12 scores). This 
validated score consists of twelve domains which address pain, function and activities 
of daily living. Within each domain a score of 0 is the worst, whilst 4 is the best. The 
overall best possible total score is 48 and the worst is 0. These questionnaires were 
completed by the patients without medical assistance. In the first four years of the 
NZJR all patients were invited to complete these questionnaires and did so with a 
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compliance rate of 70%. Since this time 28% of patients have been randomly selected 
and PROMs distributed to this group to ensure a 20% return rate.  
 
Statistical analysis 
All-cause revision rates were expressed as rate/100cy with 95% confidence intervals. 
Hazard ratios with 95% confidence intervals were examined and Kaplan-Meier 
survival analysis performed. Subsequently, Cox multi-variate regression analysis was 
used to examine the influence of stem group on all-cause revision rates and revisions 
due to stem-related failures such as aseptic loosening and fracture adjusting for 
gender, age, and approach. The Oxford 12 scores were compared between study 
groups using an ANOVA. 
 
Funding 






There were 43,427 Exeter cemented stems reported in the NZJR between 1st January 
1999 and 31st May 2018. There were 1,501 Exeter short stems with offsets of 35.5mm 
and below (Short 37-), 657 Exeter short stems with standard i.e. 37.5mm, 44mm and 
50mm offsets (Short 37+) and 41,269 standard length stems (Standard). 
 
Patient demographics and diagnosis 
The Short 37- group was significantly younger than the other two groups with 41.6% 
under 65 years of age (mean 65.71, SD 12.97) compared to 37.2% (66.95, SD 10.96) 
(Short 37+ group) and 26.9% (69.97, SD 10.14) (Standard group) (p < 0.01). There 
was also a significantly higher proportion of female patients in the Short 37- group 
(1412; 94.1% female: 89; 5.9%; p < 0.001) whilst the gender distribution was equally 
split in both the Standard and Short 37+ groups.   
 
Osteoarthritis was the primary diagnosis in 87.6% in the Standard group, 93.8% in the 
Short 37+ group and 79.3% in the Short 37- group. The proportion of patients 
undergoing THR for dysplasia was higher in the Short 37- group (6.9%) whilst it was 
only 1.5% and 1.1% in the Short 37+ and Standard groups respectively. The 
distribution across the other diagnoses was similar between the three groups (Table 
13). There was no significant difference in ASA class between the groups however 
BMI was significantly higher in the both the Short 37- and Short 37+ groups compared 
to the Standard group (Short 29.09, SD 7.07; Short 37+ 29.69, SD 6.67; Standard 





























Short Count 1191 36 20 70 103 21 6 51 25 49 1501 
% 79.3% 2.4% 1.3% 4.7% 6.9% 1.4% 0.4% 3.4% 1.7% 3.3% 100.0% 
Short 
37+ 
Count 616 2 2 13 10 3 0 17 1 8 657 
% 93.8% 0.3% 0.3% 2.0% 1.5% 0.5% 0.0% 2.6% 0.2% 1.2% 100.0% 
Standard Count 36144 567 224 2061 364 566 76 1178 252 872 41926 
% 87.6% 1.4% 0.5% 5.0% 0.9% 1.4% 0.2% 2.9% 0.6% 2.1% 100.0% 
Total Count 37951 605 246 2144 477 590 82 1246 278 929 43427 




In all groups the posterior approach was the preferred surgical approach (Short 37- 
76.6%; Short 37+ 94.7%; Standard 76.1%; p < 0.001). The distribution of femoral 






















Table 14. Distribution of femoral component offsets (mm) between groups of Exeter cemented stems 
 
  Offset Total 
30 33 35.5 37.5 44 50 56 
Short/standard 
stem 
Short Count 12 13 1476 0 0 0 0 1501 
% 0.8% 0.9% 98.3% 0.0% 0.0% 0.0% 0.0% 100.0% 
Short 
37+ 
Count 0 0 0 245 326 86 0 657 
% 0.0% 0.0% 0.0% 37.3% 49.6% 13.1% 0.0% 100.0% 
Standard Count 0 0 0 9061 27094 5010 95 41260 
% 0.0% 0.0% 0.0% 22.0% 65.7% 12.1% 0.2% 100.0% 
Total Count 12 13 1476 9306 27420 5096 95 43418 






All-cause revision rates and reasons for revision 
The overall all cause revision rate for all Exeter stems at a maximum of approximately 
19 years follow-up (289980.9cy) in the NZJR was 0.56/100cy (95%CI 0.53 to 0.59). 
The all-cause revision rate for standard stems was 0.55/100cy (95% CI 0.52 to 0.58). 
The low offset short stem (Short 37-) group had a higher rate of revision compared to 
the Standard group (all cause revision rate 0.92/100 cy (95%CI 0.74 to 1.13; Hazard 
Ratio 1.60 (95% CI 1.30 to 1.98; p < 0.001) whilst the Short 37+ group had an all cause 
revision rate of 0.80/100cy (95%CI 0.25 to 1.65; hazards ratio of 0.84 compared to the 





Figure 12. Kaplan-Meier survivorship curve of all-cause revision free survival rates 




The comparison between groups of reasons for revision are shown in Table 15. There 
was a higher proportion of deep infection in the Short 37+ group and this is not 
attributed to the characteristics of this stem (5 deep infection, 83.3% of revisions in 
this group) whilst in the Standard group the most common cause of revision was 
instability (458, 29.9%) and in the Short 37- group it was acetabular loosening (39, 
42.4%). Aseptic loosening of the femoral component was not seen in the Short 37+ 
group compared to 7.9% in the Standard group and 1.99% in the Short 37- group 





















Table 15. Comparison of reasons for revision between groups 
 
Reason for Revision   
                    












Short 37- Count 39 18 17 11 8 5 51 
% 42.4% 19.6% 18.5% 12.0% 8.7% 5.4% 55.4% 
Short 
37+ 
Count 0 0 0 1 5 0 0 
% 0.0% 0.0% 0.0% 16.7% 83.3% 0.0% 0.0% 
Standard Count 408 110 458 135 250 202 484 
% 26.6% 7.2% 29.9% 8.8% 16.3% 13.2% 31.6% 
Total Count 447 128 475 147 263 207 535 













Figure 13. Kaplan-Meier survivorship curve of revisions of aseptic loosening compared between Exeter cemented stem groups. 
Given insufficient numbers in the Short 37+ group was excluded.  
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Cox multivariate regression analysis of all-cause revision rates is shown in Table 16. 
When regression analysis of all-cause revisions was performed, and adjustments 
made for gender, age and approach in the model, the statistically significant difference 
in revision rate between the Short 37- and the Standard groups persisted (Hazard 




Table 16. Cox multivariate regression analysis (all cause revision rates) 
 
  B SE Wald df Sig. HR 
95.0% CI for HR 
Lower Upper 
Short/standard stem     15.167 2 0.001       
Standard stem v Short 0.439 0.116 14.472 1 0.000 1.552 1.237 1.946 
Standard stem v short 37+ -0.350 0.449 0.605 1 0.437 0.705 0.292 1.701 
Sex Female -0.201 0.053 14.577 1 0.000 0.818 0.738 0.907 
Age     78.441 3 0.000       
Age <55 v 55-64 -0.347 0.082 17.740 1 0.000 0.707 0.601 0.831 
Age <55 v 65-74 -0.598 0.079 56.870 1 0.000 0.550 0.471 0.642 
Age <55 v >=75 -0.686 0.087 62.297 1 0.000 0.503 0.425 0.597 
Approach     6.705 3 0.082       
Approach Anterior v Posterior -0.071 0.126 0.322 1 0.570 0.931 0.727 1.192 
Approach Anterior v Lateral -0.222 0.135 2.696 1 0.101 0.801 0.614 1.044 
Approach Anterior v Troch-
Osteo 
0.265 0.464 0.327 1 0.568 1.303 0.525 3.235 
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Stem survival for aseptic loosening is displayed graphically in Figure 12. When the 
regression analysis focused on aseptic loosening as a cause of revision (Table 17), 
aspetic loosening was significantly higher in the Short 37- group compared to the 
Standard group (Hazards Ratio 2.72; 95%CI 2.04 to 3.633, p < 0.001) and this 
remained significant even after adjusting for age, gender and approach (Hazards Ratio 
2.429, 95%CI 1.76 to 3.35, p < 0.001). There was no significant difference between 
Short 37- and Standard groups in both unadjusted comparisons (Hazards ratio 0.66; 
95%CI 0.27 to 1.59, p = 0.353) and adjusting for age, gender and surgical approach 
























  B SE WALD DF SIG. HR 95.0% CI FOR HR 
LOWER UPPER 
SHORT V STANDARD 
STEM 
0.887 0.164 29.350 1 0.000 2.429 1.762 3.349 
SEX -0.114 0.094 1.489 1 0.222 0.892 0.743 1.072 
AGEGRPS     45.064 3 0.000       
AGEGRPS(1) -0.133 0.138 0.935 1 0.334 0.875 0.669 1.146 
AGEGRPS(2) -0.467 0.136 11.793 1 0.001 0.627 0.480 0.818 
AGEGRPS(3) -0.988 0.169 34.001 1 0.000 0.372 0.267 0.519 
APPROAC     11.791 3 0.008       
APPROAC(1) -0.506 0.183 7.645 1 0.006 0.603 0.421 0.863 
APPROAC(2) -0.329 0.196 2.826 1 0.093 0.720 0.490 1.056 
APPROAC(3) 0.494 0.604 0.670 1 0.413 1.639 0.502 5.348 
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Functional outcome scores 
The Oxford scores were significantly higher in the Standard group compared to the 
Short 37- group at both 6 months and 5 years. The Oxford score was also significantly 
higher in the Standard group compared to the Short 37+ group at 6 months. There 
was insufficient data for statistical analysis of the Short 37+ group at 5 years. The 
magnitude of the differences between groups was small and is unlikely to represent 




















Table 18. Oxford functional scores compared between groups at both 6 months and at 5 years 
 
  
Short Short 37+ Standard Total 
 
Oxford Score 6m Mean 39.28 39.11 40.29 40.25 p=0.018 
Std. Deviation 8.14 7.83 7.61 7.63   
Minimum 5 15 0 0   
Maximum 48 48 48 48   
N 378 72 9957 10407   
Oxford Score 5 years Mean 40.20   42.27 42.21 p=0.003 
Std. Deviation 8.39   7.01 7.06 
  
Minimum 14   5 5 
  
Maximum 48   48 48 
  
N 106 0 3614 3720 
  




The results of this study show that the use of the Exeter stem for primary hip 
replacement in New Zealand provides excellent function and survivorship at 20 years. 
According to the most recent NZJR report overall primary hip replacements have an 
all-cause revision rate of 0.72/100cy (95%CI 0.71 to 0.74) therefore the Exeter stem 
overall, with a revision rate 0.56/100cy (95%CI 0.53 to 0.59), is a positive outlier for 
survivorship (7). Our results also show that patients who received a short Exeter stem 
with an offset 35.5mm or less were significantly younger and more likely female than 
those who received a standard-length Exeter stem. This lower offset group, perhaps 
predictably, also had a higher prevalence of dysplasia. We cannot comment on patient 
ethnicity from our study, nor the precise nature of femoral geometry. In our study the 
posterior approach was the preferred approach for implanting the Exeter stem and on 
multivariate analysis the surgical approach did not affect revision rates. The Exeter 
short stems of offset 35.5mm or less were significantly more likely to undergo revision 
compared to standard length Exeter stems. Short Exeter stems with regular 37.5-
50mm offsets also had a higher revision rate compared with standard length stems, 
however it should be noted that the reasons for revision varied between groups and if 
deep infections were excluded the Short 37+ group displayed similar results to the 
Standard group.  When we examined revisions for stem-related reasons the Short 37- 
stem had a higher likelihood of failure for aseptic loosening compared to standard 
Exeter stems. There was no difference between groups when examining revisions for 
stem fracture. This is noteworthy as one might suspect that a short Exeter cemented 
stem with a higher offset might have an increased varus moment that potentiates its 
failure by either aseptic loosening or fracture. There were no implant breakages. Whilst 
Oxford scores were superior in the Standard Exeter cemented stem group the 
difference observed is below the mean clinical important difference for this outcome 
measure and this clearly limits the clinical significance of this statically significant 
result.  
 
In the Australian NJR study at 7 years there was no significant difference in 
survivorship rates between short stems with offsets less than 35.5mm (3.4% revised; 
95%CI 2.4 to 4.8%) compared to standard length Exeter stems (3.5%; 95%CI 3.3 to 
3.8%) (Choy et al., 2012). This contrasts with the findings of our study where the 
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standard-length Exeter stems had lower revision rates in the NZJR (Figure 12). In the 
Australian NJR, short stems with offsets of 37.5mm, 44mm and 50mm were not 
included, however, our study’s results suggest that these newer stems behave more 
like the standard-length Exeter stems. The findings of our study compliment a recent 
study that showed that low offset cemented femoral component offset was associated 
with a higher risk of revision (Wyatt et al., 2018). Moreover, the offset and shape of 
the proximal stem may be more critical than stem length with the cemented Exeter as 
rotational stability is provided by the proximal body (Wilson et al., 2012).   
 
In this study cohort we have combined the standard-length Exeter Universal stems 
grouped with V40 stems of standard length. The Exeter Universal stem was introduced 
in 1988 and proved highly successful. With aseptic loosening as an endpoint the first 
325 hips implanted demonstrated a 100% femoral component and 90.4% acetabular 
component survivorship (Carrington et al., 2009). As there were no published 
differences of altered survivorship with the change from the Universal to the V40 
Exeter stems we feel that this combination is justified for the purpose of this study 
(Westerman et al., 2018).   
 
This study is a retrospective analysis of prospectively, systematically and 
consecutively collected registry data with a > 96% capture rate. The revision rate of 
the Exeter stem is low therefore large datasets are needed to provide adequate 
statistical power for an intelligible comparison. Over 40,000 Exeter stems were 
available for the analysis provided in our study, which we feel substantiates this as an 
important and pertinent study. However, the study is limited by the relatively low 
numbers of Exeter stems £ 125mm length. The study is representative of a wide 
spectrum of Orthopaedic surgeons with varied clinical experience covering an entire 
nation. The inclusion of 43,427 Exeter cemented stems is the largest comparative 
series of Exeter short and standard length stems to our knowledge. 
 
National Joint Registry data can support evidence-based practice, implant 
surveillance, hospitals, surgeons and PROMs. They can also identify subtle trends, 
which would not be logistically feasible through other methods. Such trends can be 
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then investigated through other scientific means (Konan and Haddad, 2013). We were 
unable to allow for possible confounders such as severity of joint disease or the 
precise and increasing complexity of patient comorbidities or medications. We have 
used age and ASA as proxy indicators for comorbidities with the rationale that these 
are the best indices in recent research (Ondeck et al., 2018). All-cause revision rates 
do not capture patients too unwell to undergo revision surgery or for whom the joint 
replacement may be functioning poorly. The decision to revise a THR depends on 
patient factors such as comorbidity and choice, surgical factors such as perceived 
risk/benefit analysis, surgical skills and departmental resources. Furthermore, the 
NZJR does not include revisions for soft-tissue procedures. Moreover, no radiographic 
comparisons have been made in our study cohort and therefore we cannot critique 
cementing technique or implant alignment. The anteversion of the femoral stem is not 
accounted for in our study and excessive cement stresses can occur with highly 
anteverted stem positions in finite element models (Harman et al., 2016).  
 
Shorter Exeter cemented stems were introduced to address femora which were either 
smaller or had fluted or narrower internal geometries. Accurate preoperative 
templating will allow the surgeon to predict the need for a shorter stem in most cases. 
During surgery the perceived inability to gently pass the larger T-handled fluted reamer 
can indicate that a short stem may be required. Whilst a short, low offset stem is 
undoubtedly desirable in order to recreate native hip biomechanics in dysplastic or 
small femora, the results of our study suggest that an Exeter stem of offset 37.5mm 





At 20 years there was a significant difference in all-cause revision rates with standard 
length Exeter stems out-performing short stems with offsets 35.5mm or less. In 
contrast, short stems with offsets of 37.5mm or greater performed similarly to standard 







The previous Chapter showed that in the NZJR the Exeter short cemented stems with 
the most common offsets (i.e. 37.5, 44 and 50mm) had survivorships comparable to 
the standard-length Exeter stems with the same offsets. To clarify the three groups 









This study suggests that the length of the Exeter cemented stem per se is not the 
critical determinant of survivorship and that the short 37+ Exeter stems behave 
similarly to the standard Exeter stems. The findings in Chapter 2 indicated that femoral 
offset was an important factor in cemented stem survorship and we did not model this 
directly in Chapter 3 which is a potential weakness; instead we subdivided the Exeter 
stems into three categories i.e. we did not model for offset itself as a continuous 
variable in our analysis. In chapter 2 both low and high offset cemented stems were 
at greater risk of all-cause revision yet in chapter 3 this risk was attributed to the lower 
offset group only. In the previous Chapter we examined the Exeter cemented hip only 
whilst in Chapter 2 other cemented designs were included in the analysis. The study 
can also be criticised as there were no baseline Oxford hip scores which is therefore 
a potential confounder when comparing Oxford hip scores at 6 months and at 5 years 
between groups. Despite the methodology used and adjustments made during the 
analysis the influence of patient factors especially age and underlying diagnosis such 
as hip dysplasia may be highly pertinent to the observed results.    
All Exeter cemented stem THR 
(NZJR (20 year report) 
Standard  (150mm) length 
Exeter stems 
(Offsets 37.5mm, 44mm 
and 50mm) 
“Standard group” 
Short (125mm) length 
Exeter stems 
(Offsets 37.5mm, 44mm 
and 50mm) 
“Short 37+ group” 
Short (125mm) length 
Exeter stems 
(Offsets £35.5mm) 
“Short 37- group” 
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Up-to-date literature search 
The following databases were searched from 2018 to 30.3.2020 using the programme 
Papers: were searched on 30.3.2020: ACM, ADS, arXiv, CERN DS, CrossRef DOI, 
DBLP, Espacenet, Google Scholar, Gutenberg, Highwire, IEEExplore, Inspire, 
JSTOR, OAIster, Pubget, PubMed, ScienceDirect, Scopus and Web of Science. 
Search terms related to:  Short stem AND cemented AND Total hip. 
 
25 references were identified of which 6 were collected as potentially relevant. Two 
articles that cited the study described in this chapter were examined. Journals with 
impact factors <2 were excluded. Any correspondence relating to the article described 
in this chapter was reviewed. There was no correspondence nor recent similar studies 
comparing cemented short stems to standard length cemented stems. Despite the 
potential weaknesses the Chapter 3 study does highlight the excellent results of Exeter 
cemented stems in the hands of many surgeons across the whole of New Zealand 
and therefore has high external validity. 
 
Short stems with uncemented fixation have been compared to standard length 
uncemented stems (Giardina et al., 2018). In this Registry study from 2000 to 2016 
short stems were defined as less than 12cm in length and were compared with 
conventional ones. The short stems were then classified according to the classification 
of Feyen and Shmimin 2014. Short stems were found to have been implanted into 
younger patients in this study. Similar to the results shown in Chapter 3 there were 
comparable survival rates in the short and conventional length stems and survival 
rates were >90% at 15 years (Giardina et al., 2018). Uncemented short stems 
therefore can achieve reliable long-term survival and longer-term studies will elucidate 
whether this applies to cemented short stems as well. 
 
Let us now consider that 42% of patients presenting to an Orthopaedic surgeon with 
osteoarthritis of the hip have bilateral disease (Stavrakis, SooHoo and Lieberman, 
2015). Should patients with bilateral hip disease receive single anaesthetic bilateral 
THR (SABTHR) and if so, what protocol should be followed? The potential advantages 
of SABTHR are a shorter overall anaesthetic time, shorter total length of hospital stay, 
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quicker overall recovery, lower costs and a more expeditious recovery of function  
(Della Valle et al., 2003). However the key issue of contention in performing especially 
cemented SABTHR remains safety (Tsiridis, Pavlou and Charity, 2008) and 
specifically whether early mortality rates are increased. The next Chapter will focus on 
the 40-year experience of cemented Exeter stems in the context of SABTHR to 
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Symptomatic bilateral hip osteoarthritis can be surgically treated with either staged or 
single anaesthetic bilateral total hip replacement (BTHR). Today the younger, fitter 
patient with severe bilateral hip disease, the typical candidate for BTHR, is more likely 
to receive cementless rather than cemented implants. We present the Exeter 
experience of single anaesthetic bilateral fully cemented and hybrid THR performed 
through the posterior approach and, to our knowledge, the largest prospective single-
centre series. 
 
We performed a cohort study of all patients (319 patients: 638 hips) having BTHR at 
our institution between December 1977 and December 2015. No case was lost to 
follow-up. Data was collected prospectively but reviewed retrospectively. Lengths of 
stay and complication rates were assessed.  Locally collected data were compared 
with Hospital Episode Statistics (HES) data for the operations carried out between 
March 2005 and June 2014 to confirm local database validity. 
 
The rates for mortality, deep vein thrombosis (DVT), non-fatal myocardial infarction 
(MI) within 6 months were each 0.3% (1 episode) and non-fatal pulmonary embolism 
(PE) 0.6% (2 episodes). There were no intraoperative periprosthetic fractures or any 
readmissions within 30 days. Our study shows a low risk of complications when 
performing fully cemented and hybrid BTHRs for appropriately selected patients and 
the risk of complications compares favourably with published results. Overall 





Surgical management options of bilateral hip osteoarthritis comprise staged or single-
anaesthetic bilateral total hip replacement (BTHR), the latter having been first 
described by Charnley (Stavrakis, SooHoo and Lieberman, 2015; Jaffe and Charnley, 
1971). Advocates of BTHR over staged operations assert the benefit of a single 
anaesthetic providing shorter overall anaesthetic time, length of hospital stay and 
recovery period. A 30% saving in cost and further cost-savings for the patient from the 
perspective of time off work have been shown with BTHR (Della Valle et al., 2003).  
Those recommending staged operations may prefer the standard protocol of a 
unilateral procedure, avoiding the more prolonged surgical time of a BTHR. On the 
other hand, from the patient’s perspective are the significant advantages of not having 
to face a second anaesthetic and major procedure along with its known risks. The key 
issue of debate in performing BTHR appears to be safety (Tsiridis, Pavlou and Charity, 
2008; Haverkamp et al., 2010).  
 
The National Joint Registries of England and Wales, Norway, Sweden, Australia and 
New Zealand all show an increasing trend for cementless fixation, particularly in 
younger, fitter patients who are the typical candidates for BTHR (Wyatt et al., 2014). 
A number of studies using cementless hip replacements have compared BTHR with 
staged procedures.  These studies show, in general, excellent functional results and 
no difference in risk of complications and mortality between groups but show a higher 
transfusion risk with BTHR (Parvizi et al., 2006; Kim, Kwon and Kim, 2009; Hooper et 
al., 2008).  Although studies reporting on cemented BTHR are uncommon, cemented 
BTHR has been performed at our institution since 1977, becoming routinely performed 
in selected cases since 1991.  The aim of this study therefore was to examine whether 
cemented BTHR is safe and efficacious at our institution and how this method 




Patients and Methods 
 
Subjects of this study 
The hip research team at the Princess Elizabeth Orthopaedic Centre, formerly the 
Princess Elizabeth Orthopaedic Hospital, has been collecting data prospectively from 
every elective hip arthroplasty patient prior the first BTHR, performed in December 
1977. We searched our unit’s database, patient records and hospital electronic record 
systems for all consecutive cases of BTHR until December 2015. Data was reviewed 
and analysed retrospectively. The database identified 319 patients (638 THRs) who 
received BTHR. 
 
We offered BTHR to patients aged 70 years or younger with American Society of 
Anesthesiologists (ASA) grade 1. Early in the series BTHR was selectively offered to 
fit and healthy patients irrespective of age. The perioperative management of these 
patients has evolved over four decades of practice. Our current practice mandates 
that all patients undergo thorough preoperative assessment, led by specialist nursing 
staff, in a specific outpatient clinic at one to 2 weeks prior to surgery and includes 
consultation with a hip surgeon. A consultant anaesthetist is available to review cases 
on request in advance of surgery. Prior to the introduction of this clinic (April 2009) 
patients were admitted the night before surgery with an anaesthetic assessment that 
evening on the ward. The anaesthetic technique most commonly used in this series 
was an epidural blockade and sedation, enabling top-up analgesia requirements for 
the first 36 to 48 hours and mobilisation the day following surgery. In the last 5 years 
spinal anaesthesia combined with either general anaesthesia or sedation, along with 
periarticular local anaesthetic infiltration, has become the technique of choice, allowing 
all patients to start mobilisation from the first postoperative day and still providing 
adequate analgesia. Blood conservation measures of intravenous tranexamic acid 
(15mg/kg IV) at the time of induction of anaesthesia and use of a cell salvage system 
have been incorporated as routine practice for the last 5 years. This is in keeping with 
the recommendations of recent studies (Babis et al., 2011; Lindberg-Larsen et al., 
2013; Rasouli et al., 2014). The transfusion threshold depends on an individualised 
assessment that takes into account preoperative haemoglobin levels, but largely is of 
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a haemoglobin level of 80 g/l. Since 1995, thromboprophylaxis has included 
mechanical prophylaxis (foot or calf pumps), early mobilisation, prophylactic use of 
low molecular weight heparin starting 6 hours postoperatively and continuing for 6 
weeks following surgery, either with the same drug or oral anticoagulation. Prior to 
this, thromboprophylaxis comprised of TED stockings, aspirin or hydroxychloroquine 
in combination with mobilisation. 
 
Surgical care 
The first 4 patients (8 hips) received a monoblock matt surfaced Exeter stem 
(Howmedica) with the remainder receiving a polished modular Universal Exeter stem 
(Stryker Orthopaedics, Mahwah, NJ) The type of socket fixation (cemented or 
uncemented) varied according to surgeon preference. All operations were performed 
by a consultant level surgeon or an arthroplasty fellow / senior registrar under direct 
supervision. The more symptomatic side was replaced first. 
 
Routine practice is to inform the anaesthetist when cement is about to be introduced 
into the acetabulum or femur. In the acetabulum, thorough high pressure irrigation is 
performed and the bony surface then dried, prior to hand insertion and then 
pressurisation of the cement. On the femoral side, specific technical measures to 
minimise embolic potential are high pressure saline irrigation and suctioning of the 
canal prior to each instrumentation (Timperley and Whitehouse, 2009). Before the 
cement gun nozzle is introduced, the canal is suctioned by a small diameter catheter 
and is cleaned and dried with ribbon gauze. (Until January 2015, the ribbon gauze was 
routinely soaked in 1.5% hydrogen peroxide solution for all primary THRs at our 
institution. However, due to regulations set by The Medicines and Healthcare products 
Regulatory Agency [MHRA 2014], peroxide has since been replaced by 0.9% saline 
solution.) The suction catheter is left in position until blocked by the retrograde 
insertion of cement, when it is removed. As soon as the canal is full of cement, it is 
pressurised as per modern practice, followed by insertion of the implant to the planned 




Postoperative care and follow-up 
Patients followed a uniform perioperative care pathway. Follow-up was routinely made 
in the outpatient department at 6 to 8 weeks postoperatively, which included an 
aftercare physiotherapy review, and then at 6 months, 2 years, 5 years and every 5 
years thereafter for clinical and radiographic assessment (The Exeter Hip. 40 years of 
innovation in total hip arthroplasty, 2010). 
 
Outcome measures 
Data collected prospectively included: age at operation; diagnosis; operating surgeon 
grade; duration of in-hospital stay; mortality at 6 months; cardiorespiratory and 
thromboembolic complications at 6 months; periprosthetic fractures; 30 day 
readmission rates and reasons for revision up to the most recent follow-up. The 
extended time point of 6 months after surgery for assessment of mortality, 
cardiorespiratory and thromboembolic complications was chosen to ensure enough 
time for complete recovery and return to usual activities for the entire cohort, 
considering the difference in rehabilitation protocols from the initial cases in the series 
to our current practice. National Health Episode Statistics (HES) data were used to 
capture complications that may have been missed by the local database or occurred 
elsewhere.  HES data was available from March 2005 to June 2014 and matching was 
carried out using anonymised datasets linking age, sex and operation date. We were 
able to apply this to 240 patients (75% of the cohort) having their complication rates 




Demographics and complication rates were calculated. Data was analysed using 





The mean age in the study group was 58.6 (range 21-83; 95% Confidence Interval 
(CI) 57.3 to 59.8) years. BTHR was performed infrequently before the senior author 
was appointed as consultant to the Hip Unit in 1991, as shown in Figure 14. Diagnoses 
for each hip are shown in Table 19. There were 32 different surgeons recorded as first 
surgeon, 16 of which were consultant level. All operations were either performed by a 
consultant level surgeon or a senior registrar / arthroplasty fellow under direct 
supervision. A total of 319 patients were included for review, with no BHTR exclusions. 
A fully cemented THR was used in 412 hips (65% of series) and a hybrid combination 
in 226 hips (35%). Although the majority of patients underwent standard primary 
procedures, five patients had at least one side performed as a complex or revision 
procedure (Table 20). The median length of stay for the overall series was 7.0 days 
(range 3 to 49, interquartile range (IQR) 5), decreasing to a median of 5.0 days in the 
































































































































Table 19. Diagnosis of patients having BTHRs  
 
 
Diagnosis Hips (n = 638) 
OA 530 (83%) 
Osteonecrosis 24 (3.8%) 
Protrusio 17 (2.7%) 
Dysplasia 16 (2.5%) 
Rheumatoid arthritis 15 (2.4%) 
Epiphysiolysis 12 (1.9%) 
Ankylosing spondylitis 6 (0.9%) 
Other inflammatory arthritides 6 (0.9%) 
Perthes 5 (0.8%) 
Failed THR 4 (0.6%) 
Failed osteotomy 2 (0.3%) 





Table 20. Details of patients submitted to at least one complex or revision procedure 
as part of a BTHR 
 
 
Patient Year First side Second side 
1 1991 Primary THR Revision THR for acetabular 
loosening and cemented 
femoral revision 
2 1999 Primary THR Revision THR for acetabular 
loosening and in-cement 
femoral revision 
3 2001 Complex THR with acetabular 
impaction grafting 
Complex THR with acetabular 
impaction grafting 
4 2004 Revision THR with acetabular 
impaction grafting for socket 
loosening and in-cement 
femoral revision 
Revision THR with in-cement 
acetabular revision to a 
constrained liner 
5 2005 Removal of sliding hip screw 







Figure 15. Scatterplot showing length of stay (days) versus time (years) 
 
 
Medical complications within the first 6 months 
In 1992, one death (0.3% of series) was recorded at 62 days postoperatively, a likely 
but unconfirmed myocardial infarction following readmission of a 73 year old patient 
under the general surgical team. 
 
In 2009 one patient (0.3% of series) suffered a non-fatal myocardial infarction in the 
recovery room immediately after surgery. This patient had a previous history of 
hypertension and thyroid dysfunction. 
 
In 2009 and 2010 there were two cases of pulmonary embolism (0.6% of series) on 
days 6 and 89, respectively, treated with full anticoagulation for 6 months. Both 
patients had a body mass index (BMI) of over 30 kg/m2 and were not mobilised until 
the second postoperative day due to epidural catheterisation. Chemoprophylaxis with 
low molecular weight heparin for one of these patients was started only once the 
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In 2014 one patient (0.3%) sustained unilateral deep vein thrombosis that was treated 
with full anticoagulation for 12 weeks. There were 19 (2.97%) revisions in the entire 
series. The reasons for any revision for the entire series are shown in Table 20. There 
were no intraoperative periprosthetic fractures or any readmissions within 30 days. No 
discrepancy was found when comparing our database with available HES data. 
 
Revisions 
The most common cause for revision was aseptic loosening of the acetabular 
component (Table 21). 
 
Table 21. Reasons for revision THR 
 
Patient Year First side Second side 
1 1991 Primary THR Revision THR for acetabular 
loosening and cemented 
femoral revision 
2 1999 Primary THR Revision THR for acetabular 
loosening and in-cement 
femoral revision 
3 2001 Complex THR with acetabular 
impaction grafting 
Complex THR with acetabular 
impaction grafting 
4 2004 Revision THR with acetabular 
impaction grafting for socket 
loosening and in-cement 
femoral revision 
Revision THR with in-cement 
acetabular revision to a 
constrained liner 
5 2005 Removal of sliding hip screw 




Two patients (three hips) required revision for sepsis: one patient treated with a first 
stage revision on the right side in 1993 at 17 months after surgery with no subsequent 
surgery and the other patient with a background of Hepatitis C having a two-stage 
revision on the right side in 2013 at 9 years after surgery and a first stage revision on 




This non-randomised, prospectively collected study of consecutive patients with 
bilateral hip disease is the largest single-centre series with the longest follow-up of 
BTHR where only cemented femoral components were used. A similar study by 
Gaston et al., 2006 examined 49 cemented bilateral THRs and compared them with 
215 unilateral cemented THR.  In that study there was no difference in mortality rates, 
complications, instability or function but an increased transfusion rate was noted in the 
BTHR group.  Age and underlying diagnoses were similar to those of our study. There 
was a trend for patients receiving BTHR to be younger with no patients greater than 
70 years of age for the last 5 years. The length of stay in our study showed an expected 
trend towards more expeditious discharge from hospital over time with a mean stay of 
5 days over the last 10 years. 
 
This series suggests a mortality risk at 6 months of 0.3% and compares favorably to 
a large data-set study of the Swedish Hip Registry (0.3% at 90 days) (Garland et al., 
2015). The overall 90 day mortality rate for unilateral THR is 0.29% in the National 
Joint Registry of England and Wales (Hunt et al., 2013), being therefore higher than 
that of our study where patients were submitted to 2 total hip replacements at a single 
setting. The mortality rate in our study is not higher than that of several uncemented 
series (Stavrakis, SooHoo and Lieberman, 2015; Wyatt et al., 2014; Parvizi et al., 
2006; Aghayev et al., 2010; Lamo-Espinosa et al., 2015; Berend et al., 2005; Martin 
et al., 2016; Gondusky et al., 2015). 
 
There were 2 cases (0.63%) of pulmonary embolism (PE) within 6 months in our 
series, both with BMI > 30.  PE rates of 0.45% have been reported in larger cohorts of 
uncemented bilateral THRs performed in the United States (Timperley and 
Whitehouse, 2009) and other uncemented series (Aghayev et al., 2010; Lamo-
Espinosa et al., 2015; Martin et al. 2016; Gondusky et al., 2015).   
Three hips in 2 patients were revised for deep infection in our series. The patient with 
bilateral deep infection was found to be Hepatitis C positive at preoperative screening 
for bone donation and subsequently required a two-stage revision on the right side 
and a first stage revision to an articulating spacer on the left, not requiring further 
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interventions after that. The rate of deep infection reported by Stavrakis, SooHoo and 
Lieberman (2015), was 0.54% infection rate.  We feel important points of relevance 
are strict patient selection, careful surgical technique, avoidance of prolonged surgical 
time and hypothermia, thorough haemostasis and irrigation, meticulous wound 
closure, timely administration of prophylactic IV antibiotics according to an agreed 
local protocol and the use of antibiotic-loaded cement (pre-mixed by the manufacturer) 
that in conjunction may confer additional prophylactic effect. 
 
Our study has some limitations and did not examine transfusion rates, although these 
issues have been addressed in previous studies (Parvizi et al., 2013; Romagnoli et 
al., 2013). It is a retrospective analysis of prospectively, systematically and 
consecutively collected data. Another potential criticism is whether or not the findings 
of this study can be generalised. However, this series comprised those operated on 
by 32 different surgeons of which seven were specialist hip surgeons. Macaulay et al. 
in 2002 recommended that BTHR should be best performed in dedicated centres and 
we support this recommendation. Furthermore, we could not identify how many 
patients were initially intended to have bilateral THR and then had staged surgery 
because of anaesthetic concerns following completion of the first side. However, there 
was only one such case recalled by the senior author (GAG). Overall our study showed 
a low rate of complications for cemented BTHR in patients with very few or no risk 
factors.  There were no revisions for early instability.  
 
We conclude by endorsing the use of cemented and hybrid BTHR in fit and well 
patients of 70 years or less with no known comorbidities in specialist centres that follow 
safe cementing techniques.  We advocate appropriate patient selection through strict 
preoperative assessment, use of anaesthetic techniques that enable mobilisation from 
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In the previous chapter performing cemented SABTHR using Exeter stems in a 
specialist centre was shown to be safe in appropriately-selected patients using a strict 
care protocol ie patients less than 70 years of age and ASA 1 or 2. Whether the 
excellent outcomes demonstrated are generalisable to other centres or with other 
cemented implants is unknown however. Another potential confounder to 
acknowledge in this study was the potential influence of tariff and renumeration for 
single versus bilateral THR and whether there might be a financial incentive for the 
surgeon or healthcare provider to do staged operations.  
 
Up-to-date literature search 
The following databases were searched from 2018 to 30.3.2020 using the programme 
Papers: ACM, ADS, arXiv, CERN DS, CrossRef DOI, DBLP, Espacenet, Google 
Scholar, Gutenberg, Highwire, IEEExplore, Inspire, JSTOR, OAIster, Pubget, 
PubMed, ScienceDirect, Scopus and Web of Science. Search terms related to: 
Bilateral AND Total hip.  
 
306 references were identified of which 4 were collected as potentially relevant. Those 
2 published articles that cited Chapter 4 were also examined. Journals with impact 
factors <2 were excluded. Any correspondence relating to the article described in this 
chapter was reviewed.  
 
With regards the mortality associated with SABTHR a recent publication by Partridge 
et al., 2020 examined the HES data from the entire UK and 2507 SABTHRs. In 
accordance to Chapter 4 patients in this study were younger and more likely male than 
patients having unilateral THR. SABTHR was however shown to have a greater risk 
of thromboembolism, myocardial infarction, renal failure and in-hospital mortality. 
Patients at particular risk had a higher Charlson score. This study however did not 
show patients only operated on in specialist centres nor was the same strict care 
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pathway adhered to with every patient. Patient selection bias may partially explain the 
difference in findings to Chapter 4. 
 
A recent paper published online by Villa et al., 2020 reported a single centre 
retrospective series of 670 primary staged bilateral THR and TKR between 2010 and 
2016. Patients who waited >12 months from the first operation had shorter in-hospital 
length of stay and lower overall transfusion rates than those who had their second 
operation <12months from the first. The study did not show a benefit in delaying 
surgery by a shorter time period than this. 
 
Delaying the second THR in staged bilateral THR by 90 days to allow the mortality risk 
to return to baseline is justified, however, by Hunt et al., 2013. In this study of 409,096 
THR recorded in the National Joint Registry of England, Wales, Northern Ireland and 
the Isle of Man between 2003 and 2011 linking data to the national mortality database 
and the Hospital Episode Statistics database examining details on mortality, 
comorbidity and sociodemographics were examined. Mortality rates within 90 days of 
surgery were examined using Kaplan-Meier analysis and the role of patient and 
treatment factors by Cox proportional hazards model. The type of prosthesis, in 
accordance with the findings of the previous 2 chapters was not related to mortality. 
The factors that reduced mortality were using a posterior approach (Hazards ratio 
0.82; 95%CI 0.73 to 0.92, p = 0.001), the use of thromboprophylaxis (both mechanical 
and chemical) and spinal versus general anaesthetic (Hazards ratio 0.85; 95%CI 0.74 
to 0.97; p = 0.019). 
 
Wyatt et al., 2018 examined the NZJR between 1999 and 2015 and compared the 90 
day mortality rate, all-cause revision risk and Oxford Hip scores between single-
anaesthetic bilateral THR, unilateral THR and staged bilateral THR in three groups: 
second THR within 90 days, 90 days to 12 months and >12 months. Single-
anaesthetic bilateral THRs were performed in younger and predominantly male 
patients with significantly lower BMI and ASA grades. The mortality risk for the single-
anaesthetic bilateral group was 0.26%. The hazards ratio compared to unilateral THR 
was 0.25 (95%CI 0.3 to 0.41; p<0.001) in both unadjusted analyses and adjusting for 
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age, and ASA grade. In staged bilateral THR the lowest mortality risk was observed 
when the second side was delayed at least 90 days after the first THR. The all-cause 
revision rate was not increased in the single-anaesthetic bilateral group compared to 
the unilateral group. The functional scores were significantly greater in the single-
anaesthetic bilateral group. 
 
This study though used Kaplan-Meier analysis and this warrants careful consideration. 
The use of competing risk models has been widely promoted in the literature as 
Kaplan-Meier estimates are perceived to be biased. Sayers et al., 2018 explored these 
issues and their impact on describing implant failure by simulating the differences in 
the two analyses. Competing risk estimates crude failure rates and tends to 
underestimate implant failure whilst conversely the Kaplan-Meier method estimates 
net failure. Kaplan-Meier is appropriate therefore for describing implant survival whilst 
competing risk estimates the risk of revision as the latter is a function not only of 
implant survival but also patient mortality (Sayers et al., 2018).  If describing solely a 
single implant failure then when comparing groups of implants the Kaplan Meier is 
appropriate; if concerned with resource planning, health economics or patient 
informed consent about the likelihood of requiring a revision an estimation of crude 
failure is more desirable. In the analysis of the NZJR it could be countered that a 
competing risk model would have been more appropriate. When assessing our 
functional outcome scores in staged bilateral THR we should interpret the 6 month 
Oxford scores with some caution as we did not control for baseline differences 
between groups. We also assumed that a patient having unilateral THR did not have 
a hip problem on their other side and used the Oxford scores 6 months after the 
second surgery was completed. SABTHR therefore appears safe and surgeons 
should remain confident in continuing their practise using the same indications, but 
the results of our study suggest there may well have been an element of selection 
bias. Whilst there were statistically significant differences in Oxford scores between 
groups these were less than the mimimum clinically important difference and, to be 
more circumspect, the previous chapter showed that SABTHR patients are no worse 
than those having unilateral THR. Wyatt et al., 2018 also did not examine clustering 
of surgical practices within New Zealand which may have had a confounding effect. 
The two national joint registry studies complement one another and permit 
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triangulation of the results to substantiate the research conclusions regarding a delay 
of second THR by >90 days. 
 
SABTHR is most often contemplated in younger patients. In young patients strategies 
to mitigate against the risk of revision are important not least as the survivorship of 
subsequent revision THRs diminish over time (Swedish Hip Arthroplasty Register, 
2017). Minimising aseptic loosening from bearing-surface wear is one such strategy. 
There is little evidence comparing effectiveness of various hip implant bearings 
(Lopez-Lopez et al., 2017). RCTs show similar short- to mid-term survivorship among 
ceramic-on-ceramic (CoC), ceramic-on-highly cross-linked polyethylene (HLXPE) and 
metal-on-HLXPE in patients younger than 65 years. Standard ultra-high molecular 
weight polyethylene (UHMWPE), sterilised in Ethylene Oxide and with correct 
packaging, can show good clinical results even in the long-term (Lopez-Lopez et al., 
2017).  
 
Large datasets from national joint registries show that metal-on-conventional PE has 
a higher risk of revision compared with metal-on-HXLPE. A minimum HXLPE 
thickness must be preserved as breakage of the XLPE liners has been described 
especially in steeply inserted cups with elevated rims and poor locking mechanisms. 
Osteolysis is seldom perceived with wear rates < 0.1mm per year (Dumbleton, Manley 
and Edidin, 2002).  
 
The head size that can be used is linked to the bearing material couple. For HXLPE 
the range should be from 28mm to 36mm in large acetabular cups with enough 
thickness of the HXLPE liner and for CoC from 32mm to 36mm with 40mm heads only 
for selected cases of big acetabulae with good thickness of the metal back. There is a 
lack of long-term analysis of cost-effectiveness on the use of different bearings. Long-
term follow-up data is required in order to explore the association of different bearing 
couples with the risk of revision and other outcomes. The use of big metal-on-metal 
heads is no longer considered justified and has been abandoned by most surgeons. 
CoC is not cost-effective in the older population but may be considered for young 
active patients and perhaps, at the same price, ceramic-on-HXLPE could be 
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preferable to metal-on-HXLPE. The next chapter examines the NZJR evidence for the 
most reliable bearing surface couple in terms of all-cause revision rates with the 
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We have investigated the revision rates of all bearing surface combinations for primary 
total hip replacement (THR) registered on the New Zealand Joint Registry (NZJR) to 




There were 106,139 primary THRs registered, resulting in 4,960 revisions for any 




Ceramic-on-highly cross-linked polyethylene (CoPx) had the lowest all-cause revision 
rate of 0.54/100-component-years (cys) (95% confidence interval 0.48 to 0.61). This 
was superior to all other hard-on-soft bearing combinations in unadjusted analysis. 
Furthermore, the age of patients receiving CoPx was significantly lower than for metal-
on-polyethylene (mean 62.9; standard deviation [SD] 10.1 vs. 69.1; SD 9.6; p < 0.001). 
Acetabular loosening was the reason for revision in 14.5% of CoPx, compared to 33% 
of MoP THRs (p < 0.001). Metal-on-metal bearings had the highest revision rate of 
1.43/100cys and were significantly inferior to CoPx (p < 0.001). Kaplan-Meier analysis 
and Cox regression analyses were performed and we adjusted the analyses to control 
for age, femoral head size, surgical approach and fixation. 
 
Conclusions 
CoPx remained the most durable and successful coupling used in primary THR in New 
Zealand irrespective of age, gender or size of femoral head. 
 




The most common mode of implant failure in Total hip replacement (THR) is aseptic 
loosening (Herberts and Malchau, 2000; Beksaç et al., 2009; Johanson et al., 2012) 
from osteolysis secondary to wear (Beksaç et al., 2009; Johanson et al., 2012; Kuzyk 
et al., 2011). Interest in reducing wear has driven the development of alternative 
bearing surfaces to improve the results of the traditional metal on ultra-high-molecular-
weight polyethylene articulation (MoP). These include metal (MoPx) or ceramic (CoPx) 
heads on highly cross-linked polyethylene, ceramic-on-ceramic (CoC), metal-on-metal 
(MoM) and ceramic-on-metal (CoM) articulations. Each of these combinations has 
their own unique characteristics. 
 
MoP has been used for more than 40 years as a bearing surface in THR but the 
macrophage-mediated reaction to polyethylene particles has caused osteolysis and 
limited the implant survival. Highly cross-linked polyethylene has improved wear 
characteristics compared to ultra-high-molecular-weight polyethylene (Beksaç et al., 
2009; Johanson et al., 2012; Kuzyk et al., 2011; Campbell, Shen and McKellop, 2004) 
but has altered the mechanical strength of the polyethylene and also produces smaller 
particle debris, the fate of which remains unknown. Ceramic heads are smoother, 
harder, more scratch resistant with greater wetability than metal heads and have 
shown improved in vivo wear profiles (Campbell, Shen and McKellop, 2004; 
Wroblewski et al., 1996; Urban et al., 2001; Dahl et al., 2013) but are brittle and may 
fracture. 
 
CoC articulations can demonstrate even lower rates of wear compared to both MoP 
and CoP (Campbell, Shen and McKellop, 2004; Jazrawi et al., 1999; Hernigou et al., 
2009; Nikolaou et al., 2012; D’Antonio and Sutton, 2009) but require very precise cup 
positioning and have risks of stripe wear and squeaking, plus a small but significant 
risk of catastrophic failure with subsequent limitations in salvage bearing options 
(Campbell, Shen and McKellop, 2004). CoC is the most likely bearing to achieve true 
fluid-film lubrication due to their high λ ratio (Heisel, Silva and Schmalzried, 2003). 
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MoM articulations have had recent high failure rates secondary to metal ion production 
and “pseudotumour” formation. CoM theoretically reduces the risk of squeaking and 
fracture associated with CoC but has not been shown to reduce metal ion levels 
compared to MoM articulations (Schouten et al., 2012). The aim of this study therefore 
was to use the 16 year results of the New Zealand Joint Registry to identify which 
bearing surface had the lowest rate of revisions and qualify this by surgeon practice, 
approach, head size, age, gender and reason for revision, to provide surgeons with 




Materials and methods 
We performed a retrospective cohort analysis of the 16 year results of the New 
Zealand Joint Registry (NZJR) identifying primary hip arthroplasty surgeries performed 
between 1st January 1999 and 31st December 2015 (The New Zealand Joint Registry, 
2016). The analysis consisted of four hard-on-soft bearing combinations (MoP, MoPx, 
CoP and CoPx) and 3 hard-on-hard combinations (CoC, MoM and CoM). 
 
Our primary outcome measure was the all-cause revision rate for each of the 7 bearing 
couples studied. A revision was defined as a new operation in a previously replaced 
hip joint during which one of the components was exchanged, removed, manipulated 
or added. It included excision arthroplasty and amputation, but not soft tissue 
procedures (New Zealand Joint Registry, 2016). Bilateral THRs were considered 
independently for the purposes of this study. The all-cause revision rate was chosen 
to provide the most conservative estimate of survivorship. The revision rate was 
expressed as the rate per 100-component-years (cys) to give an average estimation 
of the survival of each coupling over all follow-up by allowing for the number of years 
that the THR had been implanted. This estimate allows comparison of revision rates 
when analysing data with varying follow-up times but does assume consistent revision 
rates over time. Kaplan-Meier survival curves and Cox-proportional hazards 
regression were therefore also performed to summarise the proportion revision-free 
and to allow for confounders such as age at surgery, gender, diagnosis, surgical 
approach, surgeon volume, fixation and head size when comparing couplings. In order 
to exclude historical problems with locking mechanisms in uncemented cups we 
examined the revision rates for CoPx, CoC and MoPx over the last 10 years in THRs 
performed with 32mm and 36mm femoral heads. 
 
The reason for revision as listed on the NZJR was compared between the couplings 
used. Demographic data including age and gender as well as procedure specific data 
such as head size, fixation technique, surgical approach and surgeon volume were all 
compared between couplings using ANOVA and chi-square tests as appropriate. All-
cause revision rates were calculated with 95% confidence levels using a Poisson 
approximation. A p value < 0.05 was deemed to be statistically significant. 
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Results 
There were 106,139 primary THR registered on the NZJR during the study period with 
4,960 (4.7%) revision procedures performed on these implants, giving an overall 
revision rate of 0.74 (0.72 to 0.76, 95% CI)/100 cys. The traditional MoP bearing 
combination was the most common coupling at 33.6% (35,647) followed by MoPx at 
29.8% (31,579). Ceramic on polyethylene combinations were less commonly utilised 
with 13.6% CoPx (14,382) and 6.4% CoP (6,833). The most frequently used hard-on-
hard bearing was CoC with 10.6% (11,235), followed by MoM at 5.6% (5,989) and 
infrequently CoM at 0.4% (474). 
 
Patient demographics 
The mean age of patients varied widely when comparing the group of hard-on-hard 
with hard-on-soft bearings, with the youngest patients in the MoM group and the oldest 
in the MoP group (Table 22). The MoM patients were significantly younger than the 
other hard-on-hard bearing patients (mean age 54.1; standard deviation [SD] 9.8; p < 
0.001). Of those receiving hard-on-soft bearings there was a significantly lower mean 
age of those with CoPx (mean age 62.9 years; SD 10.1; p < 0.001) and a higher mean 
age for those with MoP bearing (mean age 72.1 years; SD 9.6; p < 0.001). 
 





Surface Mean Years (sd) % Female 
CoC 56.5 (9.9) 48.8% 
 
CoM 56.5 (9.1) 36.9% 
CoP 63.2 (10.7) 49.6% 
CoPx 62.9 (10.1) 48.4% 
MoM 54.1 (9.8) 35.8% 
MoP 72.1 (9.6) 59.3% 
MoPx 69.1 (10.1) 54.5% 
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There was a relatively equal split in gender for CoP, CoPx and CoC but males were 
much more predominant in both MoM and CoM articulations, whereas females were 
predominant when a metal head was used with a polyethylene liner/cup (MoP and 




Across all, the most common fixation technique was uncemented at 39.1%, followed 
by hybrid (cemented femur and uncemented cup) with 38.6% and cemented at 22.3% 
(Table 23). Hard-on-hard bearing combinations favoured uncemented fixation in 79% 
of CoC, 99% of CoM and 90% of MoM. Within the hard-on-soft bearing groups MoP 
was the only bearing combination that favoured cemented fixation at 58%, with hybrid 
also commonly used at 30%. CoP bearings were predominantly uncemented at 55% 
or hybrid at 39%, which was similar for CoPx with uncemented 70% and hybrid 28%. 







Table 23. Surgical features by bearing surface 
 
  Bearing surfaces 
  CoC CoM CoP CoPx MoM MoP MoPx 
  N % N % N % N % N % N % N % 
Type of 
fixation 
Cemented 0 0 0 0 421 6.2 220 1.5 7 0.1 20593 58 2434 7.7 
Uncemented 8855 79 467 98.5 3776 55 10866 70 5382 90 4390 12 8520 27 
Hybrid 2380 21 7 1.5 2636 38 4076 28 600 10 10664 30 20625 65 
                
Surgical 
approach 
Anterior 200 2 18 4 265 4 505 3.8 233 4.2 1654 5 914 3.1 
Posterior 9301 87 336 79 4117 64 9878 74 4176 75 20489 61 19514 66 
Lateral 1106 10 70 16.5 2023 31 2969 22 1181 21 11296 34 9004 30.5 
Trochanteric 
osteotomy 
6 0.1 0 0 6 0.1 13 0.1 7 0.1 43 0.1 50 2 




<10 34 0.3 0 0 51 0.7 60 0.4 24 24 0.4 661 440 1.4 
10-24 655 6 1 2 760 11.1 1302 9 498 8.4 4365 12 3930 12.5 
25-49 3555 32 210 44 2577 38 6179 43 1759 29 16458 46 14321 45 
50-74 2175 19 60 12 1846 27 4796 33 1372 23 9354 26 6492 20 
75-99 1716 15 117 24 173 2.5 1404 9.8 850 14 2859 8 3959 12 
>100 3100 27 84 18 1424 21 637 4 1461 25 1934 5 2400 8 




<28 733 6 23 5 6347 93 4254 30 2855 47 30539 85 13733 44 
32 3308 29 0 0 484 7 6855 48 481 8 5088 14 15387 49 
36 5836 52 443 94 2 0 3257 23 1002 17 8 0 2425 8 









Head size varied across all groups, but hard-on-hard bearings tended to use a larger 
head size, with CoC and CoM using ≥ 36mm heads in 64.0% and 95.1% of cases 
respectively (Table 23). MoM bearings were inserted in 2 major head sizes: 47.7% 
receiving 28mm heads, while the next most common was > 36mm at 27.5%. Size 
28mm heads were most frequently used in CoP at 92.9% and MoP at 85.7%. There 
was a tendency to use larger heads (≥ 32mm) when using highly cross-linked 
polyethylene, with MoPx at 56.5% and CoPx at 70.4%. 
 
Surgeon volumes and approach 
12.1% of the joint replacements performed were by surgeons who averaged < 25 joints 
per year (Table 23). They were relatively evenly distributed across all bearing types 
with a tendency to use hard-on-soft couplings. The most common surgical approach 
was posterior at 68.3% followed by lateral at 27.8%. There was no significant 
association between bearing type and approach used. 
 
Revision rates 
The all-cause revision rate was lowest for the CoPx which was significantly better than 
CoP (p < 0.001), MoPx (p = 0.003) CoM (p = 0.019), MoM (p < 0.001), CoC (p = 0.005) 
and MoP (p = 0.008) (Table 24). The poorest performing bearing surface was MoM. 
Furthermore, MoPx had a significantly lower revision rate than CoP (p<0.001) 
suggesting the major benefit was from the polyethylene rather than the ceramic head. 
MoP and MoPx bearing combinations had higher rates of revision for component 


























Rate / 100-component- 
years (95% CI) 
CoC 11235 58591.1 355 0.61 (0.54 - 0.67) 
 
CoM 474 2601.6 21 0.81 (0.50 - 1.23) 
 
CoP 6833 65690.0 486 0.74 (0.68 - 0.81) 
 
CoPx 14382 52521.9 283 0.54 (0.48 - 0.61) 
 
MoM 5989 55702.6 797 1.43 (1.33 - 1.53) 
 
MoP 35647 295137.1 2143 0.73 (0.70 - 0.76) 
 






Figure 16. All-cause revision rates by bearing surface combination and femoral head 
size 
 
When the analyses were adjusted to control for age, gender, femoral head size, 
surgical approach, surgeon volume and fixation, CoC bearings were better than all 
other couplings closely followed by CoPx which in turn was significantly better than 
the others (Table 25), significances both adjusted and unadjusted are shown in Table 
24. The Kaplan-Meier survivorship analyses (Figure 17) demonstrated that the 
unadjusted all-cause revision-free survivorship was highest for CoPx and lowest for 
the MoM bearings when we analysed the last 10 years’ results looking specifically at 
CoC, CoPX and MoPx with 32mm and 36mm femoral heads, however CoPx had a 





Table 25. P values from pairwise log-rank tests between bearing surfaces, values in brackets are from adjusted+ comparisons. 
 
 CoC CoM CoP CoPx MoM MoP 
CoC  
 
     
















   
MoM < 0.001*(< 0.001)*   0.005*(0.161)  < 0.001*(0.755) < 0.001*(< 0.001)*   




0.638 (< 0.001)*  
 










* Denotes statistically significant (p < 0.05) result. 
+ Values adjusted for age, gender, head size, approach, surgeon volume, and fixation. 
CoC = ceramic-on-ceramic; CoM = ceramic-on-metal; CoP = ceramic-on-polyethylene; CoPx = ceramic-on-highly cross-linked polyethylene; 





















Table 26. Analysis of total hip replacements with larger femoral heads over the last 10 years 
 
 
2008 onwards – cementless and size 32 or 36mm 
 
       
    Lower 95% CI   p values 
 
Surface Ops Cpyrs Revised Rate/100-component-years Upper 95% CI vs. CoPX vs. MoPX 
 
CoC 5,587 22,167.4 158 0.71                       0.61 0.83 0.017 0.743 
 
CoPX 6,886 19,146.9 115 0.60                       0.5 0.72  0.005 
 
MoPX 4,965 15,449.7 126 0.82                       0.68 0.97   
 
Total 17,438 56,764.1 399 0.70                       0.63 0.77   
 
 









Reasons for revision 
Loosening of components was the commonest cause for revision surgery across all 
articulations (Table 27) with acetabular loosening (22.2%, rate of 0.17/100 cys [95% 
CI 0.16-0.18]) more common than femoral loosening (16.7%, rate of 0.12/100cys [95% 
CI 0.11-0.13]). The lowest rate of acetabular component loosening was with CoPx and 
MoPx with MoPx being significantly better than CoC (p = 0.013), CoP (p < 0.001), 
MoM (p = 0.001) and MoP (p < 0.001) whereas CoPx was significantly better than 
MoM (p < 0.001) and MoP (p < 0.001). MoP had the highest revision rate for acetabular 
loosening. Femoral loosening was lowest in CoC and CoPx but this was only 










Table 27. Summary of Reason for Revision (note that each revision surgery can have more than one reason for revision) 
 
  Bearing surfaces   
Reason for revision CoC CoM CoP CoPx MoM MoP MoPx Total   





 55 15 2  9 89 18 41 14.5 117 14 708 33 1102 22 1102 22 
Femoral 
loosening 
47 13 3 14 81 16 46 16 82 10 436 20 8520 27 828 17 
 Instability 60 17 3 14 140 28 76 27 58 7 543 25 266 30 1146 23 
 Pain 56 16 5 24 49 10 26 9 229 29 270 13 86 10 721 14 
 Deep infection 40 11 7 33 42 8 49 17 57 7 217 10 178 20 590 12 
 Femoral fracture 32 9 1 5 45 9 44 16 33 4 213 10 147 17 515 10 
 Ceramic head 
fracture 
9 2.9   6 2 1 1       15 0.4 
 Ceramic liner 
failure 
34 11             34 0.5 
 Ceramic noise 24 7.8             24 0.6 
 Metallosis related         112 23     112 3.5 
 ASR implant         61 12     61 1.9 
 PE wear     30 8.4     56 3.7 3 0.6 89 2.8 
 Miscellaneous 34 15 4 19 50 12 20 15 49 10 140 9 62 13 358 11 





Dislocation was the most commonly recorded reason for revision surgery of CoP 
(28.8%), CoPx (26.9%) and MoPx (30.4%) hips (Table 27). For all bearing 
combinations except CoM, femoral heads of size 28mm or less were more commonly 
associated with dislocation (Figure 18). All hard-on-hard bearings had lower 
dislocation rates than hard-on-soft bearings. CoPx was the best hard-on-soft bearing, 
being significantly better than MoP (p < 0.001), MoPx (p = 0.005) and CoP (p < 0.001). 
 
 
Figure 18. Revision rates for instability by bearing surface combination and femoral 
head size 
 
Revision for periposthetic infection was least common in CoC (0.07/100cys, 95% 
confidence interval [CI] 0.05-0.09), CoP (0.06/100 cys, 95% CI 0.05-0.09) and MoP 
(0.07/100cys, 95% CI 0.06-0.08) and highest in CoM (0.27/100cys 95% CI 0.11-0.55) 
and MoPx (0.13/100cys 95% CI 0.11-014). 
 
Within the “other” causes for revision, ceramic component fracture was identified as 
the reason for 9.6% of CoC, 1.2% of CoP and 0.4% of CoPx revisions. This represents 
a rate of ceramic fracture of 0.30% (34/11,235) for CoC, 0.09% (6/6833) for CoP and 
0.01% (1/14382) for CoPx. Of the 12 ceramic head fractures, 11 were size 28mm 
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heads and one size 32mm. Revision for bearing-generated noise was undertaken in 
8.2% of CoC hips, which was a rate of 0.22% (18/11235). Metal-on-metal bearings 
experienced metallosis-related complications for 23.2% of their revisions, while 12.6% 




Our findings indicate that in New Zealand, CoPx bearing surfaces have the lowest all-
cause revision rate for THR. This combination outperformed all others but failed to 
reach statistical significance over the traditional MoP combination and also CoC. The 
K-M analysis clearly shows an increasing rate of revision for both MoP and CoP after 
8 years compared to CoPx and MoPx which have relatively flat curves after this time 
point. The best performing hard-on-hard bearing was CoC, whilst the poorest was 
MoM, which was not unexpected given the recent publications of metallosis-related 
failures and product recalls of these implants (Hunt et al., 2018). When these revision 
rates were adjusted for age, gender, approach, fixation method and surgical volumes 
the CoC couplings were superior followed by the CoPx, which were significantly better 
than all others. When looking at the last 10 years in THRs using 32mm and 36mm 
heads we therefore excluded the historical uncemented cups with poor locking 
mechanisms. CoPx was the significantly superior bearing surface in this group. 
Previous studies have shown that polyethylene wear is related to the level of activity 
of the patient. Older patients are quoted to have a reduction in their level of activity in 
the order of 15-20% for every decade of life (Howcroft, Head and Steele, 2008). 
Battenberg et al. (2013), studied a cohort of THR patients and found that over a 
decade of observation, a 16% reduction in gait cycles and 8.8% reduction in walking 
speed resulted in a reduction in cross-linked polyethylene wear rate of 40%. In our 
study, there was a significantly lower mean age (p < 0.001) for patients receiving CoPx 
bearings (62.9 years) compared with patients receiving MoP (71.8 years). However, 
despite patients in the ceramic group being almost a decade younger than their metal 
group counterparts, the ceramic cohort’s revision rate remained lower. A recent study 
comparing registry outcome data across 6 registries, not including the NZJR, showed 
no increased revision rate of MoPx compared to MoP in those patients aged between 
45 to 64 years who had cementless implants (Paxton et al., 2014). 
 
As anticipated, each of the bearing surfaces had an unique revision profile. Of interest 
was the percentage of revision due to aseptic loosening in both the CoP and CoPx 
combinations when compared to MoP (Table 31). This was not unexpected given that 
ultra-high-molecular-weight polyethylene has a poorer wear profile than highly cross-
linked polyethylene, but it does support the lower wear rates reported when utilising 
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ceramic heads (Campbell, Shen and McKellop, 2004; Kuzyk et al., 2011) with a 
subsequent lower rate of revision for aseptic loosening. Polyethylene wear has been 
the major cause of osteolysis and aseptic loosening with numerous studies supporting 
the use of CoP bearings, citing up to 50% reduction in polyethylene wear in vitro when 
compared with metal-on-polyethylene (Campbell, Shen and McKellop, 2004; Urban et 
al., 2001; Howcroft, Head and Steele, 2008). In vivo studies have supported these in 
vitro results showing improved wear profiles for ceramic heads compared with metal 
heads in THR with hard-on-soft articulation. Dahl et al. (2013), demonstrated that 
ceramic heads had more than a 50% reduction in polyethylene wear compared to 
chromium-cobalt heads at 10 year follow-up. Despite the reduction in polyethylene 
wear, they were unable to identify a significant difference in osteolysis or revision 
between their 2 study groups. Wang et al. 2013, also showed significantly reduced 
polyethylene wear rates for ceramic-on-polyethylene at 10-year follow-up in 22 
simultaneous bilateral primary THR with a metal head on one side and ceramic on the 
other. The authors describe no evidence of aseptic loosening of components in any of 
their study subjects. We have shown that CoP and CoPx couplings have a rate of 
aseptic loosening closer to hard-on-hard bearings with a lower rate of aseptic 
loosening compared to MoP. 
 
Femoral head size is an important consideration in bearing choice. The main concern 
with larger heads is the potential for increased volumetric wear (Cross, Nam and 
Mayman, 2012; Rajpura, Kendoff and Board, 2014), in combination with the 
requirement for a thinner acetabular liner for any given cup size. Although some have 
shown no increase in linear penetration between 28mm and 32mm metal heads on 
highly cross-linked polyethylene at either 7 or 10 years (Bragdon et al., 2013), others 
have found that although linear wear rates for smaller femoral heads (32mm or less) 
were similar to those of larger heads (36mm or more), there was greater volumetric 
wear with the larger femoral head sizes.  Although the rates were below the suggested 
osteolysis threshold, wear with 36mm heads and partially irradiated polyethylene 
continues to be a concern, particularly with younger patients (Selvarajah et al., 2015). 
One systematic review concluded that based on currently available literature, large 
diameter metal heads (> 32mm) or ceramic heads of any size are not proven to reduce 
femoral head penetration or osteolysis risk (25). Allen, Hooper and Frampton (2014), 
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found no relationship between increased femoral head size and an increase in 
functional outcome at 1 year follow-up, but did identify a trend toward reduction in 
dislocation rate with 36mm heads. They concluded that there was little advantage in 
using heads > 36mm in patients undergoing THR (Alllen, Hooper and Frampton, 
2014). Analysis of the National Joint Registry for England and Wales found that there 
was a hazard ratio of 1.5 (p = 0.005) for revision with smaller head sizes < 28mm when 
compared with 28mm heads, but there was no significant difference in revision rate 
between hips with 28mm and 32mm heads (Jameson et al., 2012). There remains a 
balance between reduced dislocation with a larger head size and increased volumetric 
wear which is likely to be patient related, and the decision on head size needs to be 
individualised for each clinical situation, as our results indicate that smaller head sizes 
of ≤ 28mm are associated with higher rates of revision for dislocation, ceramic head 
fracture and loosening when used in combination with polyethylene bearings. 
 
When looking at the last 10 years in THRs using 32mm and 36mm heads we therefore 
excluded the historical uncemented cups with poor locking mechanisms. CoPx was 
the significantly superior bearing surface in this group. Previous studies have shown 
that polyethylene wear is related to the level of activity of the patient. Older patients 
are quoted to have a reduction in their level of activity in the order of 15-20% for every 
decade of life (Howcroft, Head and Steele, 2008).  
 
Prior to 2007 all ceramic implants were either Forte ceramic or Mathys ceramic. 
Following that, delta ceramic was introduced and all changed to this except Mathys 
who continue to use their own ceramic. All ceramic liners that fractured were forte 
components, 3 of which were associated with dislocation events. All ceramic head 
fractures were with 28mm heads or smaller except 1 (32mm), evenly spread across 
the different generation ceramics, often associated with traumatic events e.g. 
dislocation. Of note is the fact that 7 of the fractured heads were in CoP or CoPx 
couplings with only 5 in CoC joints. Although revision for infection was lowest with CoC 
bearings there did not seem to be any correlation with other ceramic bearing surfaces 
combinations (CoP and CoPX) to suggest that there was a protective effect from its 
use. These results have been reported previously and caution has been advocated in 
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the interpretation because of a number of other cofounders, such as body mass index 
(BMI) and American Society of Anesthesiologists (ASA) score, which are likely to play 
a significant role in the incidence of infection (Pitto and Sedel, 2016). 
 
Bearing generated noise was the reason for 8.2% of ceramic-on-ceramic revisions in 
this study. Stanat and Capozzi’s meta-analysis found a mean rate of 2.4% (0.7% to 
20%) for CoC bearing generated noise and they noted that the underlying causes of 
this included edge-loading, as well as 3rd body ingress and subluxation (Stanat and 
Capozzi, 2012). Ceramic fracture has been another potential mode of failure for 
ceramic bearings. In our study CoPx performed the best with a fracture rate of 0.01%, 
whereas CoC implants were at greatest risk (0.33%). The very nature of a CoC 
coupling exposes 2 hard, brittle surfaces that are potentially vulnerable to injury, 
particularly in the presence of implant malposition (Campbell, Shen and McKellop, 
2004; Dahl et al., 2013; Howcroft, Head and Steele, 2008; Battenberg et al., 2013). 
Smaller femoral heads (28mm or less) were prone to fracture and the current trend 
towards larger femoral heads, partly to reduce the risk of dislocation, has resulted in 
head sizes > 32mm with a lower risk of fracture. The current production of ceramics, 
with better resistance to crack propagation, has decreased head fracture rates to 
0.004% and 0.002% for 3rd and 4th generation alumina heads respectively (Rajpura, 
Kendoff and Board, 2014). A recent systematic review of THR in patients under 30 
years of age showed that ceramic-on-ceramic bearings in combination with 
cementless implants still hold great promise for longevity in this patient population 
(Walker et al., 2016).  
 
The debate is ongoing over which surgical approach for THR is superior but a recent 
systematic review and a cohort study both favour the posterior approach (Berstock, 
Blom and Beswick, 2015; Smith et al., 2012). Few studies report on aseptic loosening 
as an outcome measure when comparing approaches; however, a recent Swedish 
Registry study found that when compared to the posterior approach, an anterolateral 
transgluteal surgical approach resulted in an increased risk of revision for aseptic 
loosening for the Lubinus SPII (relative risk [RR] 1.3, 95% CI 1.0-1.6) and Spectron 
EF Primary stems (RR 1.6, CI 1.0-2.5) (Lindgren et al., 2012). The same study found 
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no difference in revision for aseptic loosening between lateral and posterior 
approaches for the Exeter stem. Others looking at the Norwegian Registry found that 
the Charnley femoral stem had lower overall rates of revision when using a lateral 
approach with a trochanteric osteotomy, compared to either a posterior or a lateral 
approach without trochanteric osteotomy (Arthursson et al., 2007). The same study 
identified increased risk of revision for dislocation (RR 1.9, p = 0.02) when using the 
Charnley stem with the posterior approach, compared to a lateral approach without 
osteotomy. Palan et al. (2009), found no differences in Oxford Hip Score, dislocation 
or revision rates between anterolateral and posterior approach THR at 5 year follow-
up of 1,089 hips. We found no difference between the 2 commonest approaches used 
in New Zealand (posterior and lateral) but did not compare approach to implant used. 
Interestingly, we also found no significant difference in the revision rates for those 
surgeons who performed < 25 THR per year compared to the rest.  
 
The strengths of this study relate to the quality data provided by the NZJR with a high 
capture rate of 98% across the whole country (Hooper, 2013), and large data sets 
pertaining to THRs for the various bearing surfaces. A potential limitation is the choice 
of all revision rates between CoPx and MoP which may be due to the relatively low 
numbers of CoPx, with CoPx representing less than 10% of the total component years 
recorded in the NZJR. The numbers of CoPx have increased over the last 5 years and 
with time, and the accumulation of component years, statistical significance may yet 
be identified. It is also important to note that there are multiple other factors which 
impact on prosthesis wear, including cup positioning, implant fixation technique, 
implant materials and implant coating. Other patient factors may also play a significant 
role including weight and level of activity. Not all of these factors can be accounted for 
in this study. Another weakness is that we have used all-cause revision as a surrogate 
marker for failure. This has the drawback of not identifying patients who are living with 
a painful hip, awaiting revision, or who are too unwell for revision surgery. Finally, we 
have not assessed the different groups of implants used with these articulations as 





In New Zealand, the lowest all-cause revision rate in THR was found with ceramic 
femoral heads in CoPX bearing combinations. This coupling was used in patients who 
were on average almost a decade younger than those receiving MoP bearings (p < 
0.001). It is early days for follow-up in CoPx hips, but these data indicate that this is 









In our study of the 16 year results of the New Zealand Joint Registry CoPx has the 
lowest all-cause revision rate for THR in unadjusted analyses. This finding remained 
when examining the last decade of practice and using 32mm and 36mm femoral 
heads. The next best and best performing hard-on-hard bearing was CoC and this 
was best in analyses adjusted for age, gender, head size, approach, surgeon volume, 
and fixation. CoC has its own unique problems as they require very precise positioning 
to avoid stripe wear, edge loading and squeaking. The superiority of CoPx however 
did not reach statistical significance over the traditional MoP combination and also 
CoC which therefore remain viable options in terms of bearing surface combinations 
and warrant further examination. A valid criticism of our study was that in order to 
exclude cups with locking mechanisms prone for locking liner ring breakage and failure 
Chapter 5 examined uncemented cups over the last 10 years. Harris-Galante II cups, 
for example, had a propensity for breakage of the locking mechanism (Matsuno, 
Yudoh and Kimura, 2002; Yamada et al., 2009). This method therefore can be 
criticised, as an alternative method would have been to reanalyse the dataset 
removing known implants that displayed this problem. Another weakness is that the 
influence of implant fixation was not accounted for by regression analyses in our study. 
MoM was the worst performing bearing surface combination in the NZJR analysis in 
the previous chapter. This is in keeping with the UK National Registry studies (Reito 
et al., 2017; Hunt et al., 2018) and does not support its implantation. The issue of 
cobalt and chromium metal ion release and toxicity associated with MoM bearing 
surfaces is well recognised (Davies et al., 2005). 
 
Up-to-date literature search 
To update the context of the findings of Chapter 5 the following databases were 
searched from 2017 to 30.3.2020 using the programme Papers: ACM, ADS, arXiv, 
CERN DS, CrossRef DOI, DBLP, Espacenet, Google Scholar, Gutenberg, Highwire, 
IEEExplore, Inspire, JSTOR, OAIster, Pubget, PubMed, ScienceDirect, Scopus and 
Web of Science. Search terms related to: Bearing surface AND Total hip.  
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341 references were identified of which 13 were collected as potentially relevant. 
Those single published articles that cited Chapter 5 were also examined. Journals with 
impact factors <2 were excluded. Any correspondence relating to the article described 
in this chapter was reviewed.  
 
Choice of surgical approach 
The commest hip approaches in the previous chapter were the posterior and the lateral 
approaches. In a recent publication by Lenguerrand et al. (2018), there was an 
increased risk of revision for deep infection when using the lateral compared to the 
posterior approach (relative risk 1.3; 95%CI 1.2 to 1.4). Aggarwal et al. (2019) showed 
that the posterior approach was associated with fewer complications overall, with the 
DAA having the highest incidence of complications (8.5%) compared to posterior 
approach (5.85%). Interestingly the DAA had a higher rate of postoperative instability 
compared to the posterior approach in this study. Hunt et al., (2013, 2018) showed a 
decreased risk of mortality with the posterior approach compared to other approaches 
(Hazards ratio 0.82; 95%Ci 0.73 to 0.92; p=0.001). Complications aside Lindgren et 
al. (2014), showed that in the Swedish Hip Arthroplasty Register the lateral approach 
had inferior patient reported outcome measures compared to the posterior approach.  
 
Which bearing surface is superior? 
The results of Chapter 5 at first sight differ from the findings of a systematic review 
and network meta-analysis of prospective randomised controlled trials (Lopez-Lopez 
et al., 2017).  This evidence synthesis showed that there is little evidence that any 
bearing surface combination is in fact surperior to MoP bearings in terms of all-cause 
revision rates. This study focused on high-quality prospective RCT’s trials but many 
included studies were small and focused on clinical outcomes other than revision 
surgery. When considering MoP linear wear is typically 100 to 300 µm/year (Semlitsch 
and Willert, 1997) and this has been shown to not vary significantly between 22mm, 
28mm and 32mm femoral heads (Rieker, 2017). Volumetric wear of UHMWPE has 
been shown to vary between 5 and 50mm3/year. Ceramic heads have been shown to 
reduce polyethylene wear by 50% when used with UHMWPE (Meftah et al., 2013). 
Stambough JB et al. (2018), reported a prospective cohort study of 123 patients who 
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had THR at <50 years of age; although there was incomplete follow up with 101 THA 
in 84 patients mean 17,1 year FU (14.7 to 19.6). The outcomes reported were linear 
and volumetric wear, clinical outcome scores, implant survivorship and patient 
mortality.  The median linear wear was 0.206mm/yr (95%Ci 0.079 to 0.133mm) and 
volumetric wear 43.58 mm3/year (95%CI 33.4 to 53.75). With all-cause revision as the 
endpoint the survivorship was 79.2%. The majority were revised for wear-related 
causes. This study concluded that there are significant concerns for traditional MoP 
bearings at 15 years in young, active patients and alternate bearing surfaces should 
be considered.  
 
Ceramic-on-ceramic 
CoC bearings have achieved excellent long-term clinical results with an 84.4% survival 
rate at 21 years (Petsatodis et al., 2010). This bearing couple permits larger femoral 
head sizes (< 48mm) and thinner acetabular shell sizes. The bearing surface has very 
low wear rates but is very sensitive to component positioning. The registry analysis of 
risk factors associated with a higher risk of revision for infection showed that CoC had 
a relative risk of 0.6 (95%CI 0.4 to 0.7) compared to MoP at > 24 months; CoP had a 
relative risk of 0.7 (95%CI 0.5 to 0.9) compared to MoP at > 24 months (Lenguerrand 
et al., 2018). 
 
Wyatt et al. (2014), showed that the phenomenon of noise from CoC bearings is more 
common than in CoP bearings and has significant patient impact. These findings may 
or may not be generalisable to all implants. There was an element of “mix-and-
matching” with the implants used in this study as they were manufactured by a variety 
of implant companies in the previous study which may be relevant. Mathys ceramic 
heads in combination with Mathys cups were used rather than Biolox Delta femoral 
heads comprising zirconia (17%)/alumina (82%) composite heads. The Mathys 
ceramic is a zirconia (80%)/alumina (20%) composite and there is no literature to 
suggest any difference in noise generation between these and Biolox Delta types of 
ceramic. There remains however a potential for different manufacturer tolerances 





HXLPE was originally developed in the 1990s and cross-linking for polyethylene 
polymer chains permitted modulation of its molecular structure and a higher resistance 
to both abrasive and adhesive wear. Cross-linking is produced by using irradiation and 
the subsequent formation of free radicals. Once cross-linking has occurred the 
elimination of free radicals is important to diminish the risk of oxidation and this is 
achieved by annealing, remelting or in latter HXLPE generations by adding 
antioxidants. HXLPE has been shown to have linear wear rates ranging between 2 
and 20µm/year and volumetric wear rates <1mm3/year for 28mm femoral heads 
(Rieker, 2017). Volumetric wear is proportional to the size of the femoral head 
therefore a larger femoral head should only be considered where the benefits of 
reducing instability outweigh the increased volumetric wear rate. Osteolysis thresholds 
are dependant on volumetric wear and the biological activity. Biological activity is 
higher in HXLPE than UHMWPE. De Steiger, Lorimer and Graves, 2018 analysed the 
Australian NJR for all patients having THR in Australia between 1999 to 2016 
comparing HXLPE and conventional polyethylene. HXLPE was significantly less likely 
to be revised (6.2%; 95%CI 5.7 to 6.7%) compared to conventional polyethylene 
(11.7%; 95% CI 11.1 to 12.3). The hazard ratio at 9 years was 3.02 (p=0.001). 
 
The use of ceramic femoral heads with HXLPE 
Ceramic femoral heads have a low friction coefficient, are scratch resistant and harder 
than metal heads, have high wettability and do not undergo senescence in vivo. 
Volumetric wear of HXLPE using ceramic heads has been shown to be in the range 
0.1mm to 1mm3/year (D’Antonio and Sutton, 2009). The original Alumina ceramic 
heads were superseded by Biolox Delta (CeramTex; Plochingen, Germany) in the 
early 2000s. This comprised 82% alumina and 17% zirconia and has half the risk of 
crack propagation compared to all alumina heads (Reiker, 2017) and a fracture rate 
in vivo of 0.003% (Massin et al., 2014). Ceramic heads with short neck lengths are 
more at risk of fracture likely explained as shorter ceramic heads may have thinner 
ceramic between the corner on the inner surface of the female trunnion and the 
bearing surface (Callaway et al., 1995; Koo et al., 2009). 
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Ceramic heads are becoming increasingly popular compared with metal heads (NZJR 
report, 2018; Norwegian Arthroplasty Register, 2018; Swedish Hip Arthroplasty 
Register 2017) due to trunnionosis reports at the level of the head-neck junction. It 
must be evaluated when considering the cause of failure of a THR (Berstock, 
Whitehouse and Duncan, 2018). Using a ceramic head may avoid fretting and 
corrosion from the modular head-neck taper and diminish metal ion release when 
compared to metal heads. It is interesting that femoral stems made of stainless steel 
and coupled with either stainless steel or ceramic femoral heads have no reported 
incidence of trunnion corrosion (Westerman et al., 2018). Furthermore there have 
been recent concerns regarding intra-capsular fibrosis associated with the CoC 
bearing surface combination (Bertrand et al., 2018). 
 
Femoral head size 
Revision rates for aseptic loosening for 36mm heads are higher than 32mm femoral 
heads (NJR England, Wales Northern Ireland and Isle of Man, 2018) and the 
increased volumetric wear is proportional to sliding distance. Increasing the size of the 
femoral head beyond the threshold benefit for reducing instability risk is unjustified 
(National Joint Registry for England, Wales, Northern Ireland and the Isle of Man, 15th 
Annual Report, 2018) and femoral head sizes over 32mm increase the risk of 
trunionosis and does not improve the primary arc range of motion (Berstock, 
Whitehouse and Duncan, 2018). Fawsitt et al. (2019) performed a cost-effectiveness 
analysis of the UK and Swedish hip joint registries. A <36mm MoP cemented THR is 
most cost-effective in adults >65 years of age and a <36mm ceramic-on-polyethylene-
cemented THR is most cost-effective in patients <65 years of age. >36mm heads were 
not cost-effective.  
 
THR in young patients 
Two recent registry studies examined the outcomes of THR in patients less than 20 
years of age. The first, Pallante et al. (2020), reported the results from a single 
institution registry involving 91 primary THR performed in 78 patients < 20 years old 
(1998 to 2016). The bearing surfaces used were CoC (53 THA; 58%), MoPx (28 THA; 
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31%) and CoPx (10 THA; 11%). Outcome measures included revisions or 
reoperations, complications, clinical outcomes and bearing-surface wear. At a mean 
follow-up 8 years (2 to 18) the average modified HHS was 92 (54 to 100); survivorship 
at 10 years was 97.2% for all-cause revision. The commonest complication was 
recurrent instability (3%), aseptic loosening (2%) and foot-drop (2%). Linear wear was 
0.019mm/yr. There was no difference in linear wear amongst these bearing surfaces. 
There were no correlations between age, gender, BMI, bearing surface, femoral head 
size, fixation method, operative time and survivorship. Secondly Metcalfe et al. (2018) 
reported the results of the National Joint Registry for England, Wales, Northern Ireland 
and the Isle of Man between 2003 and 2017. The primary outcome was all-cause 
revision. 769 THRs were done in 703 patients with median follow-up 5.1 years (IQR 
2.6 to 7.8). 35 THRs were revised (survivorship 96% at 5 years (95%CI 94 to 98%). 
Better survival was seen in CoC and CoPx bearing surfaces couples compared to 
MoM and MoP and in higher volume surgeons.  
 
Highly cross-linked polyethylenes vary in their modes of manufacture. The latest 
generation of HXLPE contains Vitamin E as an antioxidant in order to reduce wear 
rates. The infusion of vitamin E in HXLPE reduces oxidation in vivo with the aim of 
improving the mechanical strength of HXLPE. Even if attractive from a theoretical point 
of view promising early results have been shown with very low wear even for 36mm 
heads. The next chapter examines whether Vitamin E HXLPE conveys greater 
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Vitamin E highly cross-linked polyethylene (HXLPE) was developed to reduce wear in 
total hip replacement (THR). This study aimed to provide independent synthesis of 
wear characteristics of Vitamin E treated HXLPE compared to HXPLE/UHMWPE. 




We performed a systematic review; literature searches were conducted on 14th 
November 2017 (MEDLINE, Embase on Ovid, and the Cochrane Library). We 
included randomised controlled trials, analyses of joint registries, and case-controlled 
studies of primary THR comparing cups with a Vitamin E HXLPE bearing with bearing 
surfaces made from other types of polyethylene. Initial screening was performed by 
two independent assessors; disagreement resolved in discussion with a third reviewer. 




372 studies were identified on initial screening; 5 studies met the eligibility criteria. 
There was no significant heterogeneity between studies. There was variable risk of 
bias.  At a mean of 35 months (range 20 to 60), Vitamin E HXLPE had significant 
advantages over highly cross-linked polyethylene with regards total femoral head 
penetration (p = 0.004). Given the RSA measurement errors this may not be clinically 
significant. There were neither significant differences in revision rates nor Harris Hip 







At a minimum of 3 years this bearing surface does not as yet have clinically significant 
advantages in terms of revision rates or patient function over HXLPE. 
 




Many bearing materials have been utilised in total hip replacement (THR) including 
ivory, silver, rubber, celluloid, glass and wood (Kurtz et al., 1999). Ultra-high molecular 
weight polyethylene (UHMWPE) has been in used for nearly 60 years (Del Prever et 
al., 2009). According to National Joint Registry of England and Wales (NJR) data from 
2016, it is used in 88% of THRs (NJR accessed 2017). Wear and aseptic loosening 
are common causes of revision in THR (NJR accessed 2017), wear of UHMWPE is 
predisposed to by oxidative degradation which decreases wear resistance and leads 
to increased osteolysis; a major cause of implant failure (Kurtz et al., 1999; NJR 
accessed 2017; McKellop et al., 2000; Besong et al., 1998; Harris, 2001). 
 
The sterilisation process is a major contributor to degradation of UHMWPE (Yu et al., 
1999; Costa et al., 1998). High-energy radiation, used in sterilisation processes, 
induces oxidation. Bond scission occurs with the formation of free radicals (Del Prever 
et al., 2009; Yeom et al., 1998). This reduces molecular mass and alters the 
mechanical properties of the UHMWPE. The oxidation continues during storage and 
in vivo once implanted (Costa et al., 1998). Since 1998, highly cross-linked and 
thermally treated polyethylenes (HXLPEs) were introduced to improve wear 
resistance. It was theorised they would reduce the incidence of revision. Cross-linking 
results in an increased molecular mass; improving wear resistance and mechanical 
properties compared to UHMWPE (Pruitt, 2005; Kuzyk et al., 2011). Following 
irradiation, the HXLPEs are thermally treated to remove residual free radicals. Two 
different processes, remelting and annealing, are used. Only remelting treatment 
effectively removes residual free radicals (Harris, 2004; Gomoll, Wanich and Bellare, 
2002). Other processing methods have been considered but have not been able to 
eradicate free radicals meaning oxidative degradation can occur (Kurtz et al., 2006). 
 
Vitamin E (VE) is an antioxidant that can be added to the HXLPEs to combat oxidative 
degradation and improve fatigue properties by avoiding post-irradiation melting (Oral 
2004). In vitro studies have demonstrated a protective effect of VE on oxidative 
degradation, with improved mechanical and wear properties (Bracco et al., 2007; Oral 
et al., 2006; Oral et al., 2006). Additionally, in vitro and animal studies have not 
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demonstrated adverse reactions (Jarrett et al., 2010). Despite this, there is currently 
limited clinical evidence to support the use of Vitamin E HXLPE. 
 
There are 2 methods of adding Vitamin E: the first is by blending UHMWPE powder 
with vitamin E prior to consolidation and cross-linking (blended Vitamin E HXLPE); the 
second is by doping the consolidated and cross-linked material in a hot Vitamin E 
solution, allowing vitamin E to diffuse into the material (diffused Vitamin E HXLPE) 
(Tanino et al., 2017). The purpose of this study is to provide an independent synthesis 
of the wear characteristics of Vitamin E treated HXLPE compared to HXPLE or 





Materials and Methods 
Before commencing the review, the study protocol was registered with PROSPERO 
(CRD42017074141) as recommended by the Quality of Reporting of meta-analyses 
(QUOROM) statement (Moher et al., 1999). We used a rigorous and systematic 
approach conforming to the Preferred Reporting Items for Systematic Reviews and 
Meta-analyses (PRISMA) and a PRISMA checklist is included in Appendix 1. 
 
Search Strategy 
We searched the electronic databases MEDLINE and Embase on the OVID platform, 
and The Cochrane Library using the search strategy shown in Figure 19. Searches 
were conducted from database inception to 15th November 2017. We did not limit the 
search to English language publications. We also evaluated the grey literature with 
hand searches of conference abstracts published in 6 major Orthopaedic journals in 
the 5 years before the search date. Bibliographies of relevant articles were checked 
and key citations tracked in Web of Science.  
 
1. Hip Prosthesis/ or Arthroplasty, Replacement, Hip/ or hip replacement.mp.  
2. Vitamin e.mp.  
3. Tocopherol.mp. or Tocopherols/  
4. Tocotrienol.mp. or Tocotrienols/  
5. 2 or 3 or 4  
6. 1 and 5 
 





We included all randomised controlled trials (RCTs), analyses of joint registries and 
case-controlled studies including patients of all age groups receiving primary total hip 






Title and abstracts were screened by 2 independent assessors with any 
disagreements resolved in discussion with a third reviewer. If any uncertainties relating 
to inclusion occurred, we planned to contact authors for clarification. 
 
Data Extraction 
Two of the authors worked independently to extract the data using standardised forms. 
We extracted data on: study country; recruitment dates; setting; participant 
characteristics; duration of follow-up; acetabular and femoral head bearing material 
and size; outcomes relating to primarily the degree and measurement of femoral head 
penetration; secondarily the revision rates, Harris Hip Score, patient reported outcome 
measures; and risk of bias. An electronic spreadsheet was constructed to summarise 
the findings of relevant studies.  
 
Study Quality 
Potential sources of bias in RCTs were assessed using the Cochrane risk of bias tool 
(Higgins and Green, 2008). This method assesses selection, performance, detection, 
attrition, and reporting biases. Summary assessments of risk-of-bias (high, low or 
unclear) for each outcome in each trial are reported. We planned to use alternative 
risk of bias assessment methods for assessment of non-randomised studies. 
 
Statistical Analysis 
Data were combined in meta-analysis using Review Manager software (Review 
Manager (RevMan) 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane 
Collaboration; 2014). Heterogeneity was assessed using the I2 statistic representing 
the proportion of variability across studies not due to chance or random error. Pre-
specified subgroup analysis was performed relating to different polyethylene 




This study was supported by the NIHR Biomedical Research Centre at the University 
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expressed in this publication are those of the author(s) and not necessarily those of 






A total of 372 records were identified by literature searches. The titles and abstracts 
were screened to identify potentially useful articles for inclusion. After screening, 16 
articles were assessed for eligibility. A flow diagram of the progression of studies 






































Figure 20. PRISMA flow diagram 
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There were 5 articles that contributed to our estimates of femoral head penetration, 
revision and functional outcome. There were 4 prospective randomised controlled 
trials (RCTs), all from Europe with recruitment from 2008, of which 3 examined 
diffused Vitamin E HXLPE compared to HXLPE (Salemyr et al., 2015; Nebergall et al., 
2016; Shareghi et al., 2015). The remaining RCT compared Vitamin E blended HXLPE 
to conventional UHMWPE (Scemama et al., 2017). Study characteristics are 
summarised in Table 28. There was a low risk of bias amongst RCTs when we 
examined sequence generation, allocation/concealment, blinding, completedness of 
data and reporting (Table 29). One other study from Japan had a case-control design 
and compared blended Vitamin E HXLPE and HXLPE. Although the authors reported 
propensity matching, we considered the study to be at high risk of bias because under 
a quarter of the 348 patients recruited were followed up (Tanino et al., 2017). 
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Overall risk of bias 
Key results 
RCTs: Vit E diffused HXLPE vs HXLPE 






51: 25: 26 (24; 26 
received allocated 
intervention) 
62 (6); 62 (5) 
58%; 56% 
Vit E diffused HXLPE liner 
vs standard HXLPE liner 
Uncemented acetabular 
shell. Uncemented stem 







Low risk of bias 
Included in meta-analysis 
Head penetration in transverse x (p = 0.004) and vertical y (p = 0.035) axes 
were lower in Vit E group. Similar in anteroposterior z axis (p = 0.629). Total 
penetration similar between groups (p = 0.09). 
Revisions: 1; 1 
HHS (p = 0.295) and EQ-5D (p = 0.173) similar between groups. Overall 
number of complications similar between groups. 






82: 41; 41 (32; 35 
received allocated 
intervention) 
Median (range) 67 
(43, 76); 65 (40, 73) 
50%; 54% 
Vit E diffused HXLPE liner 
vs medium cross-linked PE 
liner 
Uncemented acetabular 
shell. Uncemented stem 






Unclear risk of bias due to uneven loss to follow up at 5 years (4; 9) 
Included in meta-analysis 
Head penetration in mediolateral x, proximodistal y and anteroposterior z axes 
similar between groups. 
Revisions: 2; 3 
No differences between groups in HHS, UCLA activity, SF-36 physical 
function, EQ-5D, VAS pain and satisfaction. 
No osteolysis observed 






61 (70 hips): 38; 32 
hips 
Median (range) 58 
(20, 73) 
Vit E diffused HXLPE liner 
vs heat-treated HXLPE 
Uncemented acetabular 
shell. Uncemented stem 






Unclear risk of bias due to uneven loss to follow up (1; 6) and randomisation 
method 
Included in meta-analysis 
Total head penetration and head penetration in proximal y axis lower in Vit E 
group than heat treated group (p = 0.004 and p < 0.001 respectively). 
Revisions: 0; 1 
No difference in HSS between groups (p = 0.90) or pain score (p = 0.80). 
RCT: Vit E blended HXLPE vs UHMWPE 







100 (50; 50) 
Median (range) 67 
(32, 74); 66 (49, 75) 
48%; 56% 












Unclear risk of bias due to high losses to follow up (13; 11). 
No suitable data for meta-analysis 
Total head penetration lower in Vit E HXLPE group compared with UHMWPE 
(p = 0.04). No differences between groups in Merle d’Aubigné grade (p > 
0.99). No adverse events related to Vit E HXLPE 
Case control study: Vit E blended HXLPE vs HXLPE 





170; 178 (180; 193 
hips). 44; 41 (45; 45 
hips) followed up 
61.1 (range 42, 89) 
Sex not reported 
Blended Vit E HXLPE liner 
vs conventional HXLPE 
liner 
32mm CoCr head 
Radiography,  
2 years 
High risk of bias. Propensity matched but only partial follow up 
No differences between femoral head penetration (p = 0.161). 
Dislocation 1; 2. Infection 1; 0. 
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Vitamin E HXLPE compared to HXLPE 
All RCTs used radiostereometry (RSA) to examine femoral head penetration. In 2 
studies with 187 patients followed up for 2 and 5 years (Salemyr et al., 2015; Shareghi 
et al., 2017), total reported femoral head penetration was presented. In the meta-
analysis shown in Figure 21, total reported femoral head penetration was significantly 
less in the Vitamin E diffused HXLPE groups compared with conventional HXLPE, 
mean difference 0.08mm (95%CI 0.13, 0.02; p = 0.004) and no heterogeneity was 
evident (Figure 21). However, the RSA measurement errors in these 2 studies were 
0.13mm and 0.14mm respectively therefore this numerically significant difference is 
unlikely to be clinically significant. Furthermore, only one study was at low risk of bias 
(Salemyr et al., 2015) and in this study with 51 patients followed up, the difference 
between groups was not statistically significant (p = 0.09). In one case-control study 
there was no difference between patients in femoral head penetration between 
Vitamin E blended HXLPE and HXLPE liners (p = 0.161) but risk of bias was high due 




Figure 21. Meta-analysis of total femoral head penetration 
 
Meta-analyses of femoral head penetration by vector are shown in Figures 22-24. 
Transverse femoral head penetration was reported in 2 RCTs with data from 104 
patients followed up for 2 (Salemyr et al., 2015) and 5 years (Nebergall et al., 2017). 
In the meta-analysis shown in Figure 22 transverse femoral head penetration was 
lower in patients receiving a Vitamin E diffused HXLPE liner, mean difference 0.08mm 
(95%CI 0.03, 0.14; p = 0.003) with no heterogeneity evident. In the one study at low 








Figure 23. Meta-analysis of vertical femoral head penetration 
 
 
Figure 24. Meta-analysis of anteroposterior femoral head penetration 
 
 
Three RCTs with 167 patients followed up for 2 (Salemyr et al., 2015) or 5 years 
(Nebergall et al., 2017) reported vertical femoral head penetration. In the meta-
analysis shown in Figure 23, vertical head penetration was lower in patients receiving 
a Vitamin E diffused HXLPE liner, mean difference 0.10mm (95%CI 0.07, 0.14; p < 
0.00001) and there was no heterogeneity between studies. In the one study with low 
risk of bias (Salemyr et al., 2015), the difference was statistically significant, p = 0.035. 
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Two RCTs with 104 patients followed up reported anteroposterior femoral head 
penetration at 2 and 5 years (Salemyr et al., 2015; Nebergall et al., 2017). The meta-
analysis in Figure 24 showed a high level of heterogeneity between the studies, I2 = 
56% and we only show the results for completeness. One study showed a trend 
favouring the group that received a Vitamin E diffused HXLPE liner (Nebergall et al., 
2017) and the other a trend favouring the control group receiving HXLPE (Salemyr et 
al., 2015). Neither trend was statistically significant and only the latter study was at 
low risk of bias. 
 
Revision rates 
Study sample sizes were small and revision rates low. Overall there were 3 revisions 
in the Vitamin E diffused group and 5 revisions in the control HXLPE group. Two 
revisions for dislocations occurred in patients receiving Vitamin E diffused HXLPE and 
1 in control patients receiving HXLPE but all were in a study with unclear risk of bias 
due to uneven losses to follow up between groups at 5 years (Nebergall et al., 2017). 
In the case control study with high risk of bias, there was 1 dislocation in patients 
receiving blended vitamin E HXLPE liners compared with 2 in those receiving an 
HXLPE liner. 
 
Patient reported outcomes 
Two RCTs with 104 patients and data suitable for meta-analysis reported the Harris 
Hip Score at 2 years (Salemyr et al., 2015) and 5 years (Nebergall et al., 2017) follow 
up. As shown in Figure 25, heterogeneity between studies was high. One study with 
low risk of bias showed no statistically significant difference between groups at 2 years 
(p = 0.295). One RCT with data suitable for meta-analysis (Nebergall et al., 2017) and 
another only reporting medians and ranges (Shareghi et al., 2017) had unclear risk of 
bias due to uneven loss to follow up. In neither was there a statistically significant 




Figure 25. Meta-analysis of Harris hip scores 
 
In two RCTs, patient reported health related quality of life was assessed using the EQ-
5D (Salemyr et al., 2015; Nebergall et al., 2017). There were no differences between 
outcomes in either study, including one at low risk of bias (Salemyr et al., 2015). 
 
Vitamin E blended HXLPE compared to UHMWPE 
In one RCT with 100 patients randomised and followed up for 3 years, vitamin E 
blended HXLPE liners were compared with UHMWPE liners (Scemama et al., 2017). 
Total head penetration was lower in the vitamin E HXLPE group (p = 0.04) but the 
study was at unclear risk of bias due to high losses to follow up. There was no 






Total hip replacement is a clinically effective and cost-effective intervention (Garellick 
et al., 1998). Any improvement in the outcome of THR is likely to arise through 
reducing the incidence of adverse events or reducing the need for subsequent revision 
surgery. This systematic review and meta-analysis have shown that Vitamin E HXLPE 
has reduced femoral head penetration over highly cross-linked and conventional 
polyethylenes. However, the differences are small in comparison with the 
measurement error of the techniques used to measure it and there is no evidence from 
our rigorous systematic review to show a clinically significant benefit of Vitamin E 
HXLPE over HXLPE in terms of revision rate or function at this early stage. The lack 
of difference in functional scores is perhaps not surprising as Harris Hip Score is a 
score to assess the effect of THR as an intervention and not to tell the difference 
between patients undergoing THR with different types of bearing surface. Ceramic-
on-HXLPE in primary total hip replacement has been shown to have the lowest all-
cause revision rates in a large National Joint Registry study (Sharplin et al., 2017) and 
the reduced wear evident with the use of Vitamin E HXLPE may lead to further 
reduction in revision rates. A reduction in revision rates has not been shown in this 
study.  
 
The findings of our study should be interpreted with caution. A recent high-quality 
systematic review and network meta-analysis of 3,177 THRs concluded that there was 
currently insufficient evidence to recommend any bearing combination over a 
traditional metal on UHMWPE THR (Lopez-Lopez et al., 2017). A prospective RCT of 
122 patients at 10 years follow-up not included in this systematic review and network 
meta-analysis showed that HXLPE liners have a significantly reduced wear and 
greater survival rate compared to UHMWPE liners (Devane et al., 2017). Furthermore, 
although in vitro evidence has shown increased bacterial resistance with Vitamin E 
HXLPE (Banche et al., 2015), there was no evidence in our study to support a 
decreased rate of revision for periprosthetic infection with this bearing surface. 
 
Systematic review and meta-analysis with assessment of risk of bias can help 
clinicians to interpret results of studies in diverse settings with different outcome 
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measures. There are limitations to this study however. There are a limited number of 
randomised controlled trials all of limited follow-up from which to extract data and there 
were only 187 patients contributing to the meta-analysis of total femoral head 
penetration. Further RCTs examining Vitamin E HXLPE are underway however (Jäger 
et al., 2014; Sköldenberg et al., 2016). We did not perform a network meta-analysis to 
compare blended and diffused Vitamin E HXLPE especially given the high risk of bias 
determined in the only study that examined the latter.  There were a variety of femoral 
head sizes used in the studies and both metal and ceramic femoral heads were 
included. However, we extracted data using rigorous selection criteria and there was 
low heterogeneity for total femoral head penetration.  
 
Long-term follow-up, high-quality independent RCTs involving large numbers of 
patients and using consistent outcome reporting or large generalisable observational 
cohorts with comprehensive coverage are required to determine if lower wear results 
in lower revision rates. Such studies should be undertaken however before guidance 





This systematic review and meta-analysis showed that there were numerically but not 
clinically significant wear advantages in terms of femoral head penetration for Vitamin 
E HXLPE over HXLPE. There was no improvement in revision rates or functional 
outcome at this stage. However, there were few high quality studies and longer-term 







In the previous chapter the systematic review and meta-analysis showed that Vitamin 
E HXLPE, at least at this stage, has no clear clinical advantage over HXLPE in terms 
of all-cause revision rates despite the theoretical advantages of increased resistance 
to oxidation. The RSA studies did not show Vitamin E HXLPE to be inferior to HXLPE 
in terms of wear which suggests that Vitamin E HXLPE may prove advantageous in 
the future.  
 
If we accept an average life expectancy for a male aged 55 is 32 years and females 
is 34 years then THR ideally should last for 40 years before revision. Bone and soft-
tissue preservation are crucial concepts to permit this and to potentiate the ease with 
which a revision THR can be performed. In theory, these goals can be achieved by 
excellent surgical techniques and sensible implant choices that have minimal stress-
shielding with bearing surfaces, and that have wear rates beneath the osteolysis 
threshold of 0.05mm/year (Dumbleton, Manley and Edidin, 2002) or cumulative 
osteolysis threshold of 670mm3 (Elke and Rieker, 2018). In recent studies a 
monoblock pressfit Vitamin E HXLPE cup showed linear rates of 0.02mm/year 
compared to UHMWPE at 0.058mm/year (Rochcongar et al., 2018, Wyatt et al., 2017) 
on RSA studies.  This is in concordance with the results of Chapter 6. Vitamin E 
HXLPE with a 32mm head should therefore last more than 40 years before osteolysis 
threshld. Vitamin E HXLPE cups may be more forgiving in terms of the angle at which 
they are inserted as there was no demonstrable increase in wear rates between 45 
degrees and 80 degrees in terms of wear rates (Halma et al., 2014). Long term registry 
studies will determine whether these benefits are realised. 
 
Up-to-date literature search 
To update the context of the findings of Chapter 6 the following databases were 
searched from 2019 to 30.3.2020 using the programme Papers: ACM, ADS, arXiv, 
CERN DS, CrossRef DOI, DBLP, Espacenet, Google Scholar, Gutenberg, Highwire, 
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IEEExplore, Inspire, JSTOR, OAIster, Pubget, PubMed, ScienceDirect, Scopus and 
Web of Science. Search terms related to: Vitamin E AND Total hip.  
 
111 references were identified of which 6 were collected as potentially relevant. Those 
single published articles that cited Chapter 6 were also examined. Journals with impact 
factors <2 were excluded. Any correspondence relating to the article described in this 
chapter was reviewed.  
 
Galea et al. (2019), reported the 7 year results of their RCT for Vitamin E HXLPE liners 
in conjunction with uncemented shells. In this small RCT, RSA wear rates were were 
low at <0.1mm/yr in patients receiving botha Vitamin E HXLPE or a moderately cross-
linked polyethylene liner. Interestingly Skoldenberg et al. (2019) performed a double-
blind noninferiority RCT with cemented Vitamin E HXLPE liners in reverse hybrid THR 
constructs. 42 patients (mean age 67) were included. The total RSA migration and 
proximal migration of the Vitamin E HXLPE cemented cups were significantly higher 
than standard polyethylene at 2 years. There were no differences in clinical outcomes. 
Therefore, there was no evidence of non-inferiority but the early proximal migration 
the authors suggested is a reason for ongoing monitoring of Vitamin E HXLPE. 
 
When performing this systematic review other properties and outcomes of interest 
concerning Vitamin E HXLPE became apparent. Vitamin E HXLPE has, in some 
studies, been shown to reduce the adhesive abiliity of bacteria commonly involved in 
periprosthetic joint infections including Staphylococus epidermidis, Staphylococcus 
aureus and Escherichia (Banche et al., 2011; Banche et al., 2014). A decreased 
adhesion of blended Vitamin E HXLPE has also been found for Candida albicancs. 
Vitamin E-blended HXLPE did not however reduce the attachment or formation of 
bacterial biofilms of a clinically relevant strain of methicillin resistant Staphylococcus 
aureus compared to conventional UHMWPE or highly cross-linked UHMWPE.  Some 
authors have shown that Vitamin E blended with UHMWPE (not HXLPE) decreased in 
vitro the adherence ability of some of the most common bacteria involved in 
periprosthetic joint infections (Staphylococcus epidermidis, Staphylococcus 
aureus and Escherichia coli) in comparison with untreated UHMWPE. In addition, a 
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decreased adhesion on Vitamin E blended UHMWPE has been also found 
for Candida albicans. These studies therefore suggest that it is the addition of Vitamin 
E that produces the anti-adhesive effect and not the type of polyethylene potentially 
limiting the extent of bacterial adhesion and subsequent biofilm formation (Williams et 
al., 2015). This property of Vitamin E HXLPE may therefore inhbit the potential for 
periprosethetic joint infection and long-term studies will elucidate this (Banche et al., 
2015).  
 
Whilst periprosthetic THR infection is rare it remains a devastating complication. It 
costs at least 4 times the cost of the primary THR to address, and these costs are 
climbing (Mistry et al., 2017; Blom et al., 2003). The incidence of infected THR is 
increasing (Kurtz et al., 2008). A periprosthetic infection after THR also has extremely 
negative effects on the physical, emotional, social and economic aspects of a patient’s 
life (Beswick et al., 2012). The annual incidence is 1 to 2.5% (Bozic et al., 2014). The 
key strategies to address this problem therefore are primary prevention of infection 
and should it occur early diagnosis and effective management by a multi-disciplinary 
team (Zimmerli, 2014).  
 
Preventing periprosthetic infection comprises numerous methods employed 
preoperatively, intraoperatively and postoperatively. Preoperative skin cleaning with 
chlorhexidine cloths lower the incidence of infection in patients undergoing THR for 
example (Kapadia et al., 2013). Intraoperatively the patient’s skin is ideally shaved 
with clippers and then prepared with 2 treatments of chlorhexidine gluconate (Mistry 
et al., 2017). The use of woven drapes is inferior to disposable plastic drapes and the 
bacterial penetration rate is > 100,000 times higher if the drapes are wet (Blom et al., 
2000; 2002). Increased staff traffic volume is associated with an increased risk of 
infection and the use of antibiotic prophylaxis is mandatory. In a recently published 
systematic review however there was no evidence to support a difference between 
reusable or disposable drapes to reduce the riks of surgical site infection in 
orthopaedic surgery (Kieser et al., 2018).  Intraoperative measures to prevent infection 
can also include management of the theatre environment which was first recognised 
and pioneered by Sir John Charnley. Such measures included the use of laminar flow 
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and wearing space suits which will be explore in the next chapter as these factors are 
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total hip and knee replacement? The 10-year results of the New Zealand Joint 
Registry 
 
Reference: Hooper, G., Rothwell, A., Frampton, C. and Wyatt, M. (2011). Does the 
use of laminar flow and space suits reduce early deep infection after total hip and 
knee replacement?: the ten-year results of the New Zealand Joint Registry. Journal 
of Bone and Joint surgery, British volume, 93(1), pp.85-90. 
 
Authors contributions: 
Hooper G – lead author, final editing 
Rothwell Ag – editing the paper 
Frampton C – statistical analysis and data retrieval from Registry 





We have investigated whether the use of laminar-flow theatres and space suits 
reduced the rate of revision for early deep infection after total hip (THR) and knee 
(TKR) replacement by reviewing the results of the New Zealand Joint Registry at 10 
years. 
 
Of the 51,485 primary THRs and 36,826 primary TKRs analysed, laminar-flow theatres 
were used in 35.5% and space suits in 23.5%. For THR there was a significant 
increase in early infection in those procedures performed with the use of a space suit 
compared with those without (p < 0.0001), in those carried out in a laminar-flow theatre 
compared with a conventional theatre (p < 0.003) and in those undertaken in a laminar-
flow theatre with a space suit (p < 0.001) when compared with conventional theatres 
without such a suit. The results were similar for TKR with the use of a space suit (p < 
0.001), in laminar-flow theatres (p < 0.019) and when space suits were used in those 
theatres (p < 0.001). These findings were independent of age, disease and operating 
time and were unchanged when the surgeons and hospital were analysed individually. 
 
The rate of revision for early deep infection has not been reduced by using laminar 
flow and space suits. Our results question the rationale for their increasing use in 






Deep infection after total joint replacement is a devastating complication. Although the 
incidence of recurrent infection after a revision procedure is low (Biring et al., 2009) it 
still remains a significant complication which may require several procedures at 
considerable expense (Bannister, 2002). The estimated financial cost of revision for 
infection is four times that of the initial procedure (Dreghorn and Hamblen, 1989). 
 
Early infection is predominantly secondary to intraoperative contamination (Charnley, 
1964; Whyte, Hodgson and Tinkler, 1982). The prophylactic use of antibiotics both 
systemically and within cement has reduced the rates of early infection but the 
development of resistant bacteria continues to be a major concern (Ericson, Lidgren 
and Lindberg, 1973). 
 
Airborne contamination can be decreased by limiting the number of personnel and 
their movement within the operating room, and also by changing the ventilation within 
it (Fitzgerald and Washington, 1975; Ritter, 1999; Lidwell, 1998). The creation of a 
clean-air environment by the use of laminar-flow systems was introduced by Charnley 
1979 and resulted in a significant reduction in his rates of early infection. The 
‘cleanliness’ of the air within an operating theatre can be further improved by 
increasing the rate of exchange of air within the room. Conventional plenum ventilation 
theatres have rates of air exchange of 30 times per hour, whereas laminar-flow 
theatres exchange the total volume of air in the room over 300 times an hour. This 
clean air delivered at a positive pressure should result in a maximum of 10 colony-
forming units per cubic metre (cfu/m3), but with values as low as 1 cfu/m3. The Medical 
Research Council trial (Lidwell, 1998) confirmed the value of laminar-flow theatres in 
the reduction of cfus. 
 
Protective suits with hoods and self-contained exhaust systems (space units) have 
been used to improve sterility further. The cfus/m3 can be reduced to a value as low 
as 1.0 with the combined use of both laminar flow and space suits (Lidwell, 1998; 
Davis et al., 1999). This reduction in bacteria has been assumed to be associated with 
a lower risk of contamination of the wound and subsequent early infection. Although 
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the combined use of laminar flow and space suits make intuitive sense there have 
been limited studies investigating early rates of infection after total joint replacement 
using these methods (Davis et al., 1999). 
 
Since the overall rate of infection in joint replacement is extremely low and there are 
a multitude of factors potentially responsible (Willis-Owen, Konyves and Martin, 2010) 
conducting randomised trials with sufficient statistical power is unrealistic. Joint 
registries allow the study of large prospective data bases in a reliable manner and are 
able to produce powerful data for rare complications such as infection. We have 
studied the use of laminar flow and space suits and related this to the rate of early 
deep infection in revision arthroplasty by using data over 10 years from the New 
Zealand Joint Registry. This registry captures 98% of both primary and revision 
arthroplasties performed in New Zealand and records revision procedures secondary 
to deep infection. Our hypothesis was that both laminar flow and the use of space suits 
would result in a lower rate of early deep infection requiring a revision procedure 




Patients and Methods 
We retrospectively analysed the data from the New Zealand Joint Registry between 
1999 and 2008 to record the early rates of revision for infection for all registered 
primary THRs and TKRs. We defined revision due to early infection as any such 
procedure performed within 6 months of the initial operation for infection. 
 
The Joint Registry collects information on all revision procedures performed and 
documents the reason for the revision. It also captures information on whether the 
initial procedure was performed within a conventional or laminar-flow operating room 
and whether space suits were used at the time of the operation. 
 
The rate of infection was recorded as a percentage of all the THRs or TKRs performed 
over the 10 years with a minimum follow-up of 6 months from these operations. The 
rate was compared between those procedures performed in a conventional operating 
room with those undertaken in a purpose-built laminar-flow operating room, and 
between operations using space suits with those without. Operations using both 
laminar flow and space suits were compared with those using neither. 
 
In order to minimise associated variables such as the operating time, the use of 
antibiotics and the surgical technique, we then compared the revision rates for those 
surgeons who had experience in both conventional and laminar-flow operating 
theatres and who had performed at least 50 procedures in both. We also compared 
the revision rates of those surgeons who had used space suits in both surgical settings 
and who had completed at least 50 procedures in each. We made the assumption that 
these surgeons were likely to have maintained similar surgical practices between the 
differing operating environments. This was further investigated by sending a 
questionnaire on their surgical practice to all the surgeons who fulfilled the above 
criteria. These results were further evaluated by reviewing the data, the patient’s 
clinical details and the duration of the operation in the Joint Registry for each surgeon. 
The questionnaire also requested information from the surgeons on the frequency of 
use of space suits, which members of the surgical team wore them, whether their 
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practice changed depending on the operating theatre or surgical team and whether 
they wore full suits or just a hood with a fan system. 
 
In order to decrease the impact of variables associated with individual hospitals, we 
analysed each hospital to see whether there was any difference among hospitals for 
those surgeons who used space suits and laminar flow compared with those who 
operated without them in conventional theatres. Finally, we asked all the hospitals to 
confirm which theatre ventilation system they used, the rate of air exchange and the 
maintenance programme of the filters.  
 
Statistical Analysis 
The percentages with revision for deep infection were compared between groups 
using the chi-squared test or Fisher’s exact test when expected frequencies were low. 





There were 51,485 primary THRs and 36,826 primary TKRs registered on the New 
Zealand Joint Registry during the period of study with full information on the theatre 
environment. The most common diagnosis before the initial procedure was 
osteoarthritis (94% for both THR and TKR) with a low incidence of inflammatory 
arthritis (3% THR, 4% TKR). Laminar-flow theatres were used for 33% of all THRs 
compared with 38% of all TKRs. Space suits were used in 21% of all THRs and in 
26% of all TKRs. There was a steady increase in the use of laminar-flow theatres and 
the use of space suits between 1999 and 2008 (Table 30) and in 2008 almost half of 
these procedures were performed in laminar-flow theatres with space suits. 
 
Table 30. The increase (%) in use of laminar-flow theatres and space suits over the 
last ten years recorded on the New Zealand Joint Registry for total hip and knee 
replacements 
 








 THR TKR THR TKR 
1999 21 21 9 12 
2004 36 40 21 24 
2008 49 53 42 44 
 
 
Total hip replacements (Figure 26)  
There were 46 (0.089%) patients who required early revision for deep infection. There 
was a significant increased association  with the rates of early revision for deep 
infection for those procedures performed with the use of a space suit (0.186%) when 
compared with those without (0.064%, p < 0.0001) (Figure a) and for operations 
performed in a laminar-flow theatre (0.148%) compared with a conventional theatre 
(0.061%, p < 0.003) (Figure b). There was also a significant increase in the rates of 
revision for deep infection in procedures performed in a laminar-flow theatre with a 
space suit (0.198%) compared with those in a conventional theatre without a space 
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suit (0.053%, p < 0.001) (Figure c). These results were independent of age and the 
diagnosis at the time of the initial procedure. 
 
There were 43 surgeons who performed more than 50 procedures in both operating 
environments. These operations had an infection rate of 0.110% in the laminar-flow 
theatre compared with 0.028% in the conventional theatre (p < 0.03). 
 
There were 33 surgeons who sometimes did and sometimes did not wear a space 
suit. The incidence of infection was 0.082% with a suit compared with 0.057% without 
(p = 0.755). Additionally, 30 surgeons had operated both with a space suit and laminar 
flow and without a space suit in a conventional environment. The operations performed 
in a conventional theatre without a suit had no infections from 3598 procedures, 
compared with 0.1035% carried out in a laminar-flow theatre with a suit (p = 0.09) The 
clinical details of the patients were similar in both groups with no significant difference 





Figure 26. Graphs showing the percentage of total hip replacements requiring 
revision for deep infection within six months comparing a) the use of a space suit 
with no suit, b) the use of laminar flow with a conventional operating theatre, and c) 
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There were 50 (0.136%) patients requiring early revision for deep infection. 
 
There was a significant increase in early revision, similar to THR, for those TKRs 
performed with the use of a space suit (0.243%, p < 0.001) compared with those 
without (0.098%, p < 0.001) (Figure d), when laminar-flow theatres (0.193%) were 
compared with conventional theatres (0.100%, p < 0.019) (Figure e), and when 
laminar flow and space suits (0.25%) were used compared with no space suits and 
conventional theatres (0.087%, p < 0.001) (Figure f). Again, these results were 
independent of the patients’ age and diagnosis at the time of the initial procedure. 
 
There were 23 surgeons who performed at least 50 TKRs with or without a space suit. 
There was almost a tenfold increase in the rate of early revision because of deep 
infection in those who used a space suit (0.251% compared with 0.028%, p = 0.016). 
There were 32 surgeons who operated in both laminar-flow and conventional theatres, 
but in contrast to THR there was no significant difference in the revision rate for deep 
infection (0.147% compared with 0.189%, p = 0.597). Again, as with THR, there was 
no difference in the patients’ clinical details between the groups and the duration of 




Figure 27. Graphs showing the percentage of total knee replacements requiring 
revision for deep infection within six months comparing d) the use of a space suit 
with no suit, e) the use of laminar flow with a conventional operating theatre, and f) 
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The infection rate compared with the operating theatre  
There were 64 hospitals that supplied data to the registry. Only one was identified as 
having a significantly increased rate of revision for early deep infection when the use 
of a conventional theatre and no space suit was compared with laminar flow with a 
space suit. This hospital contributed only a small number to the database and when 
these were removed from the analysis there was no change in the significance of the 
results. 
 
All hospitals confirmed that they had a regular maintenance programme for filters. 




There were 35 responses from the 60 surgeons who had been sent a questionnaire, 
giving a response rate of 58.3%. All respondents currently use a space suit in all of 
their replacement procedures, and all stated that they used the same surgical 
technique regardless of the theatre environment. Most (28 of 31) used full suits for the 
surgeon, assistant and scrub nurse. All the suits were contemporary in design and no 
surgeon worked in a fully enclosed space. No surgeon worked with all the staff in the 






Our study has shown that the combined use of laminar flow and space suits did not 
protect against infection requiring revision within 6 months of the primary joint 
replacement and may have increased the risk. These results are surprising 
considering that the microbiological evidence suggests that their combined use should 
decrease the total number of colony-forming units within the operating theatre which 
should reduce the rate of infection (Bannister, 2002). To date, there have been no 
studies which have shown conclusively that a decreased number of colony-forming 
units relates to a lower rate of wound contamination and infection. 
 
Although ultraclean air environments using laminar flow have been widely accepted 
as reducing the risk of wound contamination, there has only been one other major 
multicentre study which has examined the effect of laminar flow on wound infection in 
orthopaedic procedures (Lidwell, 1998). Lidwell et al., 1987 published the Medical 
Research Council’s prospective trial and concluded that the incidence of confirmed 
sepsis was higher in conventional theatres. However, this study included only 8,052 
procedures up to 4 years after surgery, with a mean of 2.5 years, and hence all may 
not have been due to intraoperative contamination. This trial has also been widely 
criticised because of the variable and uncontrolled use of perioperative prophylactic 
antibiotics. In New Zealand prophylactic antibiotics are given for most THR and TKR 
operations. The Joint Registry shows a use of prophylactic antibiotics of 96% and of 
antibiotics in the cement of 60% (NZJR report, 2010). We do not feel therefore that 
this is a significant confounding variable in our study. 
 
Brandt et al. (2008), reviewed the German experience with surgical site infection in 
99,230 general surgical and orthopaedic procedures. They concluded that laminar 
flow did not reduce surgical site infection and may have contributed to a higher rate of 
infection in THR. Others have found that bacterial contamination of the wound in THR 
was not reduced with laminar-flow ventilation (Clarke et al., 2004). 
 
In order to be effective, laminar flow requires no obstructions to the path of the high 
flow of air. Obstructions cause eddies which in turn can produce areas of risk for 
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increasing contamination and infection (Taylor and Bannister, 1993; Salvati et al., 
1982). The layout of operating theatres varies considerably between hospitals. Our 
study could not control this variable, but by comparing surgeons in different theatre 
environments we believe that we have minimised such variables as the position of the 
surgeon and staff with respect to the patient and the individual surgical setup, all of 
which may interfere with the flow of air within an operating theatre. 
 
The removal of airborne particles including bacteria and spores requires the use of 
high-efficiency particulate air filters, which in turn require regular maintenance. All the 
hospitals confirmed that they complied with these maintenance programmes and the 
observations that there were no hospitals using laminar flow which skewed the results 
suggests that this potential source of contamination was unlikely to be a factor. 
 
The shedding of bacteria from the skin of the surgical team has been implicated as a 
major potential source of wound contamination (Ritter, 1999). The large air flows from 
laminar systems are commonly vertical and push air and debris from the ceiling to the 
floor. These flows pass the head and upper body of the surgeon and assistants and 
can potentially contaminate the wound from this source. The ears, which are not 
covered by the traditional hood and mask, are the most common part from which 
bacteria are shed. The use of enclosed hoods and exhaust systems combined with 
occlusive gowns should decrease wound contamination from this source. However, it 
has been shown that disposable hoods and masks are as effective as helmet aspirator 
systems (Friberg et al., 2001). Charnley, 1979 reported the lowering of infection after 
THR from 10% to 1% with the use of laminar flow and full-body exhaust suits. Our 
study has shown that the rate of infection in both theatre environments was increased 
with the use of space suits. Surgeons who returned a questionnaire made comments 
about the current space suits used, indicating that at times their spatial awareness 
was limited by the hood. Others suggested that it was easier to contaminate 
themselves while wearing a space suit since there was an apparent false sense of 
security within it. Observers who have been present during operations using space 
suits have noted that surgeons often adjust the suit or hood during the procedure and 
subsequently unknowingly contaminate their gloves. Another possible cause of 
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contamination may be the exhaust systems of the space suits. There is no information 
as to the flow of the expelled air from exhaust systems and whether the air is 
concentrated with debris and significant numbers of colony-forming units close to the 
surgical site. 
 
The causes of wound infection are multifactorial. We have tried to limit confounding 
variables in our study by including a group of surgeons who had operated in a variety 
of environments. Our assumption was that their operating procedures would not differ 
between different hospitals. Therefore, such factors as the duration of the operation, 
the patient mix, surgical technique, the use of antibiotics, the movement within the 
theatre and the general sterile procedures, would be similar. This was confirmed by 
the questionnaire which was sent to these surgeons, although a response rate of 
58.3% could be regarded as low. Analysis of the patients registered on the New 
Zealand Joint Registry confirmed that there was no difference in the patient’s clinical 
details between the hospitals for these surgeons. In particular, there was no difference 
in the number of patients perceived to have a higher risk of infection, such as those 
with inflammatory arthritis. The duration of the operation was the same in the 2 groups 
suggesting that the complexity of the operations was similar. 
 
We also studied each individual hospital and in particular looked at those that had both 
a laminar flow and conventional theatre. We found only one hospital in which the trend 
towards revision for infection was increased in a conventional theatre. This was a 
provincial hospital and performed only a small number of procedures. When they were 
removed from the analysis the results were unchanged. We believe that this removed 
any bias which may have occurred because of a particular ‘rogue’ hospital. We defined 
early joint infection as that requiring a revision procedure within 6 months of the initial 
operation. It is generally accepted that any deep infection which develops within this 
timeframe is most likely to be due to bacterial contamination at the time of the 
replacement (Antti-Poika et al., 1990; Tsukayama, Estrada and Gustilo, 1996) but we 
acknowledge that not all joint infections will be captured by this method. Not all early 
deep infections would have had a revision procedure within this timeframe, especially 
those in older and infirm patients who may have been treated with suppressive 
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antibiotics. Subacute infections which presented after 6 months were not captured by 
our study. However, we believe that including infections outside this period would be 
more likely to confuse the data with increasing numbers of infections from a secondary 
source. We accept that our study only captures those patients with severe deep 
infections who require a revision procedure. However, we believe that this is the most 
important group of patients since they suffer the most severe morbidity and are a large 
drain on health resources (Dreghorn and Hamblen, 1989). 
 
Previous studies (Hooper et al., 2009; Rothwell et al., 2010) have shown the value of 
national joint registries which record large numbers of procedures and produce 
valuable data for rare complications which would be extremely difficult to produce in 
prospective, randomised trials. In response to the surgeon questionnaire, several 
surgeons made the comment that they monitored their infection rate and thought that 
their results were acceptable. However, the rates of early revision for infection were 
small (0.08% for THR and 0.13% for TKR). Therefore, an individual surgeon would 
have extreme difficulty in observing any change over time in their rate in relation to the 
use of laminar flow or space suits. 
 
In conclusion, our study has shown that there is no benefit in the use of laminar flow 
or space suits in reducing the rate of revision for early deep joint infection in total joint 






The estimated costs of revision surgery for periprosthetic joint infection are escalating 
(Haddad, Ngu and Negus, 2017; Sousa et al., 2018). Our study of the NZJR in the 
previous chapter showed an increased rate of early deep infection with the combined 
intra-operative use of vertical laminar flow and modern positive-pressure helmet suits 
in patients undergoing both THR and TKR surgery. The Lidwell prospective 
multicenter randomised controlled trial in 1982 found that the incidence of infection in 
laminar flow theatres was reduced when compared to the control group. This study 
found that infection rates were reduced further when the ultraclean environment was 
combined with the practice of wearing body exhaust suits. However there was no 
accounting for the use of antibiotic prophylaxis. Subsequent studies that did control 
for the use of antibiotics did not demonstrate a significant difference in infection rates 
between traditional theatre environments and laminar flow theatres (Marotte et al., 
1987). Brandt et al. (2008) also found that laminar flow did not convey an advantage 
in reducing infection rates although strictly this study was not specifically focused on 
orthopaedic procedures. Further consideration on the details of both laminar flow and 
space is warranted however, as Chapter 7 did not deduce any mechanism for these 
observational findings nor does it in itself permit triangulation with more recent 
published research to substantiate its validity. Our study chose revisions for deep 
infection within 6 months to likely be due to intraoperative contamination however 
Zimmerli, Trampuz and Ochsner (2004) suggested that intraoperative contamination 
was responsible for deep infections occurring up to 24 months following surgery. 
Another criticism of the previous chapter is that there was no regression analysis 
performed and adjustment for potential confounders. 
 
Up-to-date literature search 
To update the context of the findings of Chapter 7 the following databases were 
searched from 2010 to 303.3.2020 using the programme Papers: ACM, ADS, arXiv, 
CERN DS, CrossRef DOI, DBLP, Espacenet, Google Scholar, Gutenberg, Highwire, 
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IEEExplore, Inspire, JSTOR, OAIster, Pubget, PubMed, ScienceDirect, Scopus and 
Web of Science.  Search terms related to: Laminar flow OR Suits AND Infection.  
 
215 references were identified of which 12 were collected as potentially relevant. 
Those 149 published articles listed in PubMed that cited Chapter 7 were also 
examined. Journals with impact factors <2 were excluded. Any correspondence 
relating to the article described in this chapter was reviewed. The NZJR reports since 
2010 were examined. 
 
National joint registries update 
In every annual NZJR report (2011-2019) since the publication of Chapter Seven there 
has remained a significant difference in revision rates for deep infection within 6 
months of surgery between conventional (lower) and laminar flow theatres. There has 
been 2.1 to 2.4 times increased risk in using a suit in either laminar flow or conventional 
theatres. In addition the risk of revision for deep infection within 6 months for laminar 
flow and suit has been 1.7 to 3.2 times that of a conventional theatre combined with 
no suit. In another NZJR study Tayton et al. (2016) showed no evidence that modern 
surgical helmet systems reduce the risk of PJI and that laminar flow may increase the 
risk of revision for deep infection within six months of surgery. In addition, Smith et al. 
(2018) examined 91,585 THRs in the NZJR between 2000 and 2014.  Multivariate 
analysis again showed a significant association of PJI with the use of laminar flow (OR 
1.98; 95%CI 1.01 to 4.6). 
 
Evidence synthesis  
Bischoff et al., 2017 performed a systematic review and meta-analysis of 12 
observational studies concerning orthopaedic, general and vascular surgery. The role 
of the operating room’s ventilation system in the prevention of surgical site infections 
was examined. Laminar flow was compared with conventional ventilation systems to 
assess their effectiveness in reducing the risk of surgical site infections. Laminar flow 
made no difference to the rate of surgical site infections (>300,000 THR) OR 1.29 
(p=0.07) The study concluded that the added expense of laminar flow systems was 
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therefore unjustified and that this equipment should not be installed in new operating 
theatres.  
 
Young et al., 2016 performed a systematic review examining the evidence for modern 
positive pressure surgical helmet systems and the Charnley type negative pressure 
exhaust suits.  This systematic review showed that positive-pressure surgical helmet 
systems did not reduce contamination or deep infection during arthroplasty in contrast 
to Charnley-type body exhaust suits. 
 
Proposed mechanisms for findings of registry and evidence syntheses 
 
Laminar flow 
Our study did not include details on the type of laminar flow theatres reported and this 
may have a confounding effect. Ventilatory systems were purported to reduce the 
airborne bacterial contamination through the production of positive air pressure that 
displaced contaminated air away from the operation site. Air is taken in at ceiling level 
of the theatre through a series of fans and bacteria are removed most commonly using 
“High-efficiency particulate air” (HEPA) filters. Three types of ventilatory systems are 
available: plenum, ex-flow system (Howarth enclosure), laminar flow. Plenum relies 
on the pressure being greater in the operating theatre compared to the outside. Clean 
air enters through diffusers via the wall/ceiling and exits through vents at floor level. 
As air can also exit through open doors plenum is less reliable as an aseptic 
environment. Ex-flow system allows the flow of clean air from the theatre in the shape 
of an inverted trumpet with air moving down and outwards. This system therefore 
prevents the phenomenon of peripheral entrainment which is problematic with vertical 
laminar flow. Laminar flow is achieved when the entire body of air from the theatre 
suite moves with equal velocity in parallel flow lines, Ultraclean air from HEPA filtering 
achieves < 10 colony-forming units per metre cubed of bacteria. Laminar flow can 
operate by either a horizontal or a vertical system and in  New Zealand the latter only 
are used. Peripheral personal at the edge of laminar flow can disrupt its efficacy 
however and promote entrainment of contaiminated air into the sterile field (James et 
al., 2015).  
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McGovern et al., 2011 using neutral buoyancy bubbles found that forced air warming 
used in conjunction with laminar flow may be detrimental and increase infection rates. 
In addition Refaie et al., 2017 showed, in their experiment with neutrally buoyant 
helium bubbles, that laminar flow was affected negatively by operating lights.  Smith 
et al., 2013 showed that the laminar flow was affected negatively by theatre personnel 
traffic. Similarly Cao et al., 2018 showed that laminar air flow is disrupted by the 
presence of medical staff and the position of equipment such as the operating lamp. 
Traversari et al., 2019 in a study from the Netherlands showed how performances of 
different airflow systems compared between the operating room and the instrument 
preparation room. A number of factors affected the laminar flow of air and included the 
height of the canopy screen, position of the air exhaust terminals, the size of the 
canopy and the type of system.  
 
Space suits 
The original body exhaust suit of Charnley created a negative pressure inside the 
gown using intake/outflow tubing whilst the modern “space suit” systems incorporate 
helmet-based intake fans which use the hood material as a filter and create a positive 
pressure inside the gown. These newer devices, which are the ones used in New 
Zealand, drive convection currents and with them bacteria down from the head area 
and out of the glove/cuff interface which likely potentiates the incidence of PJI and is 
a potential rationale for the findings of our study (Young, Chisholm and Zhu, 2013). 
Vijaysegaran et al., 2018 compared particle emission rates of space suits and 
standard surgical clothing. This study found that space suits caused higher rates than 
standard clothing and therefore provide a mechanism to support the observational 
evidence in clinical studies. 
 
Findings in other types of orthopaedic surgery 
In a nationwide UK study linked to HES data of trauma surgeries surgical infection 
within 90 days was examined by Pinder et al., 2016 There was no difference in 
outcomes between plenum and laminar flow theatre i.e. laminar flow did not convey 
an advantage. Din et al., 2020 reported a single centre comparative study of both 
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laminar flow and conventional theatre ventilation in 259 fractured neck of femur 
patients. There was no significant difference in infection rates between the 2 groups. 
Teo et al., 2020 reported a single-surgeon series of 1028 procedures and concluded 
that laminar flow was of no benefit compared to conventional theatres when 
performing primary total knee replacement. Furthermore Shirley et al., 2017 
investigated the use of positive -pressure helmet systems in primary TKR surgery. 
This randomised controlled trial found, conversely, that there was no difference in 
wound contamination between standard gowns and helmet systems. 
  
International consensus, guidelines and implementation strategies to reduces 
SSI and PJI 
Graves et al., 2016 performed a cost-effectiveness study and concluded that 
systematic antibiotics, antibiotic-impregnated cement and conventional ventilation 
would be the optimum cost-effective strategy for the NHS to prevent PJI in THR.  The 
implementation of Total Joint Replacement in developing countries is expensive and 
the considerable costs of laminar flow theatre construction has been justifiably 
questioned by Pedneault, St George and Masri, 2020. Finally, the World Health 
Organisation have recommended that laminar flow systems should not be used to 
reduce the risk of SSI for patients undergoing Total Joint Replacement. The 
International Consensus Meeting on Musculoskeletal Infection concluded that the 
Orthopaedic literature did not support the requirement for laminar flow systems when 
performing Total Joint Replacement surgery. Similarly the use of body exhaust suits 
remains controversial with no published evidence to show any benefit (Goswami, 
Stevenson and Parviz, 2020). We shall now consider other riskfactors for PJI. 
 
Addressing other risk factors for PJI 
In a recent systematic review and meta-analysis Kunutsor et al., 2019 showed that 
antiobiotic cement was associated with lower rates of prosthetic joint infection 
compared to cement fixation without antibiotics. Uncemented implants had the lowest 
rates of infection overall when compared to cemented implants and hybrid 
combinations. Interestingly this superiority was reversed during the first 6 months 
when antibiotic-cemented fixation was superior (Kunutsor et al., 2019).  
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A recent large registry cohort study by Lenguerrand et al., 2018 examined the risk 
factors associated with revisions for PJI after THR. Several modifiable (male gender, 
younger age, BMI > 30, diabetes, use of the lateral approach over the posterior 
approach, use of ceramic rather than metal femoral heads) and non-modifiable factors 
(dementia, previous septic arthritis, THR being performed for a fractured neck of 
femur) were associated with the risk of revision for deep infection after THR. 
Interestingly the risk of revision for deep infection was not influenced by the grade of 
operating surgeon or surgical volume/experience. The authors advocated the 
identification of modifiable risk factors and the use of targeted intervention ro reduce 
the incidence of PJI. The effect of non-modifiable risk factors is also important to 
consider when counselling patients during the process of informed consent.  
 
Diagnosis of PJI 
Accurate diagnosis diagnosis of periprosthetic infection is of paramount importance 
yet may be very challenging as the classic clinical features may be absent.  An early 
precise diagnosis may mean that the infection can be addressed by a less radical 
treatment with debridement and retention of the implants instead of a 1- or 2-stage 
revision. The search for a single diagnostic test on synovial fluid with the requisite 
accuracy, sensitivity and specificity to determine whether a THR is infected or not is 
attractive. The search for such a test has yielded numerous biomarkers as potential 
candidates – the term biomarker meaning a biologically pertinent molecule that can 
be evaluated objectively to indicate the presence of a disease or biological state. In a 
recent systematic review and meta-analysis, the search for a standard reference test 
for determining periprosthetic infection through analysis of synovial fluid yielded 
numerous candidates. These comprised synovial leucocyte count, synovial C-reactive 
protein (CRP), alpha-defensin, leucocyte esterase, interleukin (IL)-6, IL8, IL-10, IL-1b, 
vascular endothelial growth factor (VEGF) and granulocyte-colony stimulating factor 
(G-CSF). The overall sensitivity of these biomarkers for diagnosing PJI was 0.85. 
Synovial fluid leucocyte count, CRP, alpha-defensin, leucocyte esterase, Il-6 and Il-8 
demonstrated high sensitivity for diagnosing PJI with alpha-defensin the best synovial 
marker with the highest log diagnostic odds ratio (Lee et al., 2017). Given this apparent 
 247 
superiority of alpha defensin and the readily available alternative leucocyte esterase 
which is detectable on colormetric strips that detect a colour change the next chapter 
of the thesis compares, in detail, not only the sensitivity but also the specificity and 
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Synovial biomarkers have recently been adopted as diagnostic tools for prosthetic joint 
infection (PJI), but their utility is uncertain. The purpose of this systematic review and 
meta-analysis was to synthesise the evidence on the accuracy of alpha-defensin 
immune-assay and leucocyte esterase colorimetric test strip for the diagnosis of PJI, 
compared to the Musculoskeletal Infection Society diagnostic criteria. 
 
Methods 
We performed a systematic review to identify diagnostic technique studies evaluating 
the accuracy of alpha-defensin or leukocyte esterase in the diagnosis of PJI. 
MEDLINE and Embase on Ovid, ACM, ADS, arXiv, CERN DS, Crossref DOI, DBLP, 
Espacenet, Google Scholar, Gutenberg, Highwire, IEEExplore, Inspire, JSTOR, 
OAlster, Open Content, Pubget, PubMed and Web of Science were searched from 
inception until 30th May 2015 along with grey literature. Classification of studies and 
data extraction were performed independently by 2 reviewers. Data extraction 
permitted meta-analysis of sensitivity, specificity with construction of receiver operator 
characteristic curves for each test. 
 
Results 
We included 11 eligible studies. The pooled diagnostic sensitivity and specificity of 
alpha-defensin (six studies) for PJI were 1.00 (95% CI 0.82-1.00) and 0.96 (95% CI 
0.89-0.99) respectively. The Area Under the Curve (AUC) for alpha-defensin and PJI 
was 0.99 (95% CI 0.98-1.00). The pooled diagnostic sensitivity and specificity of 
leucocyte esterase (five studies) for PJI were 0.81 (95% CI 0.49-0.95) and 0.97 (95% 
CI 0.82-0.99) respectively. The AUC for leucocyte esterase and PJI was 0.97 (95% CI 






The diagnostic accuracy for PJI was high for both tests. Given the limited number of 
studies, more independent research on these tests is warranted given the large cost 
difference between the tests. 
 
Level of Evidence  






Periprosthetic joint infection (PJI) is a rare complication affecting between 0.7 and 
2.4% of patients receiving joint arthroplasty (Blom et al., 2004; Blom et al., 2003; Ong 
et al., 2009; Kurtz et al., 2012; Huotari, Peltola and Jamsen, 2015; Dale et al., 2012; 
Achermann et al., 2011; Henricson, Nilsson and Carlsson, 2011; Padegimas et al., 
2015). PJI after hip and knee arthroplasty in particular has extremely negative effects 
on physical, emotional, social and economic aspects of a patient’s life (Andersson et 
al., 2010). Early diagnosis can lead to less radical treatment with debridement and 
retention of prostheses instead of one- or two-stage revision. Establishing a diagnosis 
of infection promptly (Moojen et al., 2014) is therefore of paramount importance, yet 
may be challenging as the classic clinical features may be absent and a painful joint 
replacement may be caused by other pathologies. The Musculoskeletal Infection 
Society (MSIS) has developed diagnostic criteria to standardise and facilitate this 
diagnostic process (Table 31) (Parvizi et al., 2011). The search for a single diagnostic 
test on synovial fluid with the requisite accuracy, sensitivity and specificity has yielded 
numerous biomarkers as potential candidates – the term biomarker meaning a 
biologically pertinent molecule that can be evaluated objectively to indicate the 
presence of a disease or biological state. Alpha-defensin (Deirmengian et al., 2014) 
and leucocyte esterase (Parvizi et al., 2011) are currently among the most promising. 
 










Definition of Periprosthetic Infection 
Based on the proposed criteria, a definite PJI exists when: 
1. There is a sinus tract communicating with the prosthesis, or 
2. A pathogen is isolated by culture from two or more separate tissue or fluid   
samples obtained from the affected prosthetic joint, or 
3. When four of the following six criteria exists: 
a. Elevated serum erythrocyte sedimentation rate (ESR) and serum C-reactive 
protein (CRP) concentration, 
b. Elevated synovial white blood cell (WBC) count 
c. Elevated synovial polymorphonuclear percentage (PMN%) 
d. Presence of purulence in the affected joint 
e. Isolation of a microorganism in one culture of periprosthetic tissue or fluid, or 
f. Greater than five neutrophils per high power field in 5 high power fields observed 
from histological analysis of periprosthetic tissue at 400 times magnification 
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Alpha-defensin is an antimicrobial peptide that is released naturally from activated 
neutrophils. The peptide then integrates into, and destroys, the pathogens’ cell 
membrane (Lehrer and Ganz, 1992). The alpha-defensin immunoassay was 
developed from both genomic and proteomic studies and provides a qualitative result 
specific for synovial fluid. The advantages of this test include its simplicity and 
standardisation whilst a disadvantage is its relatively high cost of £500 per test ($760 
US) (CD Diagnostics, Wynnewood, Pennsylvania). 
 
Leucocyte esterase is an enzyme secreted by activated neutrophils recruited to areas 
of infection. Detection of leucocyte esterase has been used for many years in 
urinalysis to diagnose urinary infection (Leighton and Little, 1985). The leucocyte 
esterase colormetric strip test is performed by applying fluid to a reagent test strip. A 
detergent on the strip lyses the neutrophils within the fluid and this releases esterase 
which catalyses a reaction leading to formation of a violet dye. Advantages of this test 
are that it is quick, easy and inexpensive at 11 pence (17 cents US) per test (Combur-
7, Roche Diagnostics, Indianapolis, Indiana). A potential disadvantage is the 
invalidation of the result by blood contamination (Deirmengian et al., 2015) although 
this has been addressed by centrifugation prior to application of the fluid (Tischler, 
Cavanaugh and Parvizi, 2014). 
 
The purpose of this systematic review and meta-analysis was to synthesise the 
available evidence on the accuracy of alpha-defensin and leucocyte esterase in the 





Materials and Methods 
We used a rigorous and systematic approach conforming to the Preferred Reporting 
Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines (Moher et al., 
2009) (Appendix) and the critical evaluation of studies relating to diagnosis of PJI 
(Buntinx, Aertgeerts and Macaskill, 2009). 
 
Protocol 
A protocol was registered online with PROSPERO (CRD42015023704) before 
commencing the review as recommended by PRISMA. 
 
Search strategy 
We searched all studies indexed in MEDLINE and Embase on the Ovid platform, ACM, 
ADS, arXiv, CERN DS, Crossref DOI, DBLP, Espacenet, Google Scholar, Gutenberg, 
Highwire, IEEExplore, Inspire, JSTOR, OAlster, Open Content, Pubget, PubMed and 
Web of Science from inception until 30th May 2015 using the search strategy shown 
as applied in MEDLINE and Embase in Table 32. We also evaluated the grey literature 
with hand searches of 6 major Orthopaedic journals over the last 5 years. The 
bibliographies of the relevant articles were then cross-checked for articles not 
identified in the search. Studies in patients of all age groups were included. No 
language restrictions were applied, which is an important consideration with the 
perceived international interest in treatment of infected hip prostheses. The screening 
of studies was performed by 2 independent assessors with any disagreements 
resolved by a third reviewer. A spreadsheet was constructed to summarise the findings 
of relevant studies. 
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Table 32. Search strategy 
 
 
Defensin/ leucocyte esterase search 
MEDLINE 130715 
1. neutrophil antimicrobial peptide.mp. or alpha-Defensins/ 
2. alpha defensin.mp. or alpha-Defensins/ 
3. alpha-Defensins/ or peptide neutrophil antimicrobial.mp. 
4. beta-Defensins/ or defensin.mp. or alpha-Defensins/ or Defensins/ 
5. Arthroplasty, Replacement/ or Knee Joint/ or Arthroplasty, Replacement, Knee/ or 
Arthroplasty, Replacement, Hip/ or Hip Prosthesis/ or joint replacement.mp. or Joint 
Prosthesis/ 
6. Arthroplasty, Replacement, Knee/ or Arthroplasty, Replacement, Elbow/ or Arthroplasty, 
Subchondral/ or Arthroplasty, Replacement, Ankle/ or arthroplasty.mp. or Arthroplasty, 
Replacement, Finger/ or Arthroplasty, Replacement/ or Arthroplasty/ or Arthroplasty, 
Replacement, Hip/ 
7. Bacterial Infections/ or Prosthesis-Related Infections/ or prosthetic joint infection.mp. or 
Surgical Wound Infection/ 
8. 5 or 6 or 7 
9. 1 or 2 or 3 or 4 
10. 8 and 9 
11. leukocyte esterase.mp. 
12. leucocyte esterase.mp. 
13. 11 or 12 
14. 8 and 13 
15. 10 or 14 
 Embase 130715 
1. alpha defensins.mp. or alpha defensin/ 
2. neutrophil antimicrobial peptide.mp. or defensin/ 
3. beta-Defensin/ or defensin.mp. or alpha-Defensin/ or Defensin/ 
4. joint replacement.mp. or joint prosthesis/ 
5. shoulder arthroplasty/ or knee arthroplasty/ or finger arthroplasty/ or ankle arthroplasty/ or 
elbow arthroplasty/ or reverse shoulder arthroplasty/ or arthroplasty.mp. or arthroplasty/ or 
hip arthroplasty/ 
6. prosthesis infection/ or prosthetic joint infection.mp. 
7. 4 or 5 or 6 
8. 1 or 2 or 3 
9. 7 and 8 
10. leukocyte esterase.mp. 
11. leucocyte esterase.mp. 
12. 10 or 11 
13. 7 and 12 
14. 9 or 13 








We included all diagnostic studies that enrolled patients with true diagnostic 
uncertainty in the setting of PJI. Tests of interest were alpha-defensin assay and 
leucocyte esterase test scoring ++. Eligible studies had a reference standard for 
diagnosing prosthetic joint infection using the MSIS diagnostic criteria.  
 
Screening 
A total of 1,797 records were identified from searching the literature. The titles and 
abstracts were screened to identify potentially useful articles for inclusion in this 
systematic review. After initial screening, 30 full articles were assessed in detail for 
eligibility against criteria. A PRISMA flow diagram of the progression of studies through 
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n Additional records identified 
through other sources 
(n =  9 ) 
Records after duplicates removed 
(n = 1797) 
Records screened 
(n = 182 ) 
Records excluded 
(n =  152) 
Full-text articles assessed 
for eligibility 
(n =  30 ) 
Full-text articles 
excluded, with reasons 
(n =  17 ) 
Studies included in 
qualitative synthesis 
(n = 15 ) 
Studies included in 
quantitative synthesis 
(meta-analysis) 
(n =   11) 
    








Two of the authors (MCW and SKK) worked independently to extract the data using 
standardised forms. We extracted data on sensitivity, specificity, likelihood ratios, 
participants, joint involved, diagnostic test performed, cut off or range definitions of the 
tests, whether the cut-offs were derived with the use of receiver operator characteristic 
curves or predetermined by the study authors plus the nature and characteristics of 
the reference standard test. Quality assessment of each study was also performed 
using the QUADAS-2 tool (Whiting et al., 2011). 
 
Statistical analyses 
Overall sensitivity and specificity values for the diagnosis of PJI were pooled using the 
bivariate meta-analysis framework (Reitsma et al., 2005). The bivariate model is an 
improvement and extension of the traditional summary receiver operating 
characteristic (sROC) and jointly models sensitivity and specificity as the starting point 
of the analysis and hence may be more reliable for estimating diagnostic accuracy 
(Harbord et al., 2008; Kriston, Harter and Holzel, 2009). The sROC curve shows the 
consistency of results across studies and therefore whether there was a uniform 
Receiver Operator Curve (ROC) curve over all studies. The sROC curve data-points 
come from regression analysis of each study whilst the ROC curve data-points come 
from each threshold. In addition the area under the curve (AUC) depicts the accuracy 
of the test. The bivariate model employs a random effects approach, which takes into 
account the heterogeneity beyond chance between studies. In addition, it also 
accounts for between-study correlation between underlying sensitivity and specificity, 
caused by the use of different thresholds across studies. I2 was used to assess 
inconsistency between studies. An I2 statistic is the proportion of variability across 
studies due to patient population variability rather than to sampling error. I2 lies 
between 0% and 100%. A value of 0% indicates no observed heterogeneity, and 
values greater than 50% may be considered to indicate substantial heterogeneity. A 
priori hypotheses to explain potential heterogeneity included site of the prosthesis and 
diagnosis of infection occurring at different time points. 
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Pooled positive and negative likelihood ratios were calculated using the summary 
estimates of sensitivity and specificity. Potential sources of heterogeneity across 
studies could not be investigated because of the limited number of studies. In addition, 
tests for publication bias (e.g. Egger’s test) require at least 10 studies and lower 
heterogeneity to be useful and valid, therefore we were unable to investigate for 
publication bias. All analyses were conducted using Stata version 14 (Stata Corp, 
College Station, Texas) and the “midas” and “metandi” commands were used for all 
analyses. 
 
Sources of funding 
This article presents independent research funded by the National Institute for Health 
Research (NIHR) under its Programme Grants for Applied Research programme (RP-
PG-1210-12005). The views expressed in this article are those of the authors and not 





There were 10 articles reporting 11 evaluations (Deirmengian et al., 2014; Parvizi et 
al., 2011; Deirmengian et al., 2015; Tischler, Cavanaugh and Parvizi, 2014; Bingham 
et al., 2014; Deirmengian et al., 2014; Frangiamore et al., 2015; Colvin et al., 2015; 
Wetters et al., 2012; Deirmengian et al., 2015) contributing to our estimates of 
diagnostic accuracy for both tests. Six studies explored the diagnostic accuracy of 
alpha-defensin for PJI (Deirmengian et al., 2014; Deirmengian et al., 2015; Bingham 
et al., 2014; Deirmengian et al., 2014; Deirmengian et al., 2015), while the remaining 
5 studies explored the diagnostic accuracy of leucocyte esterase for PJI (Parvizi et al., 
2011; Deirmengian et al., 2015; Tischler, Cavanaugh and Parvizi, 2014; Colvin et al., 
2015; Wetters et al., 2012). Study characteristics are summarised in Table 33. All of 
the included studies were published within the last 5 years and originated from the 
USA. The largest contribution for the alpha-defensin test was from Deirmengian and 
colleagues (Deirmengian et al., 2014; Deirmengian et al., 2015; Deirmengian et al., 









Site Inclusion criteria 
Number of patients/ 
(patients with infection) 
Mean age in years 








Total hip or 
knee 
arthroplasty 
Pain at site of total hip or 
knee arthroplasty 
149 (37) 









Hip, knee or 
shoulder  
Samples from patients in 
the setting of a workup for 
prosthetic joint infection 
1937 (244) 







Hip or knee Failed or painful hip or 












Hip or knee Patients being evaluated 
for possible infection of a 
hip or knee arthroplasty 
95 (29) 







Shoulder All patients evaluated for a 
painful shoulder 
arthroplasty by 2 surgeons 
33 (11) 








Hip or knee Patients being evaluated 
for possible infection of a 
hip or knee arthroplasty  
46 (23) 







Hip or knee Patienty with revision total 
knee or hip arthroplasty for 
either aseptic failure or 
periprosthetic infection 
189 (52) 
63 years (range 21-90); 
48% male 








Unexplained painful hip, 
knee, elbow or ankle 
arthroplasty, routine 
implant testing, or clinical 
Chemstrip 10 UA or 
Chemstrip 7 urine test 
strips (Roche) 
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suspicion of periprosthetic 
infection or septic arthritis 
52 (19) 





Knee Patients undergoing 
revision knee arthroplasty 




64 years (range 28-89); 
44% male 




Hip or knee Patients with suspicion of 
periprosthetic joint 
infection after hip or knee 
arthroplasty 
158 (39) 
63.3 years (range 33-88); 
45.5% men 





Hip or knee Patients being evaluated 
for possible infection of a 
hip or knee arthroplasty  
38 (11) 
Mean age 65 years; 43% 
male (includes 8 patients 
with samples excluded due 
to blood interference) 





Five studies of alpha defensin included patients with hip or knee arthroplasty 
(Deirmengian et al., 2014; Deirmengian et al., 2015; Bingham et al., 2014; 
Deirmengian et al., 2014; Deirmengian et al., 2015) and 2 studies included patients 
with shoulder arthroplasty (Frangiamore et al., 2015; Deirmengian et al., 2015). When 
details were provided, the mean ages of patients in these studies ranged from 61-67 
years and 43-47% were male. In the studies of leucocyte esterase, all studies included 
patients with knee arthroplasty (Parvizi et al., 2011; Deirmengian et al., 2015; Tischler 
et al. 2014; Colvin et al., 2015; Wetters et al. 2012), four studies included patients with 
hip arthroplasty (Deirmengian et al., 2015; Tischler, Cavanaugh and Parvizi, 2014; 
Colvin et al., 2015; Wetters et al., 2012), and one study also included patients with 
elbow or ankle arthroplasty (Colvin et al., 2015). The mean ages of patients ranged 
from 63-69 years, and 43-48% were male. Only one study reported the time since the 
index arthroplasty, 42.7 months (range 7 days to 458 months) (Wetters et al., 2012). 
The total numbers of patients contributing to the meta-analyses of alpha-defensin and 
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In Table 34 the QUADAS-2 assessments for each study are reported. Using the 
QUADAS-2 tool had a mean score of 13.3 (range 12 to 14) where a maximum score 
is 14. This indicates that the studies used in this meta-analysis were of good quality. 
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Table 34. QUADAS-2 evaluation 
 
 
Study QUADAS score 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Total 
Alpha-defensin 
Bingham 2014 1 1 1 1 1 1 1 1 1 1 1 1 1 0 13 
Deirmengian 2014 1 1 1 1 1 1 1 1 1 1 1 1 1 1 14 
Deirmengian 2014 1 1 1 1 1 1 1 1 1 1 1 1 1 0 13 
Frangiamore 2015 1 1 1 1 1 1 1 1 1 1 1 1 1 1 14 
Deirmengian 2015 1 1 1 1 1 1 1 1 1 1 0 1 1 0 12 
Deirmengian 2015 1 1 1 1 1 1 1 1 1 0 1 1 1 0 12 
Leucocyte esterase 
Tischler 2014 1 1 1 1 1 1 1 1 1 1 1 1 1 1 14 
Wetters 2012 1 1 1 1 1 1 1 1 1 1 1 1 1 1 14 
Parvizi 2011 1 1 1 1 1 1 1 1 1 1 1 1 1 1 14 
Colvin 2015 1 0 1 1 1 1 1 1 1 1 1 1 0 0 11 
Deirmengian 2015 1 1 1 1 1 1 1 1 1 0 1 1 1 0 12 
 
 
QUADAS scores  
1. Was the spectrum of patients representative of the patients who will receive the test in 
practice?  
2. Were selection criteria clearly described? 
3. Is the reference standard likely to correctly classify the target condition? 
4. Is the time period between reference standard and index test short enough to be 
reasonably sure that the target condition did not change between the 2 tests?  
5. Did the whole sample or a random selection of the sample, receive verification using a 
reference standard of diagnosis? 
6. Did patients receive the same reference standard regardless of the index text result?  
7. Was the reference standard independent of the index test (i.e., the index test did not form 
part of the reference standard)?  
8. Was the execution of the index test described in sufficient detail to permit replication of 
the test? 
9. Was the execution of the reference standard described in sufficient detail to permit its 
replication? 
10. Were the index test results interpreted without knowledge of the results of the reference 
standard? 
11. Were the reference standard results interpreted without knowledge of the results of the 
index test? 
12. Were the same clinical data available when test results were interpreted as would be 
available when the test is used in practice? 
13. Were uninterpretable/intermediate test results reported?  





Diagnostic value of alpha-defensin for prosthetic joint infection 
The pooled diagnostic sensitivity and specificity of alpha-defensin for PJI were 1.00 
(95% CI: 0.82 to 1.00) and 0.96 (95% CI: 0.89 to 0.99) respectively (Figure 29). There 
was substantial heterogeneity between studies; I2 (95% CIs) for sensitivity and 
specificity values were 98.2 (95% CI: 97.5 to 98.9) and 98.8 (95% CI: 98.4 to 99.2) 
respectively. The pooled Positive Likelihood Ratio (PLR), Negative Likelihood Ratio 
(NLR), and diagnostic score were 27.0 (95% CI: 9.0 to 80.6), 0.00 (95% CI: 0.00 to 
0.22), and 8.94 (95% CI: 4.73 to 13.15) respectively. The AUC for alpha-defensin and 
PJI was 0.99 (95% CI: 0.98 to 1.00) (Figure 30).  
 















Figure 30. Summary receiver operating characteristic curves of Alpha Defensin in the 
diagnosis of prosthetic joint infection; HSROC = Hierarchical summary receiver-
operating characteristic curve for the diagnostic performance of Alpha Defensin; 
Summary point= The summary sensitivity and specificity; 95% confidence region = 
95% confidence region around the summary sensitivity and specificity; 95% predicted 
region=used to illustrate the extent of statistical heterogeneity (This is the region 
within which, assuming the model is correct, there is 95% confidence that the true 




Diagnostic value of leucocyte esterase for prosthetic joint infection 
The pooled diagnostic sensitivity and specificity of leucocyte esterase for PJI were 
0.81 (95% CI: 0.49 to 0.95) and 0.97 (95% CI: 0.82 to 0.99) respectively (Figure 31). 
There was substantial heterogeneity between studies, I2 (95% CIs) for sensitivity and 
specificity values were 94.6 (95% CI: 91.4 to 97.9) and 93.3 (95% CI: 89.0 to 97.6) 
respectively. The pooled PLR, NLR, and diagnostic score were 23.9 (95% CI: 3.8 to 
152.1), 0.19 (95% CI: 0.06 to 0.66), and 4.82 (95% CI: 2.27 to 7.36) respectively. The 
AUC for leucocyte esterase and PJI was 0.97 (95% CI: 0.95 to 0.98) (Figure 32).  
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Figure 31. Sensitivity and specificity of leucocyte esterase in the diagnosis of 







Figure 32. Summary receiver operating characteristic curves of leucocyte esterase in 
the diagnosis of prosthetic joint infection. HSROC = Hierarchical summary receiver-
operating characteristic curve for the diagnostic performance of Alpha Defensin 
Summary point = The summary sensitivity and specificity; 95% confidence region = 
95% confidence region around the summary sensitivity and specificity; 95% predicted 
region = used to illustrate the extent of statistical heterogeneity (This is the region 
within which, assuming the model is correct, there is 95% confidence that the true 






The prompt diagnosis of PJI remains a clinical challenge due to the diverse clinical 
presentations of patients suffering from this complication and the overlap of some of 
these features with other diagnoses and causes of failure of joint arthroplasty. The 
distinction between PJI and other causes of failure is important as the surgical 
management and chance of a successful outcome differs according to the mode of 
failure and thus the treatment strategy employed. 
 
This systematic review has shown that alpha-defensin is extremely sensitive and 
specific in identifying PJI and that leucocyte esterase is slightly less sensitive, but also 
extremely specific. Both are therefore good candidates for diagnostic biomarkers. 
Traditional tests to diagnose PJI are less effective. In a study examining diagnostic 
accuracy for inflammatory serological markers in PJI (Berbari et al., 2010) the pooled 
sensitivity and specificity for the erythrocyte sedimentation rate were 88% (95% CI: 
86% to 90%) and 70% (95% CI: 68% to 72%) respectively. The pooled sensitivity and 
specificity for C-reactive protein were 97% (95% CI: 93% to 99%) and specificity 91% 
(95% CI: 87% to 94%).  However, this study did not use the MSIS criteria as its gold 
standard. 
 
Several other synovial biomarkers have been investigated in relation to PJI. The 
synovial white blood cell count typically shows sensitivity of 84-93% and specificity of 
51-100% (Lenski and Scherer, 2015; Zmistowski et al., 2012; Bedair et al., 2011; Yi et 
al., 2014). The proportion of synovial white blood cells that are polymorphonuclear and 
thus concerned with fighting infection typically shows sensitivity of 81-93% and 
specificity of 69-83% (Lenski and Scherer, 2015; Zmistowski et al., 2012; Bedair et al., 
2011; Yi et al., 2014). While C-reactive protein in serum may have high sensitivity and 
poor specificity for PJI, measurement in synovial fluid shows sensitivity of 96-97% and 
specificity of 90-93% (Deirmengian et al., 2014; Omar et al., 2015). In one study 
included in our review, a broad range of synovial biomarkers were investigated and 
several in particular including neutrophil elastase, bactericidal/ permeability-increasing 
protein, neutrophil gelatinase-associated lipocalin and lactoferrin merit further study 
(Deirmengian et al., 2014).  
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The strengths and potential limitations of this analysis deserves mention. Our meta-
analysis is the first of its kind and it examined nearly 2,000 in studies that were 
performed to a very high standard. All studies included in the review used the MSIS 
criteria, thereby minimising classification bias by using a common and widely accepted 
reference standard (Parvizi et al., 2011). The studies in our meta-analysis mainly 
included patients with hip and knee arthroplasty though some studies included 
patients with shoulder, ankle and elbow arthroplasty. The age ranges and proportions 
of male patients were similar between studies but information on the time since 
arthroplasty was highly limited. This may be important as some biomarkers may have 
different diagnostic accuracy in the early postoperative period (Yi et al., 2014) Future 
studies should aim to assess differences in diagnostic accuracy relating to potential 
sources of heterogeneity including arthroplasty site, time since index surgery and 
patient characteristics. 
 
A number of the studies of alpha-defensin came from the same research group, which 
could hamper the generalisation of our findings; however, these findings were 
replicated by other groups. The limited number of studies precluded the ability to 
explore for publication bias, an important issue in diagnostic accuracy studies where 
results of new tests with poor sensitivity and specificity may remain unpublished. None 
of the studies reported on blinding, which potentially may have introduced selection 
bias. Further large-scale, independent and rigorous studies are warranted to evaluate 
the use of these synovial markers as diagnostic tools for PJI.  
 
Alpha-defensin is substantially more expensive (£500 GBP per test) than leucocyte 
esterase (£0.11 GBP per test) though the latter may require the initial capital cost of a 
centrifuge and costs associated with its use. However, alpha-defensin may be more 
specific in diagnosing PJI and both tests may have clinical roles as biomarkers.  We 
recommend that further comparisons are made between these 2 promising 







Chapter 8 is a formal systematic review and meta-analysis of the diagnostic properties 
of alpha-defensin and leucocyte esterase. A critism of this study not mentioned in the 
Discussion is the large confidence intervals for both sensitivity and specificity of 
leucoctye esterase shown in the summary receiver operating characteristic curve 
Figure 32. Since the publication of Chapter 8 the MSIS diagnostic criteria of PJI have 
evolved and further research into synovial biomarkers has been published and 
therefore at the time of publication both the diagnosis and management of PJI were 
not standardised worldwide. Since publication of Chapter 8 further clinical research 
has focused on synovial biomarkers to advance the potential complex task of PJI 
diagnosis.  
 
Up-to-date literature search 
To update the context of the findings of Chapter 8 the following databases were 
searched from 2016 to 8.4.2020 using the programme Papers: ACM, ADS, arXiv, 
CERN DS, CrossRef DOI, DBLP, Espacenet, Google Scholar, Gutenberg, Highwire, 
IEEExplore, Inspire, JSTOR, OAIster, Pubget, PubMed, ScienceDirect, Scopus and 
Web of Science. Search terms related to: Alpha defensin OR Leucocyte esterase AND 
Infection.  
 
237 references were identified of which 11 were collected as potentially relevant. 
Those 23 published articles listed in PubMed that cited Chapter 8 were also examined. 
Journals with impact factors <2 were excluded. Any correspondence relating to the 
article described in this chapter was reviewed.  
 
Diagnosis of PJI 
The Musculoskeletal Infection Society (MSIS) published the original diagnostic 
approach consisting of 2 major and 6 minor criteria (Parvizi et al., 2011). The diagnosis 
of PJI required the presence of either one of the major or ³4 minor criteria. The 
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Internation Consensus Group on Periprosthetic Joint Infection meeting in Philidelphia 
modified the MSIS criteria in 2013 by removing purulence of synovial fluid as a minor 
criterion and added the leucocyte esterase test as a potential option to assess synovial 
White Blood Cell count. Different thresholds for the minor criteria were clarified and 
PJI was determined as present if >1 major or ³3 minor criteria are present (Parvizi, 
Gehrke and Chen, 2013). The MSIS diagnostic criteria were then amended again in 
2018 to improve the sensitivity and specificity to 97.7% (from previously 79.3%) and 
99.5% (from previously 86.9%) as follows: 2 positive cultures or the presence of a 
sinus tract were considered major criteria; a serum CRP elevated >1mg/dL, D-dimer 
>860ng/mL, ESR >30mm/h were awarded 2, 2 and 1 points respectively. An elevated 
synovial WBC>3000 cells/µL, alpha-defensin (signal to cutoff ratio >1), leucocyte 
esterase (++) PMN percentage >80% and synovial CRP >6.9mg/L received 3, 3, 2 
and 1 points respectively. An aggregate score ³6 indicates PJI whilst a score 2 to 5 
requires the inclusion of intraoperative findings to confirm or refute the diagnosis 
(Parvizi et al., 2018). Therefore, the latest consensus defining criteria of PJI now 
includes both alpha-defensin and leucocyte esterase.  
 
Alpha-defeinsin immune assay 
The ELISA for alpha-defensin is performed in the laboratory. This immunoassay 
method is more time consuming that the lateral flow “Synovasure” test. The findings 
of Chapter 8 showed high pooled diagnostic sensitivity (100%) and specificity (96%) 
of the immunoassay. In another systematic review by Li et al., 2017 these results were 
reaffirmed. The leucocyte esterase test and alpha-defensin lateral flow tests are 
influenced by the sample quality in this review. Bonanzinga et al., 2017 performed a 
prospective study and demonstrated that the alpha-defensin immunoassay had a 
sensitivity and specificity of 97%; negative predictive value 99% and positive predictive 
value 88%. 
 
Alpha-defensin lateral flow test 
Lateral flow devices can be used to test for synovial levels of alpha-defensin 
comparatively swiftly both intraoperatively and at the bedside. Gehrke et al., 2018 
assessed the accuracy of the Synovasure lateral flow test to the MSIS criteria. In this 
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study of 195 joint aspirations the overall sensitivity was 92.1% and specificity 100%. 
The positive predictive value was 100% and negative predictive value 95.2%. Despite 
these results the lateral flow test is not as accurate as the laboratory immunoassay 
(Suen et al., 2018) yet its high specificity and relatively rapid response time makes it 
useful for “ruling in” infection for example intraoperatively which may well avoid 
unnecessary treatments.  The lateral flow test has therefore been suggested as a 
confirmatory rather than a screening test (Renz et al., 2018). 
 
Synovial biomarkers such as alpha-defensin and leucocyte esterase should therefore 
be used as adjuncts to synovial white cell count and microbiological culture. Both form 
part of the latest MSIS diagnostic recommendations. Ultimately the increased 
commercial costs associated with such biomarkers must be balanced by the potential 
savings in duration of hospital stay, shorter duration of antibiotic use and the 
associated positive effect regarding bacterial resistance rates. Further research will 






















Synopsis/implications of the results from this thesis 
 
This thesis aimed to focus on the pertinent issues of femoral stem fixation, optimal 
bearing surface and reducing the risk of infection.  
 
Section 1 Stem fixation 
With regards to stem fixation I had identified that the optimal mode of stem fixation for 
a particular patient in New Zealand within the clinical literature was unknown. I 
proposed to address this in Chapter 1 and examined which fixation of femoral stem 
was the most reliable for a particular patient undergoing primary THR comparing 
results from the national joint registries with the NZJR. The answer to the first chapter’s 
research question, interpreted in the context of recent results and trends, was that 
cemented stem fixation is preferable in terms of all-cause revision rates – the singular 
most important outcome of interest for an individual patient. This type of stem can be 
used in any type of patient assuming the surgeon is well trained in their technique 
(Keeling et al., 2020) although uncemented stems also have excellent results in 
younger patients (Tyrpenou et al., 2020). The results of Chapter 1 remain valid 
therefore in the context of more recent literature. In fact, the practice of choosing 
cemented stems has, in recent research, set the benchmark for all other types of stem 
fixation (Deere et al., 2019). The use of a non-inferiority trial permits an implant 
performance to be compared to the accepted range of performance compared to a 
reference implant. The type of benchmarking study performed by Deere et al., 2019 
for THR using UK NJR data using the NZJR would be valuable. This type of analysis 
of the NZJR would also provide useful information to guide patients, surgeons and 
healthcare funders. This is the topic of current further research I am undertaking. 
 
Moreover, the influence of femoral offset on THR survival and whether this differed 
between cemented and uncemented stem fixation was unknown within the clinical 
literature. Chapter 2 therefore examined the NZJR for the effect of femoral offset on 
THR survivorship or reasons for revision. Moreover, the effect of femoral component 
offset on these outcomes of interest have not been examined with regards different 
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types of fixation. The answer to the research question investigated  in the second 
chapter was that there was a greater association with stem offset and outcomes in 
cemented versus uncemented stems. This implies that precise attention to surgical 
planning and templating may be of greater importance when using cemented stems. 
Whilst the methodology precluded modelling of offset as a continuous variable and 
has the potential weaknesses of analysing observational data the findings convey an 
important principle. This study has not been repeated elsewhere therefore clinicians 
should consider these results carefully in assisting decision making. Future research 
that applies the methodology of Chapter 2 to other National Joint Registries would be 
of interest. In addition, it would be interesting to record whether the THRs in question 
were preoperatively templated and to compare templated and untemplated THR 
results. 
 
The literature concerning the influence of cemented stem length on THR survival 
remained inconclusive. Therefore Chapter 3 examined the outcomes of short 
cemented Exeter stems in the NZJR compared to standard length cemented Exeter 
stems.  This chapter showed that the standard Exeter stem is a positive outlier for 
survivorship compared to the overall mean revision rate 0.72/100 cy (95%CI 0.71 to 
0.74) compared to 0.56/100 cy (95%CI 0.53 to 0.59). The length of a cemented Exeter 
stem within the typical offsets of 37.5mm, 44mm and 50mm from the results of Chapter 
3 is perhaps not as critical with short stems displaying similar results to standard length 
Exeter stems. The lower offset short stem group had poorer results which is most likely 
attributable to confounding from a higher proportion of patients with OA secondary to 
hip dysplasia in this group. This confounding is one of the inherent weaknesses of an 
observational study. Whilst the NZJR records Oxford scores these are not recorded 
preoperatively, and this is a further weakness of the study. There are currently no other 
published articles on survivorship of the Exeter short cemented stem with these 
offsets. Future validation of our NZJR findings in other National Joint Registries would 
be of interest and support clinical application of our research findings.  
 
The safety of performing bilateral THR under a single-anaesthetic using cemented 
stems was contentious. Chapter 4 therefore examined the safety of single-anaesthetic 
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bilateral THR with cemented stems in Exeter. The answer to the research question 
addressed in Chapter 4 was that during 4 decades of performing SABTHR using 
cemented stems in Exeter this practise was safe in terms of mortality and compared 
favourably with the published literature. However I would caution the interpretation of 
our results which were achieved with strict patient selection (i.e. ASA grade 1 or 2) 
and adherence to a rigorous perioperative protocol. Exeter is an academic centre of 
excellence for cemented THR. The technical aspects of canal irrigation/evacuation 
and meticulous cementing technique were followed for all patients in our study. The 
rigour achieved in Exeter and therefore the results of Chapter 4 may limit the wider 
application of our results. This study remains the largest published series of SABTHR 
with cemented stems and clinicians may consider applying the protocols and 
techniques described when performing cemented SABTHR. Whether SABTHR using 
uncemented stems can be performed in a greater variety of patients with higher 
ASA/comorbidities than this series would be of great interest for further research. 
 
Section 2 Bearing surfaces 
 
I had identified that the optimum bearing surface combination for a patient having had 
THR in New Zealand remained unknown. Therefore Chapter 5 examined the NZJR to 
detetermine which bearing surface combination had the best all-cause revision rate. 
CoPx had the lowest all-cause revision rate for THR in unadjusted analyses. In 
adjusted analyses CoC and CoPx were the best performers. When examining 32mm 
and 36mm femoral head sizes in THR for the previous decade CoPx was superior. 
The findings of this chapter support therefore the use of 32mm ceramic femoral heads 
in combination with a HXLPE acetabular component as the bearing surface 
combination least likely to require revision in New Zealand. These results compliment 
those of a recent study (Metcalfe et al., 2018). This finding should be interpreted in the 
context of cost-effectiveness as shown by Fawsitt et al., 2019. A metal-on-
polyethylene cemented THR using a femoral head < 36mm in diameter was the most 
cost-effective option for men and women older than 65 years of age. In accordance 
with this thesis, which therefore substantiates the validity of the results, a £ 36mm 
diameter ceramic femoral head in combination with cemented fixation THR was the 
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most cost-effective choice for men and women under the age of 65.  There was no 
evidence to support the use of uncemented, hybrid or reverse hybrid THR in any 
patient group on the basis of cost-effectiveness. Clinicians may consider choosing 
CoPx in younger, more active patients undergoing THR. Future research may 
examine how different generations of HXLPE perform to refine such surgeon choices. 
 
Given the findings in the previous chapter the use of new Vitamin E HXLPE as a 
superior alternative to HXLPE was of interest. Chapter 6 therefore examined the 
performance of Vitamin E HXLPE compared to previous generations of HXLPE and 
also UMWPE. At this relatively early stage the systematic review and meta-analysis 
did not show a clinical superiority in terms of revision rate however longer-term results 
may elucidate this. The in vivo analysis of wear for Vitamin E HXLPE is promising on 
RSA studies. This research cannot therefore provide an evidence-based direction for 
clinical practise. Further examination into the longterm performance of Vitamin E 
HXLPE compared to HXLPE is warranted. An interesting potentially advantageous 
property of Vitamin E HXLPE is the reduced bacterial adhesion noted in several 
studies which may hinder the formation of biofilms which are an important factor in 
periprosthetic joint infection (Banche et al., 2014). This is an interesting area for further 
research. 
 
Section 3 Periprosthetic infection 
 
Total hip replacement is a successful operation for addressing the pain and limited 
function associated with end-stage degenerative conditions of the hip as well as 
restoring mobility to selected patients who sustain a hip fracture. Despite its success, 
problems can occur and one of the most devastating is prosthetic joint infection (PJI). 
Patients who experience this complication and their surgeons face a difficult and 
protracted course of treatment and prolonged recovery periods. The patient’s 
perspective of PJI has been characterised by recent qualitative research and PJI 
simply ruins patients’ lives (Moore et al, 2015). 
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The prevalence of revision THR for PJI after primary THR in a recent UK NJR study 
was 0.4/100 procedures and during the 10 years observed in this study (2003 to 2014) 
the burden of PJI requiring revision rose 2.6 fold (Lenguerrand et al, 2017).  In a recent 
prospective observational study the risk factors for PJI were male sex (rate ratio (RR) 
1.7, 95%CI 1.6-1.8), elevated BMI (≥30 c.f. <25 RR 1.9, 95%CI 1.7-2.2), diabetes (RR 
1.4, 95%CI 1.2-1.5), previous septic arthritis (RR 6.7, 95%CI 4.2-9.8), hip fracture (RR 
1.8, 95%CI 1.4-2.3) and use of the lateral surgical approach compared to posterior 
approach (RR 1.3, 95%CI 1.2-1.4) (Lenguerrand et al., 2018). Ceramic containing 
bearings had a lower risk of revision for PJI than metal containing bearings and these 
effects were generally seen from 3 months onwards. The risk of revision for prosthetic 
joint infection following primary hip replacement is affected by multiple factors and is 
mainly driven by patient and surgical factors. The risk of developing an infection after 
hip replacement varies with the time period of follow up. The modifiable factors 
identified should be considered by clinicians when preparing patients for hip 
replacement surgery. It is equally important for them to consider the non-modifiable 
factors and the factors that exhibit time-specific effects on the risk of prosthetic joint 
infection, to counsel patients appropriately preoperatively (Lenguerrand et al., 2018).   
 
The influence of the operating theatre environment factors of laminar flow and space 
suits was contentious in the literature. Chapter 7 therefore explored if deep infection 
could be prevented with regards the operative environment.  As the NZJR is unique in 
that it records information on the use of laminar flow and space suits in the theatre 
environment, this thesis explored the association with these widely adopted practices 
and revision for early deep infection. The results of this chapter showed that laminar 
flow and space suits were in fact associated with higher infection rates in THR which 
contrast the findings of the study of Lidwell et al. (Lidwell et al., 1987). Laminar flow 
theatre environments do not convey the reduction in deep infection rates that they 
were purported to do so, and these findings are supported by other more recent 
studies in the literature. This thesis also focused on the use of space suits and from 
its results and additional research the differences between the classic body exhaust 
suit adopted by Charnley and the modern space suits have been elucidated (Young 
et al., 2013; Vijaysegaran et al., 2018). The findings of this chapter have been 
validated in every subsequent NZJR report. With regards to the clinical application of 
 281 
our research the WHO has, cogent with our research findings, recommended against 
the cost of installing laminar flow theatres (Pedneault et al., 2020) and there remains 
little evidence to support modern space suits (Goswami et al., 2020). Our study is 
potentially affected by confounding and we did not perform regression analysis. 
Further research could be directed towards understanding the differences in theatre 
ventilation systems combined with the physical dimensions of the operating theatre 
and personel within. Furthermore a New Zealand study that replicates the work of Din 
et al., 2020 examining trauma patients would be interesting. 
 
The use of synovial biomarkers as potential diagnostic tools for PJI was unproven in 
the literature yet these were being adopted into clinical practise with alacrity. There 
was therefore a lack of evidence synthesis on the diagnostic accuracy of these 
biomarkers. Chapter 8 therefore examined the diagnostic accuracy of the 2 most 
promising synovial biomarker tests namely the alpha-defensin immunoassay and the 
leucocyte esterate calorimic strip test. Both were found to have excellent sensitivity 
and specificity. Leucocyte esterase is considerably cheaper yet remains vulnerable to 
blood contamination. Subsequent studies have shown the alpha-defensin 
immunoassay to be superior to the alpha-defensin lateral flow test (Suen et al., 2018). 
The application of the test results from these biomarker tests have evolved and the 
most recent MSIS criteria now include their results (Parvizi et al., 2018) in the decision-
making algorithm. A pragmatic approach may be to use the leucocyte esterase test 
first and the alpha-defensin test as a second line investigation.  
 
Strengths and Weaknesses of the Studies Presented  
Whilst prospective randomised-controlled trials remain the gold-standard evidence 
judicious use of large data sets is warranted from a practical perspective. The 
methodology used in this thesis has centred around the results of the New Zealand 
Joint Registry. This was the only national joint registry to record patient reported 
functional scores from its inception and at 96% has a high data capture rate. The NZJR 
fortuitously captured data on laminar flow and space suits which permitted the 
association of these theatre environment choices to be examined with respect to deep 
infection rates. The analysis of large datasets reflects the practice of an entire nation 
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and has the potential, despite adjusting for various covariates, for the introduction of 
confounders which can bias the results. The ability to interpret the analyses from a 
causal perspective is therefore compromised. In the study of the Exeter short stems 
for example, the impact of the underlying diagnosis i.e. the primary indication for THR 
surgery, is difficult to control for.  
 
The use of formal systematic review and, where possible statistical meta-analysis, 
permits a structured unbiased review of the available literature (Berstock and 
Whitehouse, 2019). The first systematic review was in essence performed by James 
Lind in 1753 who examined scurvy afflicting the Royal Navy. The systematic approach 
to minimising biases and random errors in a strict step-wise process with clearly stated 
a priori objectives allows a measured synthesis of the available evidence. The 
systematic review on alpha-defensin and leucocyte esterase was the first to use 
summary receiver operator curves to examine diagnostic tests in this way. As the 
medical literature expands at a high rate the aggregation and appraisal of the available 
evidence so that it is both intelligible and useful to clinicians. A systematic review may 





The continued debate around issues such as fixation and bearing surfaces generates 
tension and tremendous tribal rivalries. A professional, candid and openly audited 
approach with scientifically-based willingness to change personal practice, are the 
appropriate ways to justify surgical advances. In summary the results of this thesis 
endorse the practise of precise execution of a surgical plan with a proper cemented 
stem that results in the correct biomechanics. An evidence-based rationale in the 
context of the recent literature is provided for type of stem, cup and bearing surface, 
safe practise concerning bilateral OA and raised awareness of prevention of 
periprosthetic infection. At a synthesis level this thesis and the adjoining commentaries 
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